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Abstract 
The pattern recognition receptor Dscam is a key molecule mediating innate immunity 
and wiring of the nervous system in Drosophila. Intriguingly, massive molecular 
diversity is generated by alternative splicing in three exon clusters of Dscam. 
Upon pathogen exposure in Anopheles gambiae, the AgDscam splicing pattern 
changes to express isoforms that bind pathogens with higher affinity. In order to test 
the generality of Dscam splicing regulation in Drosophila, similar experiments 
involving microbial exposure were carried out, which also showed changes in Dscam 
splicing pattern.  Mutants in RNA regulatory pathways and in the RNA binding protein 
ELAV were analyzed due to their similar mutant phenotypes in nervous system 
development as Dscam. In each of these mutants, alterations of Dscam alternative 
splicing in a cluster specific manner were observed, eluding a unique mechanism for 
any of the analyzed pathways. In ELAV mutants, one of the three clusters of 
alternatively spliced exons is dramatically mis-regulated.  
Since no ELAV binding site is present in this cluster, genes downstream of ELAV 
could mediate mis-regulation of alternative splicing. From the analysis of mutants in 
ELAV differentially regulated genes it was concluded that Dscam alternative splicing 
is most prominently affected by chromatin remodeling factors, along with RNA 
binding proteins, DNA binding proteins and small-RNA processing factors. A 
heterologous transgene for expression of Dscam pre-mRNA in Drosophila was also 
developed to characterize the role of the chromatin state in alternative splicing. 
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CHAPTER 1 
INTRODUCTION 
 
Sections 1.4 and 1.5 have been published as ‘Mechanisms of Drosophila 
Dscam mutually exclusive splicing regulation’ in the Biochemical Society 
Transactions with myself as first author and Dr. Matthias Soller as 
corresponding author. Both of us planned the topics and the layout of the 
manuscript. I wrote the manuscript and drew the figures. Dr. Soller proofread 
the manuscript prior to submission. For the full article please see (Hemani and 
Soller, 2012). 
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1.1. Pre-mRNA processing 
Eukaryotic genes are characterized by the presence of protein-coding sequences 
called exons and non-coding sequences called introns. However, not all exons are 
located in the coding regions. Transcription of a gene by RNA polymerase II (RNA 
pol II) results in the formation of a single stranded precursor messenger RNA (pre-
mRNA) molecule, which undergoes many complex modifications in the nucleus to 
form a mature messenger RNA (mRNA). The pre-mRNA processing reactions 
include capping, editing, splicing and 3’ end processing. The resulting mRNA is then 
transported from the nucleus to the cytoplasm where it serves as a template for 
protein synthesis via translation (Soller, 2006).  
The first pre-mRNA processing reaction is capping which involves the addition of an 
N7-methyl GMP at the 5’ end of the pre-mRNA by an atypical 5’-5’ triphosphate 
linkage (McCracken et al., 1997). Nucleotides adjacent to the 5’ cap are also 
methylated to various degrees at the 2’-hydroxyl positions of their ribose sugars 
(Bisaillon and Lemay, 1997). Capping is important for protecting the mRNA from 5’-3’ 
exonucleases, enhancing splicing of the first intron and 3’ end processing, and for 
translation initiation (Flaherty et al., 1997; Fortes et al., 2000; Izaurralde et al., 1994; 
Lewis et al., 1996).  
RNA editing is a process of altering the sequence of nucleotides within an RNA 
transcript of a gene by either modification or insertion/deletion of bases, to a 
sequence, which does not correspond to the sequence of that gene. Editing by 
modification of bases is largely achieved by deamination of adenosine to inosine (A 
to I) or cytidine to uridine (C to U) by specialized deaminases. Editing by insertion 
involves a guide RNA, which is partially complementary to the pre-mRNA transcript; 
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interrupted by additional adenosine residues. The guide RNA acts as a template for 
the synthesis of an edited transcript with additional uridines as observed in the 
mitochondria of trypanosomes. Only a few transcripts are edited in most eukaryotes 
(Smith et al., 1997).  
Splicing is a process whereby introns, interspaced between the exons, are removed 
by the spliceosome, a multimeric RNA-protein complex, to produce an mRNA 
containing contiguous exons (Black, 2003). The mechanism of splicing and its 
regulation is explained in more detail from 1.2. to 1.4.   
The final step of pre-mRNA processing involves cleavage and polyadenylation at the 
3’ end. Conserved sequence elements, which determine 3’ processing comprise an 
AAUAAA hexamer, a CA dinucleotide located upstream of the cleavage site and a U- 
or GU-rich downstream sequence element (DSE).  These sequence elements are 
identified by two multiprotein complexes; cleavage and polyadenylation specificity 
factor (CPSF) and cleavage stimulating factor (CstF) that trigger cleavage by 
cleavage factors I and II (CFI and II) and polyadenylation by poly A polymerase 
(PAP) together with CPSF (~200 adenosines). All RNA pol II transcripts have a poly-
A tail except histone RNAs (Proudfoot, 2004; Venkataraman et al., 2005; Wahle and 
Ruegsegger, 1999; Zhao et al., 1999). 
 
1.2. Pre-mRNA splicing 
Pre-mRNA splicing comprises a series of reactions catalyzed by a multimeric RNA-
protein complex called the spliceosome (Figure 1). The spliceosome is composed of  
small nuclear ribonucleoprotein (snRNP) subunits, which consist of five core 
structural RNAs namely U1, U2, U4, U5 and U6 and over 150 accessory proteins 
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Figure 1: Spliceosome assembly and pre-mRNA splicing. Stepwise recruitment of snRNPs (U1, U2, 
U4, U5 and U6), branch point binding protein (BBP/SF1) and U2 auxiliary factor (U2AF) on an intron 
results in spliceosome assembly which catalyses the excision of the intron and joining of the flanking 
exons. Exons flanking the excised intron are shown as blue boxes. Adapted from (Zaharieva et al., 
2012). 
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 (Jurica and Moore, 2003; Luhrmann and Stark, 2009). The orderly binding and 
release of these U snRNPs and auxiliary proteins results in excision of introns and 
joining of adjacent exons (Staley and Guthrie, 1998). Specific sequence elements in 
the pre-mRNA at the exon-intron junctions called splice sites (ss) are recognized by 
particular snRNPs and splicing factors. The 5’ ss (splice donor site) and 3’ ss (splice 
acceptor site) consensus sequences are defined by AG-guragu and yag-N (- 
designates the ss), respectively, however, only the first G of the 5’ ss and the AG of 
the 3’ ss are strictly conserved (Hertel, 2008; Smith et al., 1989). Additional sequence 
elements that mediate RNA splicing are the polypyrimidine tract ((Py)n) immediately 
before the 3’ss and a branch point (ynyurac), containing a conserved adenine 
nucleotide, located upstream of the (Py)n (Black, 2003).  
The splicing reaction commences with the recruitment of U1 snRNP to the 5’ ss, 
followed by the attachment of the branch point binding protein (BBP/SF1) to the 
branch point sequence to form the E complex. U2 auxiliary factor (U2AF), a 
heterodimeric splicing factor, binds to both the (Py)n via its larger subunit (65-kDa) 
and the 3’ ss via its smaller subunit (35-kDa). This binding triggers the recruitment of 
U2 snRNP, which binds to the branch point after the release of BBP/SF1, to form the 
A complex. The U4/U6.U5 heterotrimeric complex binds to the A complex to form the 
B complex (Soller, 2006).  
At this point, a conformational rearrangement occurs within the B complex which 
results in the release of U1 and U4 snRNPs to eventually form the catalytic C 
complex. This complex catalyzes the removal of the intervening intron and joining of 
the adjacent exons via two transesterification steps. The first transesterification 
reaction occurs with the cleavage of the 5’ end of the intron from the proximal exon 
 6 
and its consequent ligation to the 2’ hydroxyl group of the adenine in the branch point 
to form an unusual 2’-5’ phosphodiester bond. At this point, there are two 
intermediates – the detached 5’ exon and the intron-3’ exon in the form of a lariat. 
The second transesterification reaction occurs with the nucleophilic attack on the 
phosphate at the 3’ end of the intron by the 3’ hydroxyl group of the separated exon. 
This results in the release of the intron, in the form of a lariat, and ligation of the two 
exons. The U2, U5 and U6 snRNPs release from the lariat, which is eventually 
linearized on hydrolysis of the 2’-5’ phosphodiester bond by the lariat debranching 
enzyme (Black, 2003; Soller, 2006) (Figure 2). This mechanism underlies the 
function of the major class of spliceosomes, which removes introns flanked by 
conserved elements, ‘gu’ at the 5’ end and ‘ag’ at the 3’ end (Patel and Steitz, 2003).  
There is however, a minor class of spliceosome, which is involved in removal of 
introns with ‘au’ at the 5’ end and ‘ac’ at the 3’ end. Apart from recognizing different 
splicing signals, the minor spliceosome has different yet functionally equivalent 
snRNPs for U1, U2, U4 and U6, which are respectively called U11, U12, U4atac and 
U6atac (Patel and Steitz, 2003).  
 
1.3. Alternative splicing 
Alternative splicing is a process by which exons in the same pre-mRNA are 
differentially spliced to produce more than one variety of mature mRNA generating 
different protein isoforms from the same gene (Soller, 2006). Humans are estimated 
to have 22,000 genes, only a fraction more than the 20,000 genes postulated for the 
simple nematode, Caenorhabditis elegans, whereas grapevine (Vitis vinifera) has  
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Figure 2: Transesterification reactions involved in pre-mRNA splicing. 
The catalytic C complex performs two transesterification reactions to 
result in efficient splicing of introns and subsequent ligation of flanking 
exons. The first transesterification step results in two reaction 
intermediates: the upstream exon and an intron/downstream exon 
fragment in a lariat conformation. The second transesterification step 
joins the two exons and excises the intron lariat. Exons flanking the 
excised intron are shown as blue boxes. Adapted from (Black, 2003). 
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 ~30,000 genes suggesting that gene number alone does not entirely define 
organismal complexity (Claverie, 2001; Zaharieva et al., 2012).  
The variability in splicing pattern via alternative splicing is a major mechanism to 
generate molecular diversity (transcriptomic and proteomic) and organismal 
complexity from the limited number of genes present in higher eukaryotes. 
Alternative splicing occurs in ~25% of C. elegans genes, ~60% of Drosophila 
melanogaster genes and ~95% of human genes, which accounts for the disparity 
between the estimated 22,000 genes in the human genome and the proposed 
100,000 proteins synthesized from them. Thus, organisms with more cell and tissue 
type complexity exhibit more alternative splicing (McManus and Graveley, 2011).  
 
1.3.1. Modes of alternative splicing 
Alternative splicing events occur in a number of different ways (Keren et al., 2010): 
 Use of cassette exons: A cassette exon can either be included or excluded in 
the final mRNA transcript (Figure 3A). When the exon is excised from the pre-mRNA, 
the splicing event is termed exon skipping which constitutes nearly 40% of all 
alternative splicing events in higher eukaryotes. 
 Alternative 3’ ss selection: Using an alternative splice acceptor site changes 
the 5’ end of the downstream exon (Figure 3B). Alternative 3’ ss selection accounts 
for 18.4% of alternative splicing events in higher eukaryotes. 
 Alternative 5’ ss selection: Using an alternative splice donor site changes the 
3’ end of the upstream exon (Figure 3C). Alternative 5’ ss selection accounts for 
7.9% of all alternative splicing events in higher eukaryotes. 
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Figure 3: Modes of alternative splicing. (A) A cassette exon can either be included in or be 
excised from an mRNA. (B and C) Alternative 3’ ss or 5’ ss selection alters the 5’ or 3’ end of 
the downstream or upstream exon, respectively. (D) Intron retention can either result in 
exclusion or inclusion of an intron in the mRNA. (E) Mutually exclusive splicing of a group of 
exons allows the splicing of only one exon at a time. (F) Alternative poly A sites alter the 3’ 
most exons in an mRNA transcript. Constitutive exons are shown as blue boxes and 
alternative exons as pink or yellow boxes. Solid lines represent splicing options. Adapted from 
(Keren et al., 2010). 
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 Intron retention: The intron can either be excluded or can be retained in the 
mRNA transcript (Figure 3D). Intron retention is the rarest form of alternative splicing 
in vertebrates and invertebrates constituting less than 5% of known alternative 
splicing events but is the most preferred mode of alternative splicing in plants, fungi 
and protozoa. 
 Mutually exclusive splicing: Two or more cassette exons are spliced in a 
mutually exclusive manner such that only one exon will be included from the whole 
variable cluster (Figure 3E). 
 Alternative terminal exons: Frequently, genes have alternative terminal exons, 
which is a different form of mutually exclusive exon usage. Here, regulation can 
occur at the level of splicing, 3’ end processing or both. Use of alternative 3’ ss 
and/or alternative polyadenylation sites result in a switch in the 3’ most exon of the 
mRNA transcript (Figure 3F).  
 
1.3.2. Regulation of alternative splicing 
Recognition of an intron by the spliceosomal components and their consequent 
assembly around its ss determines the splicing of that intron. These reactions are 
under the control of combinatorial interactions between cis-acting elements and 
trans-acting factors. Disruption of these interactions affects alternative splicing, which 
has been associated with many human disease conditions such as cancer and 
neurodegeneration. Hence, developing a better understanding of mechanisms which 
regulate alternative splicing might help rectify erroneous splicing, potentially leading 
to novel molecular therapies (Garcia-Blanco et al., 2004; House and Lynch, 2008; 
Zaharieva et al., 2012). 
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1.3.2.1. Splice site strength regulates alternative splicing 
The strength of 5’ and 3’ ss is proportional to the degree of complementarity with U1 
small nuclear RNA (snRNA) and the extent of polypyrimidine tract, respectively. 
Accordingly, an intron having stronger ss is removed more readily than an intron with 
weaker ss. Conversely, an alternative cassette exon flanked by stronger ss is 
included more frequently than an adjacent exon flanked by weaker ss (Hertel, 2008). 
 
1.3.2.2. Splicing regulatory elements and RNA binding proteins regulate 
alternative splicing 
Auxiliary sequences called splicing regulatory elements (SREs) regulate recognition 
and consequent splicing of nearby ss (Voelker et al., 2012). These cis-acting 
elements occur within both exonic and intronic regions and bind directly or indirectly 
to trans-acting RNA binding proteins (RBPs) that function as splicing activators or 
repressors (House and Lynch, 2008). 
SREs are divided into four categories based on location and function: exonic splicing 
enhancers (ESEs), intronic splicing enhancers (ISEs), exonic splicing silencers 
(ESSs) and intronic splicing silencers (ISSs). ESEs characteristically bind members 
of the serine/arginine-rich (SR) family of splicing factors and promote spliceosome 
assembly and exon inclusion (Garcia-Blanco et al., 2004). Sex-specific inclusion of 
Drosophila doublesex (dsx) exon 4 is mediated by the presence of an ESE in the 
exon, which binds RBP1 (SR protein) and transformer (Tra, an RNA binding protein), 
amongst other proteins, promoting spliceosome assembly and exon inclusion in 
females (Demir and Dickson, 2005; Manoli et al., 2005; Usui-Aoki et al., 2000). 
ESSs, however, typically bind heterogeneous nuclear ribonucleoproteins (hnRNPs) 
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and block spliceosome assembly and suppress exon inclusion (Garcia-Blanco et al., 
2004). Variable exon 4 of the human CD45 gene contains an ESS, which binds to 
hnRNP L and results in exon skipping (Rothrock et al., 2005). SR proteins (splicing 
activators) and hnRNPs (splicing repressors) function antagonistically but exist in a 
balance and a change in concentration and/or activity of one factor affects the 
splicing outcome (Long and Caceres, 2009). SR proteins and hnRNPs are 
functionally flexible and in some cases are also associated with exon skipping and 
inclusion, respectively (Han et al., 2011; Hofmann and Wirth, 2002; Konig et al., 
2011). ISEs and ISSs function similarly to their exonic counterparts and are known to 
regulate splicing of exon 8 splicing in human fibroblast growth factor receptor 2 
(FGFR2) pre-mRNA (Black, 2003; Wagner and Garcia-Blanco, 2002). 
 
1.3.2.3. Cellular signaling regulates alternative splicing 
Post-translational modifications such as methylation or phosphorylation in RBPs are 
important for determining RNA binding specificities. The most abundant class of 
phosphorylated RBPs is the one that includes SR proteins. SR proteins are active 
upon phosphorylation, which is important for alternative splicing regulation. Global 
shut down of splicing during mitosis or heat shock due to dephosphorylation of 
SRSF10 exemplifies such a splicing regulation where 5’ ss recognition and 
subsequent spliceosome assembly is hampered (Shin et al., 2004). Inhibition of 
SRPK1 (serine-arginine protein kinase 1) causes hypophosphorylation of SF2 
(splicing factor 2) which regulates alternative splicing of VEGF (vascular endothelial 
growth factor) from pro- to anti-angiogenic spliceforms beneficial in inhibiting 
progession of diabetic nephropathy and tumour growth (Oltean et al., 2012). C6 
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pyridinium ceramide, a potential anti-cancer drug, inhibits dephosphorylation of 
various splicing regulatory proteins (including, SF2/ASF and Tra2-beta1) by binding 
to the protein phosphatase 1 (PP1) catalytic subunit thereby changing alternative 
splicing patterns of several endogenous genes such as drf1, tau and syk 
(Sumanasekera et al., 2012). 
 
1.3.2.4. Tissue-specific regulatory proteins affect alternative splicing regulation 
Regulation of alternative splicing can also be mediated by tissue-specific factors, 
which are present in one cell type but not in the other. Embryonic lethal abnormal 
visual system (ELAV), a neuron-specific RBP binds to and regulates alternative 
splicing of Drosophila erect wing (ewg) and neuroglian (nrg) genes (Lisbin et al., 
2001; Soller and White, 2003). Sex-lethal (Sxl), an RBP expressed only in females, is 
a key regulator of the Drosophila sex determination pathway. Sxl regulates the 
splicing of Drosophila tra exon 2 and autoregulates its own exon 3 splicing. In both 
the cases, binding of Sxl blocks 3’ ss recognition and suppresses exon inclusion to 
produce active Tra and Sxl proteins in females but not in males, where exon 
inclusion produces truncated and inactive proteins. Sxl also mediates X chromosome 
dosage compensation by blocking splicing of the first intron in Drosophila male-
specific-lethal-2 (msl-2), and also translation of msl-2 to prevent transcriptional 
upregulation on the X chromosome as observed in males (Black, 2003; Lopez, 1998; 
Maniatis and Tasic, 2002; Schutt and Nothiger, 2000). 
 
1.3.2.5. Co-transcriptional regulation of alternative splicing 
Regulation of alternative splicing not only depends on the interaction of splicing 
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factors with their target pre-mRNA sequences but also transcription. Transcription 
and pre-mRNA processing were thought to be independent processes. However, 
studies in the Drosophila chorion genes (s36-1 and s38-1) showed that transcripts 
appear to be shorter while still being attached to the chromatin via RNA pol II 
suggesting co-transcriptional pre-mRNA splicing (Osheim et al., 1985). Moreover, 
nascent RNA sequencing data in Drosophila revealed that eighty-seven percent of 
the introns manifest >50% co-transcriptional splicing (Khodor et al., 2011). Key to 
coupling of transcription and splicing is the carboxy terminal domain (CTD) of RNA 
pol II which comprises 52 tandem repeats of the 7 amino acid consensus sequence 
YSPTSPS and is subject to post-translational phosphorylation of serine residues, 
which affects co-transcriptional alternative splicing by recruiting splicing factors. CTD 
promotes skipping of human fibronectin extra domain I (EDI) exon, independent of 
RNA elongation rate, by recruiting SR protein SRp20 demonstrating that alternative 
splicing regulation does not solely depend on regulatory element-specific trans-acting 
factors (de la Mata and Kornblihtt, 2006). 
 
1.3.2.6. Promoter type can regulate alternative splicing 
Different RNA pol II promoters alter splicing outcome of the same exon provided very 
strong evidence towards coupling of transcription and alternative splicing. 
Transcription under the -globin promoter results in a ten-fold reduction in the 
inclusion of human fibronectin EDI exon than when transcription is driven by the 
cytomegalovirus promoters suggesting that splicing can be influenced by RNA pol II 
transcription (Cramer et al., 1997). A similar regulatory function of promoters has also 
been observed in splicing of human CD44 and cystic fibrosis transmembrane 
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regulator genes (Auboeuf et al., 2002; Pagani et al., 2003). These effects are not a 
result of differences in promoter strength but due to qualitative properties attributed to 
the RNA processing machinery. This observation is in line with microarray data 
showing that transcription based on promoter strength acts independently of 
alternative splicing on different sets of genes to result in tissue-specific expression 
profiles (Pan et al., 2004).  
Promoter type affecting splicing outcome could function as a result of differences in 
promoter occupancy by factors varying in activation moieties and mechanistic 
properties (Kornblihtt, 2005). A possible mechanism that could explain such an effect 
is that the promoter itself recruits factors with functional domains for both 
transcription and splicing to the transcription site, via transcription factors that 
physically associate with the promoter or transcriptional enhancer elements within 
the promoter. The splicing of human fibronectin extra domain II (EDII) exon 
exemplifies such a mechanism where the promoter with a DR-1 transcriptional 
enhancer element binds transcription factor PPAR, which subsequently recruits the 
transcriptional co-activator PGC-1.  Due to its dual functionality, PGC-1 interacts with 
RNA pol II and the splicing factor SRp40, which results in EDII exon skipping.  
Conversely, when PGC-1 is not a part of a promoter-binding complex, EDII exon is 
included (Monsalve et al., 2000).  
 
1.3.2.7. RNA pol II processivity can regulate alternative splicing 
RNA pol II elongation rates or processivity can regulate alternative splicing 
outcomes. A putative model suggests that for an alternative exon, flanked by a 
weaker upstream and a stronger downstream ss, low RNA pol II elongation rates or 
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internal stalling sites, commonly called pause sites, would favour exon inclusion, 
whereas a high RNA pol II elongation rate or absence of pause sites would result in 
exon skipping (Nogues et al., 2003). A lower elongation rate between the two ss 
would allow more time for spliceosomal components to assemble on the weaker ss 
and delay the synthesis of the stronger downstream ss, thus favouring excision of the 
upstream intron and exon inclusion. A higher elongation rate would expose both the 
ss simultaneously before the splicing machinery, which would choose the stronger 3’ 
ss resulting in exon skipping. In the case of two constitutive strong ss, as observed in 
constitutive splicing, RNA pol II elongation rates do not affect splicing (Kornblihtt et 
al., 2004). 
Altering RNA pol II elongation rates influences alternative splicing of human 
fibronectin EDI exon. Cells treated with dichlororibofuranosylbenzimidazole (DRB), a 
potent inhibitor of RNA pol II elongation showed a three-fold elevation in EDI 
inclusion (Nogues et al., 2002; Price, 2000). Also, the C4 RNA pol II mutant, which 
has a lower elongation rate due to a single amino acid substitution (741Arg-His) in its 
largest subunit, provided a direct evidence for the kinetic coupling of transcription and 
splicing. This slow polymerase was shown to cause a three-fold increase in 
fibronectin EDI exon inclusion in human cells. This mutation also affected the splicing 
of adenovirus E1a by favouring the inclusion of the most upstream exon out of the 
three alternative 5’ donor sites (de la Mata et al., 2003).  
The Drosophila Hox gene Ultrabithorax (ubx), responsible for wing and leg formation 
in adult flies, can give rise to six different spliceforms by differential inclusion of its 
three variable exons: the B element and two microexons, mI and mII that are 
separated by very large introns. Joining of either mI or mII to the 5’ constitutive exon 
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regenerates a consensus 5’ ss which is subsequently recognized by the splicing 
machinery to result in exon skipping and shorter isoforms by a mechanism of 
recursive splicing (Burnette et al., 2005). 
In C4 embryos, Ubx pre-mRNA splicing shows an enhancement in shorter isoforms, 
which translates as a mutant phenotype termed ‘Ubx effect’. This increase in 
recursive splicing is attributed to the lowered RNA pol II elongation rate which allows 
more time for the newly formed 5’ ss to be recognized by the spliceosome before the 
downstream 5’ ss can be synthesized. Contrary to EDI and E1a, ubx shows exon 
skipping under the influence of a slow polymerase. Splicing of other alternative 
exons, such as exon 7B of the Drosophila hnRNPA1 gene is not affected by the slow 
polymerase (de la Mata et al., 2003). Inhibition of RNA pol II elongation in Jurkat T 
cells revealed that RNA pol II occupancy was enhanced on introns flanking variable 
exons that became more included. This observation, at a genome-wide level, 
supports the RNA pol II elongation model (Ip et al., 2011). 
 
1.3.2.8. Nucleosome occupancy suggests a role in alternative splicing 
regulation 
DNA is packaged together with an octamer of highly evolutionarily conserved 
proteins called histones (two each of histones H2A, H2B, H3 and H4) to form the 
fundamental repeating unit of chromatin called nucleosome. Early sequence data 
from human and mouse genes suggested a relationship between nucleosome 
positioning and exon-intron architecture based on regular distribution of ss.  Since 
splicing and transcription were regarded as independent processes then, no 
conclusion was derived from this study (Beckmann and Trifonov, 1991). 
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Deep-sequencing data from human and C. elegans genomes and computationally 
based predictions of nucleosome positioning in humans, D. melanogaster and C. 
elegans reveal that sequences favouring nucleosome positioning are located in 
exons and disfavouring sequences are a part of 50 nt intronic regions immediately 
before and after exons as if nucleosome-free regions delimit exon-intron boundaries 
(Schwartz et al., 2009). Studies in Arabidopsis thaliana and Oryzias latipes 
(Japanese killifish) have shown the enrichment of nucleosomes on internal exons 
(Andersson et al., 2009; Chodavarapu et al., 2010; Nahkuri et al., 2009). A 
nucleosome accommodates 147 bp of DNA around it, which interestingly is very 
similar to the average length of exons in higher eukaryotes (Venter et al., 2001). 
These findings might explain the mean exon length of 140-150 nt as it would facilitate 
wrapping around a nucleosome and possibly improve exon recognition (Beckmann 
and Trifonov, 1991). Nucleosomes have also been reported to cover ss junctions, 
which may protect them against mutations thereby facilitating efficient splicing 
(Hapala and Trifonov, 2011; Kogan and Trifonov, 2005).   
Exons are known to contain a slightly higher GC content than introns. In addition, 
nucleosomes preferentially occupy GC-rich sequences. However, intronic regions 
with a much higher GC content than exons show lower levels of nucleosome 
occupancy and true exons show higher levels of nucleosome positioning, despite 
having the same level of GC content as pseudo-exons; intronic sequences flanked by 
strong ss but not included in the mRNA. These findings eliminate a possible bias of 
nucleosomes towards GC-rich sequences (Tilgner et al., 2009). Tilgner et al., (2009) 
also showed that nucleosomes are particularly enriched over exons flanked by weak 
ss. In contrast, exons with strong ss show reduced nucleosome occupancy but have 
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an extended region of nucleosomes upstream of the acceptor site. This inverse 
correlation between nucleosome occupancy and ss strength suggests an interplay 
between chromatin architecture and ss choice during pre-mRNA splicing (Tilgner et 
al., 2009). Schwartz et al. suggested a positive correlation between nucleosome 
occupancy and exon inclusion when analyzing splicing of three categories of exons: 
alternative exons with less than 50% inclusion, those with more than 50% inclusion 
and constitutive exons (Schwartz et al., 2009). In parallel, exon inclusion is 
disfavoured in pseudo-exons despite the presence of strong ss, possibly due to low 
nucleosome occupancy (Tilgner et al., 2009).  
The link between chromatin architecture and ss choice is the CTD – a key 
component of transcription and splicing. In vivo data shows enhanced occupancy of 
RNA pol II over exons compared to introns (Brodsky et al., 2005; Dhami et al., 2010; 
Spies et al., 2009). These observations suggest a cross-talk between nucleosome 
positioning, RNA pol II occupancy and general/alternative splicing regulation. 
Nucleosomes positioned on alternative exons might act as natural hurdles or ‘speed-
bumps’ for the transcribing RNA pol II and lower its elongation rate. This might delay 
the synthesis of competing downstream ss and consequently allow more time for 
spliceosome assembly and exon recognition eventually promoting exon inclusion 
(Churchman and Weissman, 2011; Hodges et al., 2009). In contrast, depletion of 
nucleosomes from alternative exons would result in a faster RNA pol II and hence, 
faster synthesis and recognition of the stronger downstream competing ss by the 
nucleosome resulting in exclusion of alternative exons (Carrillo Oesterreich et al., 
2011). 
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1.3.2.9. Histone modifications and chromatin structure can regulate alternative 
splicing 
Histones are post-translationally modified at many positions, particularly in the N-
terminal tails that extend out of the nucleosomal core, by enzymes that write a 
‘histone code’ by either adding or removing chemical groups. These histone marks 
primarily include methylation, acetylation and phosphorylation. A change in the 
degree of these modifications has been shown to regulate alternative splicing events 
(Hnilicova and Stanek, 2011). 
Enrichment of specific histone modifications on nucleosomes helps distinguish exons 
from introns to facilitate efficient splicing. In order to analyse chromatin structure and 
function in C. elegans, a genome-wide map of histone H3 tail methylations, using 
chromatin immunoprecipitation (ChIP) -on-chip and ChIP sequence (ChIP-Seq) data, 
have shown that exons are preferentially marked with H3K36me3 relative to introns. 
Moreover, constitutive exons have higher H3K36me3 signal than alternative exons. 
Other modifications such as H3K4me3 and H3K9me3 do not exhibit this difference in 
levels (Kolasinska-Zwierz et al., 2009). H3K36me3 occurrence on alternative exons 
correlates with exon inclusion on a genome wide scale in humans suggesting 
interplay between H3K36me3 marking and alternative splicing regulation (Hon et al., 
2009). Other histone methylations such as H3K27me1, H3K27me2, H4K20me1, 
H3K79me1 and H2BK5me1 have also been reported to favourably mark exons 
suggesting a possible role of chromatin structure in exon definition and regulation of 
alternative splicing (Andersson et al., 2009; Dhami et al., 2010; Huff et al., 2010; 
Spies et al., 2009).  
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RNA pol II serves as a link between the transcribed pre-mRNA and chromatin 
structure and promotes cross-talk between them such that chromatin remodeling can 
alter RNA elongation rate and consequently regulate alternative splicing. Membrane 
depolarization causes hyperacetylation of H3K9 and relaxation of chromatin around 
the mouse NCAM alternative exon 18 favouring exon skipping (Schor et al., 2009). 
Conversely, inhibiting histone deacetylases with trichostatin A results in enhanced 
skipping of exon 18. Moreover, a slow RNA pol II mutant promotes exon 18 inclusion, 
suggesting the role of histone acetylation in increasing RNA pol II elongation rate and 
regulating alternative splicing in mouse NCAM. Similar effects are observed in HeLa 
cells where inhibiting deacetylase activity results in skipping of human fibronectin 
EDII exon (Hnilicova et al., 2011).  
On the contrary, small interfering RNAs (siRNAs) complimentarily binding an intron, 
downstream of the alternative human fibronectin EDI exon, enhances local H3K9me2 
and H3K27me3 marks on the exon, which promotes heterochromatin formation via 
recruitment of heterochromatin-associated protein 1α (HP1α), reduces RNA pol II 
elongation rate and as a consequence enhances inclusion of EDI exon (Allo et al., 
2009). These examples suggest a correlation between chromatin structure and 
alternative splicing regulation where histone acetylation results in more open 
chromatin architecture around an alternative exon, allowing faster RNA pol II 
processivity and consequential skipping of the alternative exon. Histone methylation, 
on the other hand, results in a more compact chromatin structure, which slows down 
RNA pol II elongation rate and hence allows more time for spliceosome assembly 
around the alternative exon resulting in an increase in its inclusion. 
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Specific histone modifications are suggested to recruit certain splicing factors, which 
mediate alternative splicing regulation. Indeed, MRG15, an adaptor protein, 
recognizes and binds to H3K36me3 modification on human FGFR2 exon IIIb and 
recruits the polypyrimidine tract-binding protein (PTB), a splicing repressor. PTB 
binds to its intronic splicing silencer sites and causes exon skipping. Conversely, 
knockdown of MRG15 and reduction in H3K36me3 results in enhanced exon 
inclusion (Luco et al., 2011).  
In human CD44, H3K9 trimethylation on variant exons recruits more HP1γ, a 
transcriptional repressor, in the phosphorylated form (HP1γS83p), which binds to the 
CD44 mRNA and slows down RNA pol II. A decrease in elongation rate in turn 
recruits splicing factors such as U2AF65 and PRP8 that facilitate inclusion of CD44 
variant exons. Apart from regulating CD44 splicing, HP1γ affects alternative splicing 
of a few other genes such as PNK2, TAF4B, GLS, BRCA1 and DSN (Saint-Andre et 
al., 2011). 
Chromatin and RNA binding factors, independent of recruitment by histone 
modifications, regulate alternative splicing of variable exons. CCCTC-binding factor 
(CTCF) binds to alternative human CD45 exon 5 and promotes inclusion by local 
pausing of RNA pol II at the variable exon. DNA methylation on exon 5, however, 
inhibits CTCF binding and favours exon skipping (Shukla et al., 2011). Splicing 
regulators ELAV/Hu proteins, bind to RNA pol II and their target pre-mRNA 
sequences around alternative exons of mouse FAS1 and Nf1 genes and stimulate 
local histone hyperacetylation. This modification increases RNA pol II elongation rate 
which promotes variant exon skipping. Moreover, Hu proteins also directly bind and 
inhibit histone deacetylase 2 activitity, which favours local histone acetylation. These 
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observations suggest a ‘reach back’ mechanism wherein splicing regulators remodel 
chromatin structure when recruited to their target pre-RNA sequences 
cotranscriptionally to ensure efficient regulation of alternative splicing (Zhou et al., 
2011). 
 
1.4. Mechanisms of mutually exclusive splicing 
Mutually exclusive splicing results in inclusion of only one exon from two or more 
variable exons (Keren et al., 2010). Mechanisms explaining mutually exclusive 
splicing involve steric hindrance due to overlapping signals required for splicing, 
incompatibility of splicing signals for the major and the minor spliceosome, regulation 
by trans-acting factors and removal of transcripts with premature stop codons by 
nonsense-mediated mRNA decay (NMD). 
In mammalian introns, a minimum of 50 nt are required between the 5’ ss and the 
branch point for splicing. A shorter distance will not allow spliceosome assembly due 
to steric hindrance. Between exons 2 and 3 of human α-tropomyosin gene, the 
distance between the 5’ ss and the branch point is only 41nt resulting in inclusion of 
either exon 2 or 3 (Smith, 2005; Smith and Nadal-Ginard, 1989) (Figure 4A). 
Although most introns are spliced by the major spliceosome using GU/AG splicing 
signals, a minor spliceosome is present where U1 and U2 snRNPs are substituted by 
U11 and U12 snRNPs, which use AU/AC as splicing signals. The ss for major and 
minor spliceosomes are incompatible and cannot be spliced together to include 
adjacent exons. The intron between mutually exclusive exons 6a and 6b in human 
JNK2 contains a U12-type 5’ ss and a U2-type 3’ ss and accordingly these exons 
cannot be spliced together (Chang et al., 2007) (Figure 4B). 
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In some exon pairs, tissue-specific expression or activity of trans-acting factors can 
favour inclusion or force exclusion of only one from two variable exons, which under 
certain conditions could also be spliced together. Such a situation is found in the rat 
α-actinin1 gene where the smooth muscle (SM) exon is preferentially included and 
the non-muscle (NM) exon is preferentially excluded in smooth muscles. Here, CUG- 
repeat-binding protein (CUG-BP) and elav-type RNA-binding protein 3 (ETR3) 
activate the SM exon but together with CUG-BP and ETR3-like factor 4 (CELF4) they 
also suppress the NM exon. Inclusion of the SM exon also involves removal of PTB 
to relieve repression from the SM exon indicating that combinatorial interaction of 
multiple RBPs is required to regulate this complex alternative splicing event (Gromak 
et al., 2003) (Figure 4C).  
In some genes, alternative splicing generates isoforms, which contain a premature 
termination codon (PTC) due to a frame shift. Such PTC containing isoforms can be 
efficiently removed by NMD thus disguising the absence of an isoform as mutually 
exclusive splicing. This situation is observed in mammalian FGFR2 gene, where 
transcripts containing both mutually exclusive exons IIIb and IIIc, harbor a PTC and 
are therefore degraded (Jones et al., 2001) (Figure 4D). 
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Figure 4: Mechanisms of mutually exclusive splicing. (A) Steric hindrance in spliceosome 
assembly is imposed by insufficient distance between 5’ ss and the branch point resulting in 
mutually exclusive splicing of adjacent exons 2 and 3 in the -tropomyosin gene. (B) The 
GU/AG splicing signals used by major spliceosomal U1/U2 snRNPs are incompatible with 
the AU/AC splicing signals used by minor spliceosomal U11/U12 snRNPs. An intron with a 
U12-type 5’ ss and a U2-type 3’ ss cannot be spliced due to spliceosomal incompatibility as 
observed between exons 6a and 6b of JNK2 gene. (C) Trans-acting factors can regulate 
mutually exclusive splicing by acting as both promoters and inhibitors of mutually exclusive 
exon pairs to prevent them from being spliced together. CELF proteins regulate splicing of 
SM and NM exons of -actinin gene resulting in mutually exclusive splicing. Disfavoured, 
but observed splicing is shown as dotted lines. (D) Inclusion of multiple mutually exclusive 
exons can result in generation of a PTC due to a frame shift. Such aberrant transcripts are 
removed by NMD as observed in FGFR2 transcripts containing both IIIb and IIIc exons. 
Constitutive exons are shown as blue boxes, and pairs of mutually exclusive exons are 
shown as pink and yellow boxes. Adapted from (Hemani and Soller, 2012). 
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1.5. The Dscam gene 
Dscam, a Drosophila homolog of human Down Syndrome Cell Adhesion Molecule 
(DSCAM) was first isolated by its affinity to Dock, an SH3/SH2 adaptor protein 
required for axon guidance (Schmucker et al., 2000). Drosophila Dscam is expressed 
in the developing nervous system and in immune cells. Dscam is important for its role 
in wiring of the nervous system and pattern recognition in the immune system 
(Hattori et al., 2007; Watson et al., 2005). 
 
1.5.1. Gene organization and protein structure 
Dscam structure resembles that of an immunoglobulin (Ig) receptor and is related to 
other cell adhesion molecules (CAMs). The Ig superfamily is known to be the largest 
group of related cell surface receptors (Harpaz and Chothia, 1994; Williams and 
Barclay, 1988). They contain ten Ig domains and six fibronectin type III (FNIII) 
domains.  Nine out of the ten Ig domains are arranged in tandem whereas the tenth 
domain is located between FN4 and FN5. It also contains a transmembrane domain 
and a unique cytoplasmic domain with multiple tyrosine phosphorylation sites 
(Schmucker et al., 2000; Yamakawa et al., 1998) (Figure 5).  
The Dscam gene comprises 115 exons of which 95 exons are alternatively spliced. 
These 95 variable exons are organized into four exon clusters namely exon 4 
(encoding the N-terminal half of Ig2 domain), exon 6 (encoding the N-terminal half of 
Ig3 domain), exon 9 (encoding the entire Ig7 domain) and exon 17 (encoding 
transmembrane domains) clusters. Alternative splicing of individual exons takes 
place in a mutually exclusive and combinatorial manner resulting in tens of 
thousands of Dscam isoforms. Each of the exon clusters can generate 12, 48, 33 and  
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Figure 5: Dscam gene organization and protein structure. The Dscam gene comprises four 
exon clusters spliced in a mutually exclusive manner generating a repertoire of upto 38,016 
isoforms. Variable exon clusters are shown in colour: exon 4 cluster (red, 12 variables), exon 6 
cluster (blue, 48 variables), exon 9 cluster (green, 33 variables), exon 17 cluster (yellow, 2 
variables). The Dscam protein comprises ten Ig domains and six FN type III domains. Nine out 
of the ten Ig domains are arranged in tandem and the tenth Ig domain is present between FN4 
and FN5 domains. Exons 4 and 6, code for the N-terminal halves of Ig2 and Ig3, respectively. 
Exons 9 and 17, code for the entire Ig7 and transmembrane domain, respectively. Adapted 
from (Wojtowicz et al., 2004). 
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two alternative forms, respectively. If all combinations were allowed, 38,016 different 
isoforms could be generated by inclusion of a single exon in each of the variable 
regions (Schmucker et al., 2000). 
 
1.5.2. Dscam mutually exclusive splicing and its regulation 
Alternative splicing of Dscam is extraordinary considering not only the resultant 
protein diversity but also its unique mechanism. Each variable exon cluster can give 
rise to multiple alternative exons, however; only one variant is included in the 
functional Dscam isoform.  
The mechanisms of mutually exclusive splicing discussed previously do not seem to 
apply to splicing of the Dscam variable exons comprising the extracellular domain. 
Introns in the variable clusters are longer than the minimal size of about 59 nt in 
Drosophila and contain splicing signals for the major spliceosome (Graveley, 2005). 
Although splicing together of exons from the exon 6 cluster would result in a 
premature termination codon, removal of such isoforms by nonsense mediated 
mRNA decay would seem a highly inefficient way to remove isoforms with multiple 
inclusions due to the large number of possibilities. Hence, a mechanism is postulated 
whereby RNA secondary structure mediates the inclusion of a specific exon by 
relieving the variable cluster from its default repressed state (Graveley, 2005; Olson 
et al., 2007). 
 
1.5.2.1. RNA secondary structures mediate Dscam variable exon selection 
Extensive sequence analysis and phylogenomics have initially identified evolutionary 
conserved intronic sequences in the exon 6 cluster consisting of a 66 nt sequence in 
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the intron after exon 5 termed the “docking site” and a partially complementary 
shorter sequence called “selector sequence” in front of each exon 6 variant  (Figure 
6). Base pairing between the docking site and the selector site is then postulated to 
bring a specific variable exon into the proximity of the preceding constant exon 
resulting in splicing of the intron by the release of a repressor (e.g. hrp36 for exon 6, 
explained in 1.5.2.2.), subsequently triggering splicing to the distal constant exon. 
Since the selector sequences overlap with one another to a certain extent, the 
docking site is thought to interact with only one selector sequence at a time 
(Graveley, 2005). 
The function of the docking site is evolutionary conserved and is required for exon 6 
splicing. Deletions in the docking site increase exon 6 skipping and alter inclusion 
frequencies of exon 6 variables. Also, swapping selector sequences from rarely to 
frequently encoded variable exons, and vice versa, alters inclusion accordingly (May 
et al., 2011). Further support for the involvement of RNA secondary structure has 
recently come from sequence analysis of the variable clusters 4 and 9, where the 
docking site is present in the intron between the entire variable cluster and the 
downstream constitutive exon and the selector sequences are located in the introns 
after each exon variant (Yang et al., 2011) (Figure 7).  
Most introns in Drosophila are spliced co-transcriptionally (Khodor et al., 2011). 
Although the variable exon 4, 6 and 9 clusters extend over 6, 12 and 15 kb 
respectively, a “polar effect” leading to preferential inclusion of variable exons closer 
to the proximal constant exon is not observed arguing for dedicated mechanisms 
regulating the inclusion of a single variable exon.  
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Figure 6: Complementarity between the docking 
site and selector sequences consensus. The most 
frequently occurring nucleotide at each position of 
the central 28 nucleotides of the selector sequence 
consensus is complementary to the docking site 
consensus. Adapted from (Graveley, 2005). 
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Figure 7: Proposed model for Dscam exon 4 mutually exclusive alternative splicing. Once an exon is 
chosen for inclusion, an RNA stem loop is formed by complimentary base pairing between the 
docking site (green box) and the selector sequence (red box) downstream of the chosen exon. For 
simplicity, only five exon 4 variables are shown. Constant exons are shown in blue and variable 
exons in a gradient from pink to yellow. Adapted from (Yang et al., 2011). 
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RNA secondary structure is also postulated to govern mutually exclusive splicing of 
the transmembrane domain encoded by the two exon 17 variables (Anastassiou et 
al., 2006; McManus and Graveley, 2011). Here, four conserved sequences that can 
form two competing RNA stem-loop structures are present in the intron distal of 
constitutive exon 16 (Figure 8). Mutually exclusive splicing of variable exon 17 is 
functionally important to localize Dscam isoforms either to dendrites (exon 17.1) or 
axons (exon 17.2) of mushroom bodies (Wang et al., 2004). 
 
1.5.2.2. Dscam variable exon clusters are in a repressed state 
Adjacent exons in each variable cluster have ss close to the consensus sequence; 
however they are not spliced together. Through RNA interference (RNAi) mediated 
knockdown of RBPs in Drosophila S2 cells (cell-line of haematopoietic origin), an 
hnRNP called hrp36 has been identified to specifically repress the joining of multiple 
exons throughout the exon 6 cluster but not the other clusters (Figure 9). An RT-PCR 
flanking the exon 6 cluster in cells depleted of hrp36 show multiple bands in contrast 
to a single band in the presense of hrp36. Although hrp36 also binds to the exon 4 
and 17 cluster, no joining of multiple exons is observed when RNAi reduces hrp36 
levels. Thus, hrp36 regulates mutually exclusive splicing of exon 6 in a cluster-
specific and cluster-wide manner.  
Other hnRNPs such as hrp38, hrp40 and hrp48 do not regulate splicing fidelity of 
exon 6. Moreover, hrp36 acts antagonistically to SR proteins to prevent ectopic 
inclusion of multiple exon variants. These observations suggest a mechanism, which 
keeps the variable exon cluster in a repressed state until one exon is chosen for 
inclusion. Though very compelling, the role of hrp36 in repressing splicing together of  
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Figure 8: Proposed model for Dscam exon 17 mutually exclusive alternative splicing. Four 
conserved intronic sequence elements are located upstream of Dscam exon 17 cluster, which have 
the capacity to form RNA secondary structures by complimentary base pairing. These stem-loop 
structures allow the inclusion of only one of the two exon 17 variable exons. Adapted from 
(McManus and Graveley, 2011). 
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Figure 9: Proposed model for Dscam exon 6 mutually exclusive alternative splicing. Once an exon is 
chosen for inclusion, an RNA stem loop is formed by complimentary base pairing between the 
docking site and the selector sequence preceding the chosen exon, the repressor hrp36 is released 
to allow for its inclusion. Only the most frequently occurring nucleotides of the core consensus 
docking site (CUG) and selector sequences (CAG) are shown. For simplicity, only five exon 6 
variables are shown. Constant exons are shown in blue and variable exons in a gradient from pink to 
yellow. Adapted from (Hemani and Soller, 2012). 
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multiple exons in the exon 6 cluster seems not to extrapolate to the whole organism. 
No splicing repressor has been associated with other variable exon clusters (Olson et 
al., 2007). Recent work in shrimp (Litopenaeus vannamei) demonstrated the role of 
Lvhrp36 as a splicing repressor of Ig2, Ig3 and Ig7 variable regions (Lee et al., 2012).  
The repression of the exon 4 cluster is governed by an RNA secondary structure, 
wherein a 27 nt stem with a 2 nt bulge and a 275 nt loop structure, called inclusion 
stem (iStem), located in the intron 18 nt after exon 3 is functionally relevant for 
inclusion of one variable exon (Figure 10). Deletion or mutation of the double 
stranded part of the iStem results in skipping of the entire exon 4 cluster (in cell 
culture) but the length and sequence of the loop in the iStem seem not to play a role 
in regulating splicing in the exon 4 cluster. It is also unknown how this loop interacts 
with the spliceosome. The iStem plays a role in repression but is not involved in exon 
choice. Genome sequence comparison showed that the iStem is evolutionarily 
conserved in all eleven Drosophila species known. This study suggests that a fine 
balance exists between choosing a variant exon and repression of the entire exon 4 
cluster (Kreahling and Graveley, 2005). 
 
1.5.2.3. RNA binding proteins regulate inclusion of Dscam variable exons 
Regulation of Dscam diversity is required to provide unique identities to individual 
neurons in mushroom bodies and to increase levels of high affinity binding isoforms 
that fight against pathogens in the immune system (Dong et al., 2006; Zhan et al., 
2004). Prime candidates to regulate inclusion of individual variants are RBPs. RNAi 
knock down of 250 RBPs in S2 cells reveals 36 proteins that have an effect on the 
splicing of exon 4 cluster, but only eight proteins that affect alternative splicing of  
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Figure 10: Regulation of Dscam exon 4 mutually exclusive alternative splicing by the iStem. The 
iStem allows selection of only one of the 12 exon 4 variables. Deletion of the iStem results in 
complete skipping of the whole exon cluster. For simplicity, only four exon 4 variables are shown. 
Constant exons are shown in blue and variable exons in a gradient from pink to yellow. Adapted 
from (Kreahling and Graveley, 2005). 
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exon 17 cluster. All eight proteins involved in splicing of exon 17 cluster also affect 
splicing of exon 4 cluster (Park et al., 2004).  
These results suggest combinatorial control in the regulation of Dscam mutually 
exclusive variable exon splicing by RBPs, but surprisingly those RBPs identified 
mostly affect inclusion of the same small set of variable exons implying that a large 
proportion of Dscam diversity is unutilized. Currently, it is not clear how specific 
exons are included over others to establish neuronal patterning and how a few exons 
are included more frequently on pathogen exposure.  
 
1.6. Biological role of Dscam in invertebrates 
1.6.1. Role of Dscam in Drosophila nervous system 
1.6.1.1. Development of Drosophila nervous system 
The insect central nervous system (CNS) comprises the ventral nerve cord and the 
brain. After gastrulation, neurogenic regions of the ectoderm are determined to form 
the neuroectoderm, a sheet of undifferentiated epithelial cells. The ventral 
neurogenic region gives rise to the ventral nerve cord and the procephalic 
neurogenic region gives rise to the brain. In each hemisegment, a few selected cells 
delaminate from the neuroectoderm as CNS progenitor stem cells, also called 
neuroblasts that divide asymmetrically by restoring themselves and producing a 
chain of secondary precursor cells called ganglion mother cells (GMCs). A single 
GMC divides to give rise to two progeny cells that differentiate into neurons and/or 
glia.  Each hemisegment has ~30 neuroblasts that generate a total of 350 embryonic 
progeny cells which include ~290 interneurons, 30 motorneurons and 30 glial cells 
(Technau et al., 2006; Urbach and Technau, 2004). Subsequently, the axons and 
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dendrites branches from these neurons must find their target cells via axon 
pathfinding and dendritic field organization, respectively (Kaprielian et al., 2000; 
Nichols, 2006). The adult fly brain comprises highly organized neuropile structures 
such as mushroom bodies, optic lobes, antennal lobes and the central complex. The 
ventral nerve cord is relatively simpler, composed of a series of uniform segments 
called neuromeres (8 abdominal, 3 thoracic and 3 gnathal) (Technau et al., 2006).  
Neural patterning in the nervous system comprises many different neurons that are 
interconnected by a complex network of synaptic connections. Precise assembly of 
these neural circuits depends on interactions between cell surface recognition 
proteins expressed on projecting neurons and specific guidance signals from target 
neurons (Zipursky et al., 2006). In Drosophila there are ~250,000 different neurons 
and only ~15,000 genes which clearly suggest that each cell recognition event 
cannot be governed by a different gene product. Despite the limited number of 
genes, several mechanisms facilitate complex neuronal wiring, including 
combinatorial use of guidance cues such as attractants, repellants or modifiers, 
diffusible gradient labels and coordinated firing activity between neurons (Schmucker 
and Flanagan, 2004). Alternative splicing of Drosophila Dscam serves as a 
mechanism to generate thousands of neuronal cell surface proteins with distinct 
recognition properties from a single gene, which could be used to establish 
connections within the fly neural circuitry (Schmucker et al., 2000; Shapiro, 2007).  
 
1.6.1.2. Dscam isoforms exhibit homophilic binding 
It would be interesting to know how these isoforms, expressed on the surface of one 
neuron, are recognized and interpreted by neighboring neurons. In vitro biochemical 
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binding assays reveal that 95% of Dscam isoforms, like many Ig superfamily 
proteins, exhibit isoform-specific homophilic binding (Wojtowicz et al., 2007). The first 
eight N-terminal Ig domains, including all three variable domains, form a symmetric S 
shaped bend and determine binding specificity of Dscam isoforms. Strong homophilic 
interactions require matching of all the three variable Ig domains. Isoforms with even 
a single variable Ig domain mismatch fail to engage in heterophilic binding 
(Wojtowicz et al., 2004) (Figure 11).  
The Ig 1-4 domains form a horseshoe shaped ‘head’ wherein Ig2 and Ig3 comprise 
two distinct binding elements on opposite sides of the ectodomain - epitope I and 
epitope II.  Dimerization and consequently homophilic interactions involve symmetric 
antiparallel pairing of epitope I but not epitope II (Sawaya et al., 2008). These striking 
observations suggest that the vast repertoire of Dscam isoforms mediates cell-
surface recognition important for neural circuit assembly in Drosophila nervous 
system development.  
Although isoform-specific homophilic interactions might appear to mediate adhesion 
forces to establish neuronal connectivity, it has been established that binding of 
identical Dscam isoforms on isoneuronal dendritic branches triggers cytoplasmic 
signaling events that result in repulsion forces between sister dendrites (Hughes et 
al., 2007; Soba et al., 2007). Accordingly, deletion of the cytoplasmic domain results 
in adhesion rather than repulsion, promoting ectopic self-crossing and formation of 
stable bridges between dendritic branches. Such contact dependent repulsion also 
underlies axonal branch segregation in mushroom body neurons. The signaling 
mechanisms downstream of Dscam however remain to be elucidated (Matthews et 
al., 2007). 
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Figure 11: Molecular mechanism of homophilic interactions 
between identical Dscam isoforms. (A) Dscam protein structure 
showing nine of ten Ig domains and one half of FN1 domain. 
Ig2, Ig3 and Ig7 domains are encoded by variable exon clusters 
4, 6 and 9, respectively. (B)  Ig2, Ig3 and Ig7 domains 
determine the binding specificity between Dscam isoforms. Ig 1-
4 domains comprise a ‘horseshoe’ conformation and a strong 
skew between Ig 4-5 domains results in an S-shaped 
conformation important for dimer formation. Matching of all 
three variable Ig domains is necessary for strong homophilic 
interactions. Adapted from (Schmucker and Chen, 2009) 
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1.6.1.3. Role of Dscam in axon guidance and dendritic field organization 
Dscam loss-of-function mutants show axon guidance defects in the embryonic 
central nervous system, disruption of axonal extension and sister branch segregation 
in mushroom body neurons, interrupted axon arborization within the ellipsoid body 
and altered olfactory receptor neuron target specificity and dendritic patterning of 
projection neurons in the antennal lobe (Hummel et al., 2003; Schmucker et al., 
2000; Wang et al., 2002; Zhu et al., 2006). Although, these findings show the 
involvement of Dscam in Drosophila nervous system development, they do not 
address the question of whether isoform diversity is essential for Dscam function. 
Indeed, individual cells express a stochastic yet biased repertoire of Dscam isoforms 
as observed in photoreceptor neurons and S2 cells (14-50 isoforms) and mushroom 
body neurons (8-30 isoforms) (Du Pasquier, 2005; Neves et al., 2004; Zhan et al., 
2004). Hence, Dscam diversity provides each neuron with a unique cell surface ‘tag’, 
which allows it to distinguish between ‘self’ and ‘non-self’ essential for intra-neuronal 
avoidance and inter-neuronal recognition (Zipursky et al., 2006). 
Different mushroom body neurons express several isoforms in varying combinations 
such that no two neurons share the exact Dscam repertoire. Dscam null mushroom 
body neurons exhibit defects in axon extension. Dscam diversity reduced to ~11,000 
isoforms by deleting various subsets of Ig2 variants, does not affect mushroom body 
development (Wang et al., 2004). Intriguingly, single isoforms of Dscam, differing 
only in their ectodomains or transmembrane domains, substantially rescue loss-of-
function defects in Dscam null mushroom bodies (Neves et al., 2004; Zhan et al., 
2004). These results imply functional redundancy between Dscam isoforms and 
hence no requisite for isoform diversity. However, expression of a single Dscam 
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isoform in a bundle of co-projecting neurons causes defasciculation in larval and 
adult mushroom body. Conversely, expression of a Dscam isoform in a single mutant 
neuron in an otherwise wild type environment rescues axonal sister branch 
segregation (Hattori et al., 2007; Zhan et al., 2004) (Figure 12). Dscam diversity is 
thus essential to provide neighboring neurons with distinct isoforms for normal 
mushroom body morphogenesis, but a single Dscam isoform is sufficient for sister 
branch segregation in individual neurons. Moreover, no specific isoform or a subset 
of isoforms is required for mushroom body development (Hattori et al., 2009; Wang 
et al., 2004). 
Dscam diversity also ensures dendritic field organization in dendritic arborization (da) 
neurons. Here, da neurons of different classes, sharing the same dendritic territory, 
need to express different Dscam isoforms. Expression of one Dscam isoform in 
single mutant da neurons significantly rescues dendritic self-avoidance but over-
expressing the same isoform in da neurons of different classes forces spatial 
segregation of the once overlapping dendritic fields. Dscam, however, does not play 
a role in heteroneuronal tiling between da neurons of the same class (Hughes et al., 
2007; Matthews et al., 2007; Soba et al., 2007) (Figure 13). 
In contrast, the role of Dscam diversity is seemingly different in mechanosensory 
neurons. Expression of randomly chosen single isoforms can restore initial axonal 
extension and early branching but cannot rescue connectivity. These neurons show 
impaired secondary and tertiary axonal branching and fail to cross the midline in the 
central nervous system to reach their target cells. Also, two independent deletions of 
five Ig2 variants show allele-specific connectivity defects, which suggest functional 
differences between different isoforms. Thus, in contrast to mushroom body neurons  
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Figure 12: Role of Dscam diversity in mushroom body 
development. In Dscam wild-type brains, each cell in a 
group of co-projecting mushroom body neurons expresses 
a unique repertoire of Dscam isoforms supporting intra-
neuronal axonal branch bifurcation (arrows). The 
expression of the same isoform in a population of 
mushroom body neurons prevents axonal branching due to 
inter-neuronal repulsion (arrows). Axonal branch 
bifurcation is not affected if only one of the neurons 
expresses the Dscam
single
 allele. Adapted from (Hummel, 
2007). 
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Figure 13: Role of Dscam diversity in dendritic field organization of dendritic arborization (da) 
neurons. (A) Sister dendrites of a single da neuron expressing the same Dscam 
isoform/repertoire do not cross each other.  Heteroneuronal tiling between neighbouring da 
neurons of the same class is however, independent of Dscam. (B) Neighbouring da neurons of 
different classes expressing completely different sets of Dscam isoforms have overlapping 
dendritic fields. Adapted from (Schmucker, 2007).  
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where a larger deletion of Ig2 variants does not affect axonal bifurcation, 
mechanosensory neurons require a greater Dscam diversity for axonal branching 
and connectivity with their target cells (Chen et al., 2006) (Figure 14). A model 
whereby mechanosensory neurons and their corresponding target cells require 
expression of identical Dscam isoforms to establish neuronal connectivity via 
homophilic adhesion forces remains plausible. 
In summary, axonal sister branch bifurcation and dendritic field organization require 
the expression of any one Dscam isoform which underlies a strictly cell-intrinsic 
process of repulsion between isoneuronal neurites. Fasciculation between co-
projecting neurons and overlapping heteroneuronal dendritic fields require each cell 
to express a different set of isoforms to allow co-existence of neighboring neurons 
arguing for adhesion forces between them (Hughes et al., 2007; Matthews et al., 
2007; Soba et al., 2007). An exceptional case of homophilic binding leading to target 
connectivity via attractive forces is also conceivable.  
 
1.6.1.4. Diversity of Dscam intracellular domain is important for neuronal 
development 
An additional level of Dscam endodomain diversity due to skipping of exon 19 and/or 
exon 23 has profound impact in neuronal development. RNAi silencing of exon 19 
containing transcripts prevents neurites from crossing the midline in Drosophila 
embryos. Intriguingly, silencing of transcripts lacking exons 19 and 23 disrupts neural 
wiring in adult flies. Moreover, isoforms without exon 19 are localized in neuritis of 
mushroom body neurons, contrary to exon 19 containing isoforms that localize in cell 
bodies as well (Yu et al., 2009). Similarly, exon 17.1 containing isoforms are targeted  
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Figure 14:  A schematic diagram of post-scutellar (pSc) mechanosensory neuron projections into 
the adult fly thoracic central nervous system (CNS). The first panel shows Dscam gene and protein 
organization along with the wildtype projection pattern of a pSc mechanosensory neuron into the 
thoracic CNS. The remaining panels show projections of pSc mechanosensory neurons in Dscam 
mutant flies, with varying degrees of reduced exon 4 isoform diversity, indicated by an expanded 
view of the exons present in each mutant. The light gray boxes indicate deletions. Ectopic or 
misrouted branches are highlighted in red; branches prevalent in either Dscam deletion mutant (but 
not both) are highlighted by blue and green arrowheads, and the blue line denotes the CNS midline. 
Adapted from (Bharadwaj and Kolodkin, 2006). 
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to dendrites and exon 17.2 containing isoforms are enriched in axons, supporting the 
evidence that ectopic expression of exon 17.2 containing Dscam rescues axonal 
branching in mushroom body (Wang et al., 2004). Unlike the ectodomain diversity, no 
mechanism has been proposed to explain location dependent neuronal function of 
Dscam isoforms, arising due to alternatively spliced intracellular and transmembrane 
domains. 
 
1.6.2. Overview of the immune system 
The immune system is a collection of defense mechanisms within an organism, 
which protects it against disease by identifying and combating foreign particles 
(bacteria, fungi, viruses and parasitic worms) and tumour cells. Importantly, it 
distinguishes them from the organism's own healthy cells and tissues  – ‘self’ from 
‘non-self’ (Kvell et al., 2007). 
The immune system has two components: innate immunity and adaptive immunity. 
The innate immune system, present in all organisms, is the first line of defense 
against any invading foreign particle and is believed to be largely invariable without 
immunological memory (as explained in 1.6.2.1.). In contrast, adaptive immunity, 
present exclusively in jawed vertebrates, generates variability in the form of 
antibodies by somatic recombination to cause an intruder-specific response coupled 
with immunological memory. Phagocytes, responsible for engulfing foreign particles, 
and B-lymphocytes, producing antibodies, are key players in the innate and adaptive 
immune responses, respectively (Kvell et al., 2007; Pham et al., 2007).  
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1.6.2.1. Insect immune system 
Insects do not have antibodies, but have a potent innate immune system. Pattern 
recognition receptors (PRRs) help insects to recognize pathogen-associated 
molecular patterns (PAMPs) such as lipopolysaccharide (LPS), peptidoglycans 
(PGNs) and double stranded RNA (Ghosh et al., 2011). Haemocytes are central to 
cell-mediated immune responses and induce wound healing and blood coagulation to 
prevent further entry of invading pathogens.  
On penetrating this barrier, pathogens are killed by phagocytosis upon recognition, 
engulfment and intracellular disintegration by haemocytes. Encapsulation wraps 
multicellular parasites with a thick wall of haemocytes and eradicates them. 
Nodulation around a microorganism comprises a central core of melanised 
haemocytes surrounded by a layer of flattened haemocytes, which also effectively 
clears pathogens (Marmaras and Lampropoulou, 2009; Rowley and Powell, 2007). 
Antimicrobial peptides (AMPs) produced under the control of two evolutionarily 
conserved pathways – TOLL and IMD, are key immunomodulators in the insect 
humoral immune response. The prophenoloxidase (proPO) cascade produces a dark 
pigment called melanin, which deposits around pathogens and facilitates capsule and 
nodule formation. Insects also produce cytotoxic reactive oxygen species (ROS) and 
reactive nitrogen species (RNS), which eliminate host pathogens (Kurata, 2006; 
Marmaras and Lampropoulou, 2009). Other effectors such as lectins, which bind 
pathogen associated sugar molecules, and complement-like factors also function in 
destroying infectious agents (Beck and Habicht, 1996). 
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1.6.2.2. Evidence for ‘trained immunity’ in invertebrates 
Due to the mostly short lifespan of invertebrates, their immune system has been 
assumed to lack any adaptive capacity. In recent years, however, evidence has 
accumulated indicating development of pathogen specific responses and 
immunological memory, which provides invertebrates with a defense system, 
independent of somatic recombination, called ‘trained’ immunity. One of the earliest 
works in this direction showed that earthworms were able to recognize and 
rejectgrafts from other earthworms. These worms demonstrated a faster graft 
rejection upon second exposure (Cooper and Roch, 1986).  
A later study reported that male American cockroaches (Periplaneta Americana) that 
were first immunized and later challenged with a lethal dose of Pseudomonas 
aeruginosa, survived better (upto 14 days) than saline injected controls. Animals 
primed with other microbes (Serratia marcescens, Enterobacter cloacae, 
Micrococcus lysodeikticus and Streptococcus lactis) failed to show similar protection 
when challenged with P. aeruginosa (Faulhaber and Karp, 1992). Similarly, 
bumblebees (Bombus terrestris) that were initially primed with Pseudomonas 
fluorescens, Paenibacillus alvei or Paenibacillus larvae showed higher survival rates 
on receiving a homologous challenge (same bacteria) as compared to a 
heterologous challenge (different bacteria) (Sadd and Schmid-Hempel, 2006). These 
results suggest that insects primed with a particular species of bacteria, show a long-
term pathogen-specific immune protection.  
Intriguingly, priming Drosophila with a sub-lethal dose of Streptococcus pneumoniae 
or Beauveria bassiana (fungal pathogen) protected it against a subsequent lethal 
challenge, but such protection was not observed in flies immunized with Salmonella 
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typhimurium, Listeria monocytogenes or Mycobacterium marinum. These findings 
suggest that protection by priming is not a general mechanism against all pathogens 
in Drosophila. Also, for the first time, phagocytes were shown to rapidly clear 
microbial challenge from the haemolymph and provide such ‘trained’ immunity (Pham 
et al., 2007). 
An interesting phenomenon observed in arthropods involves maternal transfer of 
pathogen-specific immunity onto the progeny. The water flea Daphnia magna were 
primed with two strains of pathogenic bacterium Pasteuria ramosa, strain A and 
strain G. The offsprings of these two groups when exposed to homologous challenge 
(primed and challenged with strain A or strain G) showed increased survival over 
those exposed to a heterologous challenge (primed with strain A and challenged with 
strain G and vice versa) (Little et al., 2003). Such transgenerational immune priming 
has also been observed in flour moths, bumblebees and mealworms (Moret, 2006; 
Rahman et al., 2004; Sadd et al., 2005). However, no studies have been carried out 
to explain the mechanism behind these observations. 
 The discovery of ‘trained’ immunity in invertebrates serves as a means to assess the 
importance of cellular versus humoral defenses in providing pathogen-specific long-
term protection. The investigations involving P. fluorescens and S. pneumoniae 
challenge in previously primed bumblebees and fruit flies, respectively, found no role 
of AMPs in pathogen-specific immune response (Sadd and Schmid-Hempel, 2006). 
In vivo studies in Drosophila showed that activation of proPO pathway is not required 
for their survival against infectious challenge (Leclerc et al., 2006). Relish/NF-κB 
double mutant Drosophila with fewer or no circulating haemocytes, and hence 
reduced phagocytic activity, but with fully functional AMP synthesis did not survive 
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opportunistic bacterial or fungal infections (Matova and Anderson, 2006). Moreover, 
homologous pathogen challenge post-immunization in lobsters (Homarus 
americanus) resulted in enhanced phagocytic activity of haemocytes (Mori and 
Stewart, 2006; Paterson and Stewart, 1979). These findings provide convincing 
evidence about the direct involvement of phagocytosis in challenge-specific long-
term immunity in invertebrates. It is thus imperative to further explore the mechanism 
underlying the recent paradigm shift in invertebrate immunity from being completely 
innate to being ‘trained’. 
Giardia lamblia, a human intestinal parasite, undergoes variation in antigen 
expression to escape the host’s immune system. It transcribes many of its variant-
specific surface protein (VSP) coding genes (~190 genes) but expresses only one 
VSP at any given time and can switch to express another VSP. Silencing of the RNAi 
machinery, results in the expression of multiple VSPs in individual parasites (Prucca 
et al., 2008). Generally, RNA-dependent mechanisms could represent ways to 
generate molecular diversity to evade external pathogenic challenges in 
invertebrates. 
 
1.6.2.3. Dscam splicing regulation provides ‘trained immunity’ in invertebrates 
Immunoglobulin domain containing proteins comprise the largest group of cell 
surface receptors, which play a role in antigen recognition, cell adhesion and 
signaling in vertebrates and invertebrates. In higher vertebrates, Ig containing B and 
T cell receptors and antibodies exhibit enormous diversity via somatic recombination 
and clonal selection (Watson et al., 2005). Invertebrates employ alternative splicing 
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of Dscam, a well-known PRR, to generate a vast repertoire of spliceforms to 
recognize and protect against a variety of host pathogens (Kurata, 2006).  
Watson et al., (2005) showed that Dscam is expressed in Drosophila larval 
haemocytes, fat bodies and brain tissue and is also secreted in the haemolymph. 
Haemocytes from hypomorphic and transgenic Dscam RNAi larvae; and Drosophila 
S2 cells show reduced phagocytic uptake of E. coli by ~25-35%. Moreover, Dscam 
directly binds to live E. coli in vitro via its extracellular domain. This study 
demonstrates a role of Dscam in phagocytic uptake of bacteria by direct binding and 
potentially also opsonizing circulating pathogens in the haemolymph via isoforms 
cleaved from the membrane. However, the specificity of this observation was not 
examined with different pathogenic exposures (Watson et al., 2005). 
In Anopheles gambiae, Sua5B cells (haemocyte-like cell line), on challenge with 
bacteria (E. coli, Pseudomona veronii or Staphylococcus aureus) and bacterial cell 
surface determinants (lipopolysaccharide or peptidoglycan), causes rapid change in 
AgDscam exon 4 splicing pattern to yield high affinity binding isoforms in a pathogen-
specific manner. RNAi against these isoforms decreases bacterial binding, 
phagocytic uptake by ~55-60% and survival rates on exposure to the same pathogen 
(Dong et al., 2006). Also, injecting E. coli and S. aureus in crayfish (Pacifastacus 
leniusculus) induces pathogen-specific, high affinity binding isoforms of PlDscam. 
Moreover, coating bacteria with these PIDscam recombinant isoforms hides the 
binding sites required for bacterial clearance by phagocytosis (Watthanasurorot et 
al., 2011). Feeding mosquitoes with blood meal infected with either one, two or three 
genotypes of P. falciparum results in increased AgDscam diversity (Smith et al., 
2011). The change in splicing pattern and increase in diversity suggests a 
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mechanism of increasing the probability to recognize, bind and defend against the 
invading pathogen. 
Intriguingly, shrimp (Liptopenaeus vannamei) LvDscam lacks the characteristic 
transmembrane and intracellular membrane domains associated with Dscam in other 
arthropods. Haemocytes express a total of 39 individual LvDscam isoforms – 12 
isoforms in white spot syndrome virus (WSSV)-free, 11 isoforms in WSSV-persistent 
and 16 isoforms in WSSV-acute infection conditions. This result suggests a unique 
mechanism adopted by shrimps to choose LvDscam isoforms exclusively associated 
with the intensity of viral infection (Chou et al., 2009). 
In conclusion, the results from these studies suggest that change in Dscam splicing 
pattern plays a key role in the putative invertebrate ‘trained’ immunity. Nonetheless, 
the mechanism, which regulates this splicing switch, is not understood.  
 
1.7. Model for Dscam splicing regulation 
Regulation of Dscam diversity by mutually splicing is quintessential for neural circuit 
formation, organization of dendritic fields and clearance of pathogens by Dscam 
mediated phagocytosis. For all these functions, expression of a small unique set of 
Dscam isoforms is required in individual cells of an otherwise identical population.  
Single cell analysis in R7 photoreceptor neurons and haemocytes reveals that each 
cell expresses a distinct set of about 14 to 50 Dscam isoforms (Neves et al., 2004). 
Hence, every cell in a population of neurons or haemocytes contributes towards an 
overall unique Dscam identity. Diversification of Dscam could potentially be achieved 
in the nervous system and the immune system during independent events. In the 
nervous system, an extensive array of Dscam isoforms present in undifferentiated 
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neurons is reduced to a cell-specific complement during differentiation, or a limited 
diversity of Dscam isoforms present initially is altered during differentiation to provide 
a unique neuronal identity. In the immune system, experimental evidence argues that 
the initial diversity present in a population of haemocytes diversifies into a different 
complement of isoforms on encountering pathogens.  
The mechanism underlying the choice and inclusion of specific exons is however, 
poorly understood. Particularly intriguing, signals from the cell surface seem to relay 
to the splicing machinery to regulate Dscam diversity. Encountering a pathogen 
causes high affinity binding Dscam isoforms to feedback positive selection and 
amplification of the same isoform. Contrarily, Dscam homophilic repulsion sends 
negative feedback to exclude selection of identical isoforms between neighbouring 
neurons (Figure 15). 
 
1.8. Aims 
This project is integrated in the long-term aim to identify the mechanisms, which 
regulate the choice of a single or a specific set of Dscam isoforms in the Drosophila 
immune system and the nervous system by alternative splicing. 
 
1.9. Objectives 
In order to mount an immune response, host organisms must first recognize the 
pathogen after infection. Despite the importance of this process, little is known about 
the mechanisms of pathogen recognition in invertebrates. Upon pathogen exposure 
in mosquitoes, the Dscam splicing pattern changes to express isoforms that bind the 
pathogens with higher affinity (Dong et al., 2006). To validate the generality of Dscam  
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Figure 15: Specification of Dscam isoform expression. (A) In the immune system, when Haemocytes 
encounter a pathogen, the default repertoire of Dscam isoforms is changed towards isoforms that bind 
invading pathogens with higher affinity. (B) In the nervous system, undifferentiated MB neurons could 
express either an extensive or a small repertoire of Dscam isoforms. During differentiation, expression of 
unique set of Dscam isoforms is established in individual cells either by reducing the initial diversity 
differently in each cell, or by changing the repertoire in each cell. A unique set of Dscam isoforms then 
allows mushroom body neurons to project in a common path and at the same time use Dscam mediated 
homophilic repulsion to bifurcate its axonal branches. Adapted from (Hemani and Soller, 2012).  
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splicing regulation on pathogen exposure, Drosophila S2 cells were challenged with 
different microbes. Potentially, Dscam isoforms binding to the pathogens could signal 
from the membrane to the nucleus through their associated mRNAs to induce the 
inclusion of the same exons. In support, Giardia lamblia employs RNAi to establish 
antigenic variation on its surface such that at any given time, it expresses only one 
out of ~190 variant-specific surface proteins (Prucca et al., 2008). Accordingly, a 
single Dscam isoform was expressed in Drosophila S2 cells to test if the endogenous 
Dscam splicing pattern changes to enhance the inclusion of exons present in the 
exogeneous isoform. To further explore RNA based mechanisms in altering Dscam 
alternative splicing, mutants of ago1 and elav, which have a similar nervous system 
defect as observed in Dscam mutants were tested. In addition, mutants of other RNA 
processing factors such as ago2, involved in siRNA-directed RNAi and members of 
the exosome and Trf4/Air2/Mtr4p polyadenylation (TRAMP) complexes such as rrp6 
and trf4 respectively that are involved in removal of cryptic RNA transcripts were also 
tested. Since ELAV has no obvious binding site in Dscam pre-mRNA, an indirect role 
of ELAV in regulating Dscam splicing was assumed. Consequently, mutants of RNA 
binding proteins, DNA binding proteins and chromatin remodeling factors that are 
differentially regulated in elav mutants were tested for changes in Dscam splicing. To 
further understand the regulation of Dscam splicing, transgenic flies containing a 
construct heterologously expressing an entire variable cluster were made, which will 
enable us to identify sequence elements that could play a role in selection of specific 
exons.  
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CHAPTER 2 
MATERIALS AND METHODS 
 
2.1. Drosophila husbandry and genetics 
2.1.1. Fly food 
Flies were reared in glass vials containing 11 ml of standard cornmeal-agar food 
(8.5% dextrose (w/v), 6% cornmeal (w/v), 2.5% nipagin (v/v), 1% agar (w/v) in tap 
water). Once solidified, the food was supplemented with live yeast to encourage egg 
laying. 
 
2.1.2. Fly maintenance 
Stocks and crosses were maintained in a 12 hr day/12 hr night photoperiod at 25C 
and 70% relative humidity. Crosses were flipped every second day and stocks were 
flipped every three weeks to allow healthy development of offsprings. The vials were 
monitored regularly to prevent overcrowding and dehydration.  
 
2.1.3. Embryo collection 
14-18 hr old, stage 17 embryos were used for experiments. A cylindrical chamber 
sealed at the bottom with a wired mesh and covered on top with grape juice plates 
(3% agar (w/v) and 25% grape juice (v/v) (Ritchies) in tap water with a smear of live 
yeast) was used to collect embryos. Flies were acclimatized in the chamber for 2-3 d 
prior to embryo collection. Flies were allowed to lay eggs on a plate in the evening for 
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four hr. This plate was incubated at 25 for 14 hr after which the embryos (14-18 hr 
old) were collected and dechorionated by immersing them in 50% sodium 
hypochlorite solution (v/v) for 90 sec. The dechorionated embryos were washed with 
tap water on a fine mesh using an aspirator (UniEquip) and then observed under a 
light microscope or a fluorescent microscope (Leica) if green fluorescent protein 
(GFP) expression was desired. Embryos similar in gut morphology were selected and 
stored in 10 µl of double distilled water (ddH2O) at -80C. 
 
2.1.4. Fly transgenesis with UAS Dscam 9L 
UAS Dscam 9L (containing Dscam Ex 7-11, obtained from M. Soller, Figure 16) was 
prepared by using the Qiagen plasmid purification kit (as explained in 2.4.11). 
Integration of UAS Dscam 9L in the Drosophila genome was achieved by φC31 
mediated germline transformation system (Bischof et al., 2007). UAS Dscam 9L 
carries a bacterial attachment site (attB), which allows its site-specific incorporation 
into the genome of flies containing a pre-determined phage attachment landing site 
(attP) at position 76A2 (PBac(y[+]-attP-9A)VK00013). The recombination reaction is 
initiated by a constitutively expressed φC31 integrase encoded on the X 
chromosome (y1 w* M(vasint.Dm)ZH2A).  
The injection mix was prepared by adding 2.5 μg of UAS Dscam 9L, 1X injection 
buffer (5 mM KCl, 0.1 mM Na3PO4, pH 7.8), 1 mM MgCl2 and 0.2 μM filtered food dye 
in a total volume of 10 μl. The mixture was centrifuged at 16,000g for ten min to 
remove of any interfering particles and placed on ice. The needles used for 
microinjection were made from fine borosilicate glass capillary tubes (Intracel), with 
an internal filament (0.22 mm in diameter), by a micropipette puller (Narishige).  
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Figure 16: Diagrammatic representation of UAS DSCAM 9L
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A capillary was placed in a vertical position and melted by a heating filament and 
subsequently pulled by attached weights under the force of gravity. Needles were 
filled with DNA from one end, which spread along the whole filament up till the tip, by 
capillary action. 
Approximately 300-500 flies from the y1 w* M(vasint.Dm)ZH2A ; PBac(y[+]-attP-
9A)VK00013 stock were transferred into an egg laying chamber (as explained in 
2.1.3.) and allowed to acclimatize for 2-3 d before injection. Grape juice plates were 
changed twice a day during this period. The following steps were carried out in an 
18°C room. Embryos were harvested after a 20-25 min laying period and washed 
with tap water using a squeeze bottle. They were dechorionated in 33% sodium 
hypochlorite solution (v/v) for two min and thoroughly rinsed with tap water. 
Dechorionated embryos (~80 embryos) in the pre-blastoderm were aligned with a 
paintbrush along the edge of a glass coverslip. Care was taken to align the embryos 
in the same orientation for ease of injection. Embryos were picked up by gently 
lowering a coverslip coated with heptane glue such that the embryos stuck to the 
coverslip. The affixed embryos were dehydrated for ~15 min in a desiccation 
chamber containing silica gel. This time period was adjusted according to relative 
humidity levels in the desiccation chamber such that a gap developed between the 
posterior end of the embryo and the vitelline membrane when observed under a 
phase contrast. The dehydrated embryos were covered in a thin layer of halocarbon 
700 oil (Sigma). The coverslip was fixed onto a glass slide and then placed on the 
stage of an inverted microscope (Nikon) fitted with a micromanipulator (Nikon). The 
microscope was also attached to a microinjector (Narishige) and a compressor (Jun-
Air) via a needle holder. Embryos were focused such that their posterior ends faced 
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the needle on the same focal plane. The micromanipulator was used to move the 
embryos against the static needle. Microinjection was achieved by inserting the tip of 
the needle inside the posterior end of the embryos by expelling a fixed volume of 
DNA solution under a fixed air pressure. Embryos exhibiting cellularization were 
destroyed to avoid unnecessary work after eclosion. The injected slide was tilted for 
15 min to run out the excess oil. The slide was then placed in a hydration chamber 
and larvae were collected after 48 hr. These larvae were transferred in special soft 
food (1% agar (w/v), 5% sucrose (w/v), 4% yeast extract (w/v), 2% inactivated yeast 
(w/v), 0.5% 9:1 propionic acid: phosphoric acid (v/v)). Eclosed flies from the injected 
embryos were out-crossed with yw. Apart from the attB site, UAS Dscam 9L has GFP 
as a positive transformation marker. Progeny from the outcross were screened for 
GFP expression in the eyes, indicating that transgenesis has occurred. To stabilize 
the transgenic line, transformants were crossed to a doubly balanced strain (yw; TM3 
Sb/TM6b) and a homozygous transgenic stock was established.  
 
2.2. Molecular biology 
2.2.1. RNA isolation  
Flies/embryos/tissues/cells were homogenized with a pestle in 50 µl of Trizol reagent 
(Sigma). The pestle was washed off any bound RNA with 450 µl of Trizol reagent. 
The homogenized mixture was vortexed for 2 min. Then, 200 µl of 
chloroform:isoamyl alcohol (49:1) was added to the mixture and again vortexed for 2 
min. The tube was kept on ice for five min until the phases separated. The mixture 
was centrifuged at 16,000g for ten min. Then, 200 µl of the aqueous phase 
(containing RNA) was carefully transferred into a new tube containing 1 µl of 
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glycogen. Care was taken to avoid contamination of the aqueous phase from the 
interphase (DNA) or the organic phase (proteins/lipids). Then, 200 µl of absolute 
isopropanol was added to the aqueous phase and vortexed for a few seconds. The 
solution was centrifuged at 16,000g for ten min. The supernatant was discarded and 
the pellet was washed with 750 µl of 70% ethanol (v/v) at 16,000g for ten min. The 
supernatant was removed and the RNA pellet was left to air dry for ~5 min. The pellet 
was dissolved in autoclaved diethylpyrocarbonate (DEPC) treated de-ionized water 
and stored at -20C. DEPC treated water was made by adding 0.1% DEPC (v/v) to 
de-ionized water and allowing it to stand for 2 hours at room temperature with 
intermittent shaking. DEPC was inactivated by autoclaving.   
 
2.2.2. Reverse transcription (RT) 
For a total RT reaction volume of 20 µl, a master mix (13 µl) containing the isolated 
RNA (9.5 µl), 1 µl of 10X RT buffer (200 mM Tris-HCl, 500 mM KCl, pH 8.3), 1 µl of 
100 mM dithiothretol (DTT), 20 units of ribonuclease inhibitor (RNAsin, Promega) and 
1 µl of 10 pM oligo(dT) or 1 µl of 20 µM gene-specific probe was kept at 70C for 15 
min in a thermal cycler (Eppendorf). A second master mix (6 µl) containing 1 µl of 
10X RT buffer, 1 µl of 100 mM DTT, 1 µl of 100 mM MgCl2, 1 µl of 10 mM 
deoxyribonucleotides (dNTPs) and 20 units of RNAsin were added to the reaction 
mixture just before the temperature reached 50C. After ten min of incubation at 50C 
the reaction mixture was kept at 46ºC when 20 units of Superscript II Reverse 
Transcriptase (Invitrogen) were added and reverse transcription was carried out for 
one hr. The final extension was carried out at 70C for 15 min. 
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2.2.3. Polymerase chain reaction (PCR) 
For a total reaction volume of 50 µl, a master mix was prepared containing 1 l of 
template (genomic DNA/cDNA/plasmid), 1X Dream Taq buffer (10mM Tris-HCl, 50 
mM KCl, 2 mM MgCl2, pH 8.3, Fermentas), 0.4 µM forward and reverse primers, 0.2 
mM dNTPs and 1.25 units of Dream Taq DNA polymerase (Fermentas). This 
reaction mixture was placed in a thermal cycler (Applied Biosystems) when 
temperature was >90C and subjected to an initial denaturation at 94C for 30 sec, 
then 30-40 cycles of denaturation at 94C for 30 sec, annealing at 56C for 40 sec 
and synthesis at 72C for 45 sec and a final extension for one min (annealing 
temperature and synthesis time varied with primer type and length of PCR product, 
respectively). PCRs for cloning were carried out using Phusion DNA polymerase 
(Finnzymes), a proofreading enzyme, in 1X Phusion buffer. Care was taken to 
prevent mixing of primers before introducing the tubes in the thermal cycler to avoid 
primer dimer formation. 
 
2.2.3.1. Single fly PCR  
One male fly was introduced into a PCR tube and frozen at -20C for 30 min. Then, 
200 l of isopropanol was added to the tube and incubated at room temperature for 
one hr. The isopropanol was removed by suction under vacuum for 30 min in a 
speed vacuum concentrator (Thermo Scientific). A master mix was immediately 
added to the tube and placed in a thermal cycler to proceed for a PCR reaction (as 
explained in 4.2.3.). 
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2.2.4. Agarose gel electrophoresis 
To prepare 1% and 2.5% agarose gels (w/v), 1 g and 2.5 g of electrophoresis quality 
agarose was melted in 100 ml of 1X TAE buffer (40 mM Tris, 1 mM EDTA, 20 mM 
glacial acetic acid, pH 8.0), respectively. Care was taken to fully dissolve the 
agarose. Ethidium bromide (5 µl per 100 ml of gel) was added and mixed by shaking. 
The gel mixture was poured into a gel cast (with combs) and allowed to solidify at 
room temperature. The PCR products were mixed with 2 µl of 9X loading buffer 
(43.5% glycerol (w/v), 50 mM EDTA pH 8.0-8.5, 10 mM Tris pH 7.5, 0.05% xylene 
cyanol (w/v), 0.05% bromophenol blue (w/v)) and loaded into the gels. The samples 
were run at 150-200 V for 30 min.   
 
2.3. Radioactivity used to label primers 
32P -ATP (143 Ci/l, 6000 Ci/mmol, Perkin Elmer) was used for all experiments 
involving radioactivity. Specific activity of 32P -ATP was measure using a scintillation 
counter with a counting efficiency (E) of 0.5. The counts per minute (cpm) reading 
from the counter was used to calculate disintegrations per minute (dpm) using the 
equation dpm = cpm/E. The dpm value was converted to disintegrations per second 
(dps) by using the equation dps = dpm/60. Activity of the radiolabel was calculated in 
curies (Ci) using the equation Ci = dps/3.7x1010 (1 Ci = 3.7x1010 dps). Specific activity 
of the radiolabel was calculated by determining curies per millimole (Ci/mmol) of the 
radiolabel measured in the scintillation counter (Packard).    
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2.3.1. Primer radiolabeling 
For a total reaction volume of 20 l, 10 units of T4 polynucleotide kinase (T4-PNK) 
were used to label 10 M primers with 143 Ci 32P -ATP in 1X PNK buffer 
(70 mM Tris-HCl, 10 mM MgCl2, 5 mM DTT, pH 7.6). The reaction mixture was 
incubated at 37C for 30 min. The enzyme was inactivated by incubating the reaction 
mixture at 80C for ten min. For a radioactive PCR, either the forward or the reverse 
primer (as required) was radiolabeled. All of the 32P -ATP in the reaction mixture 
was incorporated into the 10 M of primers used.  
 
2.3.2. Restriction enzyme digests of PCR products from Dscam 
variable regions 
5 l of PCR product was precipitated using 0.3 M sodium acetate and 2.5 volumes of 
absolute ethanol at -80C for ten min. The solution was centrifuged at 16,000g for ten 
min. The supernatant was discarded and the DNA pellet was washed with 500 l of 
70% ethanol (v/v) at 16,000g for ten min. The pellet was air dried for ~5 min and 
resuspended in 30 l of ddH2O. The precipitated PCR product was digested using 
appropriate enzyme combinations and buffers depending on the amplified Dscam 
variable exon cluster (as explained below). For a reaction volume of 50 l, 5 units of 
each enzyme were used to carry out restriction digests. The digested product was 
precipitated (as explained above) and dissolved in 20 l of denaturing gel loading 
buffer (98% de-ionized formamide (v/v), 10 mM EDTA pH 8.0, 0.025% xylene cyanol 
(w/v), 0.025% bromophenol blue (w/v)). The samples were denatured at 95C for 90 
sec and immediately placed on ice before loading into the gel.  
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Exon 4 cluster was digested with MboI, AluI and HinPI in 1X NEBuffer 4 (50 mM 
potassium acetate, 20 mM Tris-acetate, 10 mM magnesium acetate, 1 mM DTT, pH 
7.9) and 1X bovine serum albumin (BSA) at 37C for one hr in a total reaction volume 
of 50 l. Then, TaqαI was added to the digest mixture and incubated at 65C for 1 hr.  
Exon 6 cluster was digested with MboI, AluI and MspI in 1X NEBuffer 2 (50 mM 
NaCl, 10 mM Tris-HCl, 10 mM MgCl2, 1 mM DTT, pH 7.9) and 1X BSA at 37C for 
one hr in a total reaction volume of 50 l. Then, the reaction volume was adjusted to 
75 l with 1X NEBuffer 2 and 1X BSA and digested with BstUI, BstNI and TaqαI at 
60C for 1 hr.  
Exon 9 cluster with the forward primer radio-labeled was digested with HpyCH4IV in 
1X NEBuffer 1 (10 mM Bis-Tris-Propane-HCl, 10 mM MgCl2, 1 mM DTT, pH 7.0) and 
1X BSA at 37C for one hr in a total reaction volume of 50 l. Then, the reaction 
volume was adjusted to 75 l with 1X NEBuffer 2 and 1X BSA and digested with 
HaeIII, XmnI and MspI at 37C for 1 hr. Finally, the reaction volume was adjusted to 
100 l with 1X NEBuffer 2 and 1X BSA and digested with BstUI and BstNI at 60C for 
1 hr.  
Exon 9 cluster with the reverse primer radio-labeled was digested with HpyCH4IV in 
1X NEBuffer 1 and 1X BSA at 37C for one hr in a total reaction volume of 50 l. 
Then, the reaction volume was adjusted to 75 l with 1X NEBuffer 2 and 1X BSA and  
digested with MboI, AluI and HinPI at 37C for 1 hr. Finally, the reaction volume was 
adjusted to 100 l with 1X NEBuffer 2 and 1X BSA and digested with BstUI and TaqαI 
at 60C for 1 hr. All restriction enzymes and buffers were bought from New England 
Biolabs (NEB).  
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2.3.3. Denaturing polyacrylamide gel electrophoresis  
Denaturing polyacrylamide gel electrophoresis was carried out using the SequaGel 
System (National Diagnostics). For a total volume of 60 ml of 8% gel, SequaGel 
concentrate (1.07 M acrylamide, 26 mM methylene bisacrylamide (40:1 
acrylamide:bisacrylamide), 2.4 M urea), SequaGel diluent (4.35 M urea) and 
SequaGel buffer (89 mM Tris-borate, 2 mM EDTA, pH 8.3 and 0.75 M urea) were 
mixed together. Appropriate proportions of the concentrate, diluent and buffer for a 
range of gel percentages are listed in Table 1 (National Diagnostics). 0.04% TEMED 
(v/v) and 0.8% freshly prepared ammonium persulfate (v/v) were added to allow 
polymerization of acrylamide. The un-polymerized gel was gently mixed and cast 
between two clean glass plates (one of them silanized on one side) separated by 
plastic spacers. The comb was inserted at one end and the gel was left to polymerize 
for 1-2 hr. After polymerization, the gel was made to pre-run at 800-1000V for 15-20 
min until the temperature reached 55-60C after which the samples were loaded. 1X 
TBE (89 mM Tris-borate, 2 mM EDTA, pH 8.3) buffer was used as running buffer. 
After the completion of the run (at 1300V for ~2.5-3 hr), the glass plates were 
separated using a spatula. The gel, still stuck on the silanized surface, was fixed with 
fixing solution (10% methanol (v/v), 10% glacial acetic acid (v/v)) for ten min. The 
fixed gel was then transferred onto a clean wet filter paper and heat vacuum dried at 
85C for 1 hr. A Kodak imaging screen (Biorad) was exposed to the radioactive gel 
for 14 hr before scanning it in a molecular imager (Biorad) using Quantity One 
software (Biorad). The radioactive signal on the imaging screen was erased against a 
screen eraser (Biorad). 
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DNA Fragment 
Size (bp) 
% 
Monomer 
SequaGel 
Concentrate 
SequaGel 
Diluent 
SequaGel 
Buffer 
>200 4 16ml 74ml 10ml 
80-200 5 20ml 70ml 10ml 
60-150 6 24ml 66ml 10ml 
40-100 8 32ml 58ml 10ml 
0-50 12 48ml 42ml 10ml 
<20 20 80ml 10ml 10ml 
Table 1: Denaturing polyacrylamide gel composition. The table shows volumes of SequaGel 
concentrate, diluent and buffer (total gel volume = 100 ml) for commonly used polyacrylamide gel 
percentages required to resolve corresponding DNA fragments (National Diagnostics). 
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2.3.4 Quantification of bands 
The average intensity of each band was calculated by using the volume rectangle 
tool in Quantity One software. It measures the total signal intensity within a defined 
border drawn around the band by adding the intensities of all pixels within the volume 
boundary multiplied by the pixel area (intensity units x mm2).  The background 
intensity was subtracted from the band intensity using the local background 
subtraction method. This tool adds the intensities of all pixels in a 1-pixel boundary 
around the border drawn and divides it by the total number of boundary pixels. This 
gives a measure of the average background intensity around each volume drawn, 
which is then subtracted from the intensity of each pixel within the volume. The 
intensities of resolved exon bands (digested fragments) were divided with the 
intensity of their input bands (undigested PCR products) to obtain their respective 
inclusion levels, which were normalized against the input of the control experiment. 
Regulation of splicing changes was analyzed by determining fold differences 
between the normalized inclusion levels of a variant exon against corresponding 
exon bands in the control experiment. The quantified data were represented as best-
fit heat-maps, which were generated using the Matrix2png interface.   
 
2.4. Molecular cloning  
2.4.1. Media preparation 
Luria Bertani (LB) medium was prepared by dissolving peptone (1% (w/v)), yeast 
extract (0.5% (w/v)) and sodium chloride (0.5% (w/v)) in ddH2O. The pH was 
adjusted to 7.0 with 5 M sodium hydroxide (1.0 ml). The medium was then 
autoclaved. 
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2YT medium was prepared by dissolving peptone (1.6% (w/v)), yeast extract (1% 
(w/v)) and sodium chloride (0.5% (w/v)) in ddH2O. The pH was adjusted to 7.0 with 5 
M sodium hydroxide (1.0 ml). The medium was then autoclaved. LB plates were 
made by adding technical quality agarose (1.5% (w/v)) to LB medium and 
autoclaving. Appropriate antibiotic selection was added to the medium after it cooled 
to < 50°C. A list of antibiotics used is mentioned in Table 2.  
 
2.4.2. Preparation of competent cells 
2.4.2.1. Chemically competent cells 
From a single colony of DH5α cells, an overnight culture was set up at 37C with 
vigorous shaking. An inoculum of 2.5 ml from the fresh overnight culture was added 
to 250 ml of LB medium and grown at 37C with vigorous shaking until OD600 
reached 0.4-0.5. Care was taken to not overgrow the culture above an OD600 of 0.5. 
The following steps were carried out at 4C. Cells were harvested by centrifugation at 
1,000g for five min. The supernatant was removed and the pellet was carefully 
resuspended in 100 ml of 50 mM ice-cold CaCl2. After a recovery time of 20 min, the 
cells were centrifuged at 1,000g for five min. The supernatant was removed and the 
pellet was resuspended in 8 ml of 100 mM CaCl2 to which 2.4 ml of ice-cold 87% 
glycerol (w/v) was slowly added whilst constant mixing. Aliquots of this suspension 
were stored at -80C. 
 
2.4.2.2. Electro-competent cells 
From a single colony of DH5α cells, an overnight culture was set up at 37C with 
vigorous shaking. An inoculum of 10 ml from the fresh overnight culture was added to  
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Antibiotic 
Stock 
Concentration 
Solvent Working solution 
Ampicillin 100 mg/ml Water 100 µg/ml 
Chloramphenicol 34 mg/ml Ethanol 
25 µg/ml for 
plasmids; 
12.5 µg/ml for 
BACs  
Tetracycline 50 mg/ml Ethanol 
12.5 µg/ml; 
3 µg/ml for low 
copy number 
Table 2: List of antibiotics used during the study. The table shows the stock concentrations (mg/ml), 
solvents and working solutions (µg/ml) of all antibiotics used during the study.  
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1 lit of LB medium and grown at 37C with vigorous shaking until OD600 reached 0.6. 
Care was taken to not overgrow the culture above an OD600 of 0.6. The following 
steps were carried out at ~0C. Cells were harvested by centrifugation at 1,000g for 
15 min. The supernatant was removed and the pellet was carefully resuspended in 1 
lit of ice-cold 10% glycerol. The suspension was centrifuged at 1,000g for 15 min. 
This step was subsequently repeated with 0.5 lit and 250 ml of ice-cold 10% glycerol. 
The final pellet was resuspended in ice-cold 10% glycerol such that the concentration 
of cells was 1-3x1010 cells/ml. Aliquots of this suspension were stored at -80C. 
 
2.4.3. Primer phosphorylation 
For a total volume of 20 l, 10 units of T4-PNK were used to phosphorylate 20 M 
primers in 1X T4 DNA ligase buffer (50 mM Tris-HCl, 10 mM MgCl2, 10mM DTT, 1 
mM ATP, pH 7.5). The reaction mixture was incubated at 37C for 30 min.  
 
2.4.4. Phenol-chloroform extraction of PCR products 
The PCR product was made (as explained in 4.2.3.) upto a final volume of 200 l 
with ddH2O. An equal volume of phenol/chloroform/isoamyl alcohol (50:49:1) was 
added to the diluted PCR product, mixed and centrifuged at 16,000g for ten min. The 
upper phase was carefully taken and an equal volume of chloroform/isoamyl alcohol 
(49:1) was added. The solution was mixed and centrifuged at 16,000g for ten min. 
DNA was precipitated using 0.3 M sodium acetate and 2.5 volumes of absolute 
ethanol at -80C for ten min. The solution was then centrifuged at 16,000g for ten 
min. The supernatant was discarded and the DNA pellet was washed with 500 l of 
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70% ethanol (v/v) at 16,000g for ten min. The pellet was air dried for ~5 min and 
resuspended in ddH2O to proceed with appropriate restriction enzyme digests.  
 
2.4.5. Restriction enzyme digests of PCR products 
All restriction enzyme digests for cloning procedures were performed as 16-fold over- 
digestion where 1 unit of enzyme digests 1 μg of plasmid DNA/ PCR product per hr. 
All digestion reactions were set in a 50 μl reaction volume. Enzymatic reactions were 
inactivated by adding 100 μl of phenol/chloroform/isoamyl alcohol (50:49:1) and 
centrifugation at 16,000g for five min. From the supernatant, 50 μl was run on a 1% 
agarose gel (w/v) to proceed with gel extraction of the desired band.  
 
2.4.6. Gel extraction of digested DNA fragments 
Gel purification of digested DNA fragments was done using the gel extraction kit from 
Fermentas as follows. After running restriction digests in a 1% agarose gel (w/v), the 
desired DNA fragment was excised from the gel and weighed. For every 100 mg of 
agarose gel, 100 l of binding buffer was added. The gel mixture was incubated at 
55C for five min until the gel piece was completely dissolved. Silica powder 
suspension was then added to the mixture (5 l of silica powder suspension for ≤2.5 
g of DNA and an additional 2 l of silica powder suspension for every g if DNA 
≥2.5 g). The mixture was incubated at 55C for five min with intermediate mixing to 
allow DNA binding to the silica beads. The mixture was then centrifuged at 16,000g 
for 5 sec to form a silica pellet. The supernatant was removed and the pellet was 
resuspended in 500 l of ice cold washing buffer (2.5% concentrated washing buffer 
(v/v), 50% absolute ethanol (v/v)). This process was repeated three times after which 
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the silica pellet was air dried until all ethanol evaporated. Finally, the pellet was 
resuspended in a desired volume of ddH2O or 1X TE (10 mM Tris pH 7.5, 1 mM 
EDTA pH 8.0), incubated at 55C for five min and centrifuged at 16,000g for 1 min. 
The recovered supernatant was placed in a new tube and centrifuged again to 
remove residual silica before being used for setting up ligation reactions.  
 
2.4.7. Ligation 
Gel purified vector backbone and inserts were run on an agarose gel to determine 
the relative concentrations of each DNA fragment. Appropriate ratios of the backbone 
and inserts (total DNA amount of 100-120 ng) were ligated in a final volume of 10 l 
using 400 cohesive units of T4-DNA ligase in 1X T4-DNA ligase buffer. The ligation 
mixture was incubated overnight at 16C. 
 
2.4.8. Bacterial transformation 
2.4.8.1. Heat shock transformation  
Heat shock transformation was used only to obtain higher yields of plasmids.   
Chemically competent E. coli (DH5α strain) cells were thawed on ice. Approximately 
0.5-1g of plasmid DNA was mixed with 20 l of E. coli cells and incubated on ice for 
30 min. The mixture was incubated at 42C for 90 sec and the tube was immediately 
placed on ice for 1 min. Subsequently, 400 l of SOC medium (2% Bacto tryptone 
(w/v), 0.5% Bacto yeast extract (w/v), 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 
mM MgSO4, 20 mM glucose) was added and the cells were regenerated at 37C for 
1 hr. The bacteria were then plated on agar plates with appropriate antibiotic 
selection and incubated overnight at 37C. 
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2.4.8.2. Electro-transformation 
Electro-transformation was used while cloning fragments to obtain new constructs. 
Electro-competent E. coli (DH5α strain) were thawed on ice. The ligation mixture was 
dialyzed on membranes (0.025 m, Millipore) against ddH2O for 30 min. The dialyzed 
mixture was washed off the membrane using 8 l of ddH2O and this step was 
repeated thrice. The mixture was gently added to 25 l of bacterial cells and the final 
volume was made up to 90 l with ddH2O. This suspension was carefully transferred 
into a cold 1 mm electroporation cuvette (0.2cm, Cell Projects) without introducing 
any air bubbles. The cuvette was placed in a chilled safety slide of a pulser 
apparatus (Biorad) and pushed into the chamber until the cuvette was seated 
between the contacts at the base of the chamber. The cells were pulsated once with 
2.0 kV, 200 Ω and 25 F. The capacitance extender and time constant were 
expected to be 125 F and 4.5-5 ms, respectively.  The pulsated cells were 
resuspended gently in 500 l of SOC medium and incubated at 37C for 1 hr. The 
bacteria were then plated onto agar plates with appropriate antibiotic selection and 
incubated overnight at 37C. 
 
2.4.9. Recombineering 
Recombineering is a technique to obtain a fragment from the donor DNA in the host 
cell by transforming in a linearized vector with homologous regions (200-250 nts) at 
each end. For homologous recombination to occur the host cell requires the pRed/ET 
plasmid which encodes the genes of proteins required for recombination, which are 
induced by L-arabinaose at 30ºC. The plasmid is lost at 37ºC due to temperature 
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sensitive origin of replication. In order to detect efficient recombination, the donor 
vector needs to have a different selection than the receiving vector.  
 
2.4.9.1. Generation of pRed/ET electro-competent cells 
From a single colony of pRed/ET plasmid (Gene Bridges) containing cells (agar 
plates containing 3 µg/ml tetracycline), an overnight culture was set up at 30ºC with 
vigorous shaking. An inoculum of 5 ml from the fresh overnight culture was added to 
500 ml of LB medium (3 µg/ml tetracycline) and incubated at 30ºC until OD600 
reached ~0.2. Care was taken to not overgrow the culture above an OD600 of 0.2. 
Immediately, 15 µl of 10% L-arabinose (w/v) was added to the culture and placed in a 
37ºC water bath and then in a 37ºC shaker for one hr until OD600 reached 0.35-0.4. 
Care was taken to not overgrow the culture above an OD600 of 0.4. Cells from this 
culture were washed with 10% glycerol (w/v) to generate electro-competent cells (as 
explained in 4.4.2.2.). Linearized donor and recipient fragments with homologous 
flanking sequences (200-400 bp) were co-transformed to allow recombineering of the 
insert.  
 
2.4.9.2. Generation of Dscam BAC/pRed/ET electro-competent cells  
From a single colony of Dscam BAC (Pacman Resources) containing cells (agar 
plates containing 12.5 µg/ml chloramphenicol) an overnight culture was set up at 
37C with vigorous shaking. An inoculum of 30 µl from the fresh overnight culture 
was added to 1.4 ml of LB medium (12.5 µg/ml chloramphenicol) and grown at 37C 
with vigorous shaking until OD600 reached 0.6. Care was taken to not overgrow the 
culture above an OD600 of 0.6. The following steps were carried out at ~0C. Cells 
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were harvested by centrifugation at 10,000g for 30 s. The supernatant was removed 
and the pellet was carefully resuspended in 1 ml of ice-cold 10% glycerol (w/v). This 
step was repeated once again and the supernatant was tipped out and dripped on a 
paper towel. The cells were resuspended in the ~30 µl of glycerol left behind. Cells 
were electro-transformed using 1-5 ng of pRed/ET and grown at 30C for 70 min 
before plating (3 µg/ml tetracycline; 12.5 µg/ml chloramphenicol). The cells were 
grown on plates in the dark at 30C for 24 hr. 
 
2.4.9.3. Preparation of Dscam BAC/pRed/ET host for DNA retrieval 
From a single colony of Dscam BAC/pRed/ET containing cells (3 µg/ml tetracycline; 
12.5 µg/ml chloramphenicol) an overnight culture was set up at 30C with vigorous 
shaking. An inoculum of 30 µl from the fresh overnight culture was added to 1.4 ml 
LB medium (3 µg/ml tetracycline; 12.5 µg/ml chloramphenicol) and grown at 30C 
with vigorous shaking until OD600 reached 0.2. Care was taken to not overgrow the 
culture above an OD600 of 0.2. Then, 15 µl of 10% L-arabinose (w/v) was added to 
the culture and immediately placed in a 37ºC shaker for one hr until OD600 reached 
0.35-0.4. Care was taken to not overgrow the culture above an OD600 of 0.4. The 
following steps were carried out at ~0C. Cells were harvested by centrifugation at 
10,000g for 30 s. The supernatant was removed and the pellet was carefully 
resuspended in 1 ml of ice-cold 10% glycerol (w/v). This step was repeated once 
again and the supernatant was tipped out and dripped on a paper towel. The cells 
were resuspended in the ~30 µl of glycerol left behind and electro-transformed with 
linearized fragments with flanking sequences (200-400 bp) homologous to 
sequences flanking the region of DNA to be retrieved from Dscam BAC clone.  
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2.4.10. Plasmid DNA mini prep 
From 12-48 individual colonies picked randomly from agar plates, overnight cultures 
were set up in 3 ml of 2YT medium with appropriate antibiotic selection and grown at 
35.5C for 16-18 hr with vigorous shaking. The shaker was set at 35.5°C and not 
37C because incase the temperature goes above 37C (due to inconsistency of the 
thermostat), it has been observed that bacteria produce non-digestible DNA and also 
cause unwanted recombination events with large plasmids. From the overnight 
culture, 1.5 ml was centrifuged at 800g for five min. The supernatant was discarded 
and the cells were lysed with STET (8% sucrose (w/v), 0.1% Triton-X 100 (v/v), 50 
mM EDTA, 50 mM Tris pH 8-8.5) and lysozyme (0.7 g/l, 0.7M Tris pH 7.5). The 
solution was vortexed and allowed to stand at room temperature for five min after 
which it was boiled for 1-3 min and centrifuged at 16,000g for ten min. The protein 
pellet was removed with a toothpick after which RNaseA (0.04 g/l, 0.2 mM Tris pH 
7.5, 0.3 mM NaCl, Roche) and 0.3 M sodium acetate (pH 5.2) was added to the 
supernatant and allowed to stand at room temperature for five min. Thereafter, 500 l 
of absolute isopropanol was added and the solution was centrifuged at 16,000g for 
ten min. The supernatant was discarded and the pellet was washed with 650 l of 
70% ethanol (v/v) at 16,000g for ten min. The pellet was air dried for ~ five min and 
then dissolved in 50 l 1X TE out of which 20 l was used for analytical restriction 
enzyme digests to screen for the right clone.  
 
2.4.11. Plasmid DNA midi prep  
Plasmid DNA midi preps were done using the Qiagen plasmid purification kit as 
follows. On obtaining the right clone, a starter culture was inoculated from its 
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corresponding colony in 3 ml of LB medium with appropriate antibiotic selection. After 
six hr of culturing, it was transferred into 32 ml of LB medium and incubated 
overnight at 35.5C for 16-18 hr in a shaker. Subsequently, the cells were harvested 
by centrifugation at 800g at 4C for 15 min. The bacterial pellet was resuspended in 4 
ml of buffer P1 (50 mM Tris-Cl, 10 mM EDTA, 100 g/ml RNase, pH 8.0). Then, 4 ml 
of chilled buffer P2 (200 mM NaOH, 1% SDS (v/v)) was added and the suspension 
was mixed thoroughly by inverting the tube 4-6 times and incubated at room 
temperature for five min. Then, 4 ml of buffer P3 (3 M potassium acetate, pH 5.5) 
was added and immediately mixed by inverting the tube 4-6 times. The lysate was 
poured into the barrel of the QIAFilter Cartridge and incubated at room temperature 
for ten min. In the mean time, the QIAGEN-tip 100 was equilibrated with 4 ml of 
buffer QBT (750 mM NaCl, 50 mM 3-morpholinopropane-1-sulfonic acid (MOPS), 
15% isopropanol (v/v), 0.15% Triton X-100 (v/v), pH 7.0) and the column was 
emptied by gravity flow. A plunger was inserted in the previously equilibrated 
cartridge and the lysate was filtered into the QIAGIN-tip 100 and allowed to enter the 
resin by gravity flow. The QIAGIN-tip 100 was washed two times with 10 ml of buffer 
QC (1 M NaCl, 50 mM MOPS, 15% isopropanol (v/v), pH 7.0) by gravity flow. Finally, 
the DNA was eluted from the column by 5 ml of buffer QF (50 mM Tris-Cl, 1.25 M 
NaCl, 15% isopropanol (v/v), pH 8.5). The eluted DNA was precipitated by adding 3.5 
ml of room temperature absolute isopropanol and centrifugation at 2,500g for 30 min. 
The supernatant was discarded and the DNA pellet was washed with 2 ml 70% 
ethanol (v/v) by centrifugation at 2,500g for ten min. The supernatant was discarded 
and the DNA pellet was air dried for ~5 min and dissolved in 50-100 l of 1X TE. 
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2.4.12. DNA sequencing 
All plasmid DNA midi preps were sequenced in the Functional Genomics, Proteomics 
and Metabolomics Facility in the School of Biosciences, University of Birmingham. 
For a total reaction volume of 11 l, 0.5 M of the primer was mixed with appropriate 
amounts of DNA as suggested by Beckman Coulter (Table 3). 
 
2.4.13. Cloning of pAc5.1A Dscam Mut Exons 4-9 
The complete cloning strategy is diagrammatically represented in Figures 17 and 18. 
For cloning of the pAc5.1A Dscam Mut Exons 4-9 construct, the 3’UTR of Dscam 
was amplified from pcDNA3(-MCS)/F.L. Dscam 7.27.25.2 (kindly provided by Dr. Woj 
Wojtowicz, University of California) with primers Dscam cDNA end F1 NotI EcoRV 
(GTGCTGCGGCCGCGATATCCCGCCAACTGTGCCGAAGAGGACCAATATCG) 
and Dscam cDNA end R1 
(AAATGCCACGCCCACCGCCGCAGAGGGCGCTTACAAATTACACTG) and the 3’ 
end of the endogeneous poly A site was amplified from the Dscam BAC clone with 
primers Dscam 6kb frag F1 
(AAATGTTTTTGTACATCAATTTTCGTGTCTGTGGTCCG) and Dscam 6kb frag R1 
Xho Spe 
(GCGTCCTCGAGACTAGTCTGATAACTGCTCCCGCTGATCCTGCTAATCCCTTG).  
and cloned into pAc5.1A (Invitrogen) using NotI and SalI/XhoI sites to generate 
pAc5.1A Dscam 3’UTR ends. The first part of Dscam 5’UTR was amplified from the 
Dscam BAC clone with primers Dscam 5’UTR1 F1 BsrGI SalI BglII  
(GCGTCTGTACAGTCGACAGATCTAGAACCGGATTTCAGCGCTAGTCGGCG) and 
Dscam 5’UTR1 R1 
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Size 
(kbp) 
ng for 100 
fmol 
0.20 13 
0.30 20 
0.40 26 
0.50 33 
1 65 
2 130 
3 195 
4 260 
5 325 
6 390 
8 520 
10 650 
12 780 
14 910 
16 1040 
18 1170 
20 1300 
48 1500 
 
 
 
Table 3: Estimation of DNA amounts corresponding to size for DNA sequencing 
(Beckman Coulter). 
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Figure 17: Diagrammatic representation of the initial cloning steps to generate pAc5.1A Dscam Mut 
Exons 4-9 construct. The pAc5.1A Dscam Mut Exons 4-9 construct includes a single Dscam isoform 
comprising variable exons 4.6, 6.32, 9.25 and 17.2, which was exogenously overexpressed in S2 
cells via transfection to test if the endogenous Dscam splicing pattern alters to favour inclusion of the 
exogenous Dscam isoform. 
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Figure 18: Diagrammatic representation of the final cloning step to generate pAc5.1A Dscam Mut 
Exons 4-9 construct. The pAc5.1A Dscam Mut Exons 4-9 construct includes a single Dscam isoform 
comprising variable exons 4.6, 6.32, 9.25 and 17.2, which was exogenously overexpressed in S2 
cells via transfection to test if the endogenous Dscam splicing pattern alters to favour inclusion of the 
exogenous Dscam isoform. 
 
 84 
 (ATTGTTAACACTCACACACACACACTTGTGAGAGTGGTG) and the second part 
of Dscam 5’UTR was amplified from pcDNA3(-MCS)/F.L. Dscam 7.27.25.2 using 
primers Dscam 5’UTR2 F2 (TAATCGCATTTAAAAAACAATTTGGCCAGCCGCAG) 
and Dscam 5’UTR2 R2 NotI EcoRV 
(GCGTCGCGGCCGCGATATCTCGGGCATGGGATTGCCGCTGGCCTTG). Both 
the 5’UTR fragments were cloned into pAc5.1A Dscam 3’UTR ends using 
Acc65I/BsrGI and NotI sites to generate pAc5.1A Dscam 5’UTRs and 3’UTR ends. 
The entire 6kb inter-genic fragment from the Dscam BAC clone was recombined into 
pAc5.1A Dscam 5’UTRs and 3’UTR ends cut with SwaI to generate pAc5.1A Dscam 
5’UTR and 3’UTR (Construct A). The Dscam cDNA region was recombined from 
pcDNA3(-MCS)/F.L. Dscam 7.27.25.2 into pAc5.1A Dscam 5’UTR and 3’UTR cut 
with EcoRV to generate pAc5.1A Dscam cDNA (Construct B). In parallel to the above 
steps, the pOT Mut Exons 4-9 construct was cloned. To achieve this, a fragment 
encoding exons 1-4 was amplified from pcDNA3(-MCS)/F.L. Dscam 7.27.25.2  with 
primers Dscam Exon 1-4 F1 Xho NotI Xba HindIII Ase 
(GCGTCCTCGAGACGCGGCCGCAGTCTAGAATAAGCTTGCATTAATCGCATTTA
AAAAACAATTTGGCCAGCCGCAG) and Dscam Exon 1-4 R1 BsrGI 
(GATATCGGCGCCGTAAAACTGATTCACAACGGCTCGCACATGTACATCCCGG). 
Exons 4-5 were amplified from embryonic Dscam cDNA with primers Dscam Exon 4-
5 F1 BsrG1 
(CCGGGATGTACATGTGCGAGCCGTTGTGAATCAGTTTTACGGCGCCGATATC) 
and Dscam Exon 4-5 R1 (GTCGTCCTTTTGTGGCACTTAATCGGGTTTCTCCG). 
These two fragments were fused together by an overlapping PCR with primers 
Dscam Exon 1-4 F1 Xho NotI Xba HindIII Ase 
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(GCGTCCTCGAGACGCGGCCGCAGTCTAGAATAAGCTTGCATTAATCGCATTTA
AAAAACAATTTGGCCAGCCGCAG) and Dscam Exon 4-5 R1 
(GTCGTCCTTTTGTGGCACTTAATCGGGTTTCTCCG). Exons 5-7 were amplified 
from embryonic Dscam cDNA with primers Dscam Exon 5-7 F1 
(TAGTCATCACAGAGCCCGTTAGCAGTAGTCCGCCCAAAATCAATG) and Dscam 
Exon 5-7 R1 NgoMIV Spe Mlu BglII EcoRI 
(GCGTCGAATTCAGAGATCTGCACGCGTAGACTAGTGCGCCGGCGACGCACTT
GAGGAATACACTTGGTCCGGGTTCCATG). These two PCR products were cloned 
into pOT (kindly provided by Dr. Saverio Brogna, University of Birmingham) using 
XhoI and EcoRI sites to give pOT Dscam Mut Exons 4-6. Exons 7-8 were amplified 
from pcDNA3(-MCS)/F.L. Dscam 7.27.25.2 with primers Dscam Exon 7-8 F1 NgoMIV 
(GCGAGTGCTGAGCTGAAGCTCGGAGGCCGTTTCG) and Dscam Exon 7-8 R1 
(GAGATCCTCGAGCAGAGTATCCTTCCTGATTCTTGGC). Similarly, Exons 8-13 
were amplified from pcDNA3(-MCS)/F.L. Dscam 7.27.25.2 with primers Dscam Exon 
8-13 F1 (TAGAAGTGCAAGTCATGGTTCCACCCAAAATTACGCCCTTCGACTTCG) 
and Dscam Exon 8-13 R1 EcoRI 
(GTTGGCACTGAATTCGACGCCCTTGATCTTCCATGTG). The above two PCR 
products were cloned into pOT Dscam Mut Exons 4-6 using NgoMIV and EcoRI sites 
to generate pOT Dscam Mut Exons 4-9. Finally, the mutated Dscam cDNA from pOT 
Mu Exons 4-9 was recombined into pAc 5.1A Dscam cDNA cut with Acc65I and NheI 
and end filled with T4 DNA pol to generate pAc5.1A Dscam Mut Exons 4-9 (Final 
construct) (Figure 18).  The midi prep of the final construct was confirmed by 
sequencing the region of the insert carrying the mutations. 
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2.5. Cell culture 
2.5.1. Pathogen infection of Drosophila haemocytes 
The type and culture conditions of pathogens used are listed in Table 4. Drosophila 
Schneider 2 (S2) cells were cultured in Insect Express medium supplemented with 
10% heat inactivated foetal bovine serum (FBS) and 1% L-
glutamine/penicillin/streptomycin (w/v) at 27C with 0% CO2. They were sub-cultured 
in a ratio of 1:4 (cells:medium) to maintain 3-5x106 healthy cells/ml and to avoid 
growth. They were plated at a density of 3x106 cells/well in six well tissue culture 
plates (Corning), 24 hr prior to pathogen infection. Pathogens, used in the study, 
were harvested from an overnight culture by centrifugation at 800g for five min, for an 
inoculum size of 1x106 cells/ml and washed with sterile 1X PBS (137 mM NaCl, 2.7 
mM KCl, 8 mM Na2HPO4, 1.76 mM KH2PO4, pH 7.4). Pathogens were resuspended 
in 1X PBS and heat inactivated at 70C for 30 min, 60C and 57C each for 2.5 min 
and five min. S2 cells were replenished with serum free and antibiotic free Insect 
Express medium immediately before pathogen exposure. S2 cells were then 
exposed to either live pathogens or inactivated pathogens at an infection ratio 1:10 
(S2 cell:pathogen) and incubated at 27C with 0% CO2 for 12 hr.  
After exposure, the infected S2 cells were harvested and resuspended in 1X PBS. 
RNA was extracted from infected S2 cells for downstream analysis of alternative 
splicing. PBS treated cells were used as controls. S2 cells and S. pombe were kindly 
provided by Dr. Saverio Brogna, University of Birmingham and the Mycobacterium 
sp. and C. glutamicum was kindly provided by Dr. Apoorva Bhatt, University of 
Birmingham. 
 87 
 
Pathogens Strain Medium Temperature 
Escherichia coli DH5 Luria Bertani broth 37C 
Saccharomyces 
pombe 
040 
Yeast extract with 
supplements + 3% 
glucose (w/v) 
30C 
Mycobacterium 
smegmatis 
MC155 
Luria Bertani broth 
+ 0.05% Tween 80 
(v/v) 
37C 
Mycobacterium 
marinum 
Wild type 
7H9 broth 
+ 0.05% Tween 80 
(v/v) 
30C 
Corynebacterium 
glutamicum 
13032 Luria Bertani broth 37C 
Table 4: List of pathogens used to challenge S2 cells. The table shows pathogen strains with their 
culture conditions used to challenge S2 cells to test changes in Dscam alternative splicing.  
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 2.5.2. Treatment of Drosophila haemocytes with drugs affecting 
transcription and RNA pol II processivity 
S2 cells were cultured as mentioned in 4.5.1. S2 cells were then exposed to working 
concentrations of 10 µg/ml Actinomycin D (ActD), 100 µg/ml 6-Azauracil, 100 µg/ml 
DRB and 0.83 mg/ml sodium valproate and incubated at 27C with 0% CO2 for 12 hr 
(Table 5). After exposure, the infected S2 cells were harvested and resuspended in 
1X PBS. RNA was extracted from treated S2 cells for downstream analysis of 
alternative splicing.  
 
2.5.3. Transfection of pAc5.1A Dscam Mut Exons 4-9 in Drosophila 
haemocytes 
Transfection of S2 cells with pAc5.1A Dscam Mut Exons 4-9 was done by using 
either didecyldimethylammonium bromide (DDAB) or TransIT-LT1 (non-liposomal 
formulation of lipid and protein/polyamine mixture with low toxicity, Mirus). One day 
prior to transfection, 3x106 S2 cells were seeded per well at a concentration of 
1.5x106 cells/ml of complete Insect Express medium supplemented with 10% heat 
inactivated FBS and 1% L-glutamine/penicillin/streptomycin (w/v). On day two, 
transfection was commenced when S2 cells reached a confluency of 50-80%.  For 
transfection with DDAB, 62.5 l of serum free medium was mixed with 26 l of 1X 
DDAB (0.4 mg/ml) in one tube. In another tube, 62.5 l of serum free medium was 
mixed with 3 g of the pAc5.1A Dscam Mut Exons 4-9 construct. Both these solution 
mixtures were incubated separately at room temperature for 30 min and were later 
mixed together. For transfection with TransIT-LT1, 200 l serum free medium was  
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Drugs 
Stock 
Concentration 
Solvent Working solution 
Actinomycin D 50 mg/ml DMSO 10 µg/ml 
6-Azauracil 50 mg/ml NH4OH 100 µg/ml 
DRB 24 mg/ml DMSO 100 µg/ml 
Sodium valproate 50 mg/ml H2O 0.83 mg/ml 
Table 5: List of drugs affecting transcription and RNA pol II processivity used during the study. The table 
shows the stock concentrations (mg/ml), solvents and working solutions of all drugs used during the study.  
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mixed with 3 l of TransIT-LT1 and 3 g of the pAc5.1A Dscam Mut Exons 4-9 
construct and incubated at room temperature for ten min. To the DDAB/DNA and 
TransIT-LT1/DNA mixtures, 580 l and 700 l of serum free medium was added 
respectively. These mixtures were then added separately to S2 cells and incubated 
at 27C without CO2 for three hr. After transfection, any floating cells in the wells 
were removed using a Pasteur pipette attached to an aspirator. The cells were 
replenished with 2 ml of complete Insect Express medium and incubated at 27C 
without CO2 for 2 days. The cells were then harvested for RNA extraction and 
downstream analysis of alternative splicing. 
 
2.6. Western Blotting 
2.6.1. Sample preparation 
In order to check if the transgene UAS Dscam 9L expresses protein, Western blotting 
was done on larval progeny from a cross between homozygous transgenic UAS 
Dscam 9L and Elav Gal4 flies. Five UAS Dscam 9L/Elav Gal4 larvae were 
homogenized in 50 µl of 1X PBS. The homogenized sample was mixed with 50 µl of 
2X sample buffer (125 mM Tris-HCl pH 6.8, 4% SDS (v/v), 0.01% bromophenol blue 
(w/v), 100 mM DTT, 15% glycerol (w/v)) and heat inactivated at 95C for four min.  
 
2.6.2. Sodiumdodecylsulphate polyacrylamide gel electrophoresis (SDS-
PAGE) 
Proteins were resolved by SDS-PAGE (Resolving gel: 8% acrylamide (w/v), 0.1% 
ammonium persulphate (APS) (w/v) and 0.001% TEMED (v/v) in 1X resolving buffer 
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containing 375 mM Tris, 0.125% SDS (v/v), pH 8.8; Stacking gel: 3% acrylamide 
(w/v), 125 mM Tris-HCl pH 6.8, 0.1% SDS (v/v), 0.1% APS (w/v) and 0.001% 
TEMED (v/v); Running buffer: 25 mM Tris, 191 mM glycine, 0.1% SDS (v/v), pH 8.3), 
The samples were run at 20 mA in the stacking gel and then 25 mA in the resolving 
gel. 
 
2.6.3. Transfer 
A nitrocellulose membrane and eight strips of 0.53 mm blotting paper (Whatman 
blotting paper 3MM) cut to the size of the gel were pre-wet in the transfer buffer. A 
sandwich of these components was assembled in a semi dry blotting apparatus 
(Biorad) in the following order (from cathode to anode) – four strips of blotting paper, 
nitrocellulose membrane, SDS gel, four strips of blotting paper. The transfer was 
carried out at 0.8 mA/cm2 for 20-30 min and the membrane was then air dried.   
 
2.6.4. Blocking 
After re-wetting the nitrocellulose membrane in 1X TBST, it was washed using 5% 
dry milk (w/v) dissolved in 1X TBST (0.05% Tween 20 (v/v) in 1X TBS buffer - 25 mM 
Tris, 137 mM NaCl, 2.68 mM KCl, pH 7.4) at room temperature for 30 min on a 
shaker.  
 
2.6.5. Blotting 
After blocking, the membrane was incubated in 1X TBST/0.5% dry milk solution 
(w/v), containing anti-HA primary antibody (Roche) in a 1:100 dilution for 1.5 hr on a 
shaker.   After the primary antibody incubation, the membrane was briefly washed 
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twice followed by four ten min washes in 1X TBST. The membrane was then 
incubated in 1X TBST/0.5% dry milk solution (w/v), containing a peroxidase-
conjugated anti-rat secondary antibody (Amersham) in a 1:10,000 dilution on a 
shaker for 1.5 hr. 
 
2.6.6. Development 
Before developing the blot, the membrane was briefly washed twice followed by four 
ten min washes in 1X TBST. The blot was exposed to an X-ray film and developed 
by chemiluminescence (ECL Super Signal West femto, Thermo Scientific). 
 
Note: All commonly used chemicals were bought from Sigma or Fischer Scientific.  
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CHAPTER 3 
RESULTS 
 
3.1. Dscam variable exons in clusters 4, 6 and 9 have 
similar sizes  
The Dscam gene comprises four variable exon clusters 4, 6, 9 and 17 containing 12, 
48, 33 and 2 alternative exons, respectively, that are spliced in a mutually exclusive 
manner (Figure 5, page 27). RT-PCR (reverse transcription polymerase chain 
reaction) with primers in constitutive exons flanking each variable cluster resulted in a 
single band on an agarose gel for exon clusters 4, 6 and 9 (Figure 19). These bands 
represent a population of variable exons that are indistinguishable due to their 
identical or very similar lengths. Exon 4, 6 and 9 variants range between 159-171bp, 
116-128bp and 279-306bp, respectively. The two exon 17 variants differ in 45bp 
(exon 17.1=168bp; exon 17.2=213bp) and appeared as two separate bands on an 
agarose gel.  
 
3.2. Separation of Dscam variable exons based on 
sequence variation 
To make regulation of Dscam alternative splicing possible, it is required to be able to 
distinguish inclusion levels of individual exon variants in a Dscam variable cluster. 
Analysis of sequence variation between alternative exons in each cluster revealed 
that their annotated sequences are divergent enough so that they can be  
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Figure 19: Amplification of Dscam variable exons by RT-PCR using RNA extracted from wild type 
embryos (Canton S), with primers in the constitutive exons flanking the variable exon clusters. Gene 
specific primer (Dscam YH 11RT1) was used in the RT reaction for cDNA (complementary DNA) 
synthesis. Dscam exon 4 variants were amplified using primers Dscam YH 3F2 and Dscam YH 5R1 
(Lane 1), exon 6 variants with primers Dscam YH 5F1 and Dscam YH 7R1 (Lane 2), exon 9 variants 
with primers Dscam YH 8F1 and Dscam YH 10R1 (Lane 3) and exon 17 variants with primers Dscam 
YH 16F1 and Dscam YH 18R1 (Lane 4). The amplified products were run on a 2.5% agarose gel. 
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distinguished after digestion with a combination of restriction enzymes resulting in 
fragments of distinct lengths. To resolve shorter fragments, the forward primer was 
radiolabeled with 32P and the digested exon variants were run on a denaturing 
polyacrylamide gel. Each band on the gel can be assigned its corresponding variable 
exon number based on the distance of the restriction site closest to the labeled end. 
A diagrammatic representation of separating exon 4 cluster variants is shown in 
Figure 20. Exon 4 variants were identified by digestion with restriction enzymes MboI, 
AluI, HinP1I and TaqαI. All 12 exon 4 variants were separated by this combination of 
restriction enzymes according to their annotated sequence as follows (Figure 21; 
Lane 5 - refer to A1 in appendix). Exons 4.3 and 4.8 were identified by MboI (Figure 
21; Lane 1), exon 4.9 by AluI (Figure 21; Lane 2), exons 4.6 and 4.12 by HinP1I 
(Figure 21; Lane 3) and exons 4.1, 4.4, 4.5, 4.7, 4.10 and 4.11 by TaqαI (Figure 21; 
Lane 4). Exon 4.2 was identified by its full length due to the absence of a restriction 
site. An unspecific band, likely due to PCR artifacts was deteced and is indicated by 
a ‘*’ band. Often, two closely spaced bands were observed in the size range 
expected for exons 4.10 and 4.12. This could likely be due to incomplete 
denaturation of these fragments thus affecting their mobility on the gel. To avoid 
ambiguity, both bands were considered for exons 4.10 and 4.12 when analyzing 
Dscam exon 4 splicing regulation.  
Exon 9 variants were identified by digestion with restriction enzymes HpyCH4IV, 
HaeIII, XmnI, MspI, BstUI and BstNI. Theoretically, this combination of enzymes 
would separate 24 out of the 33 exon 9 variants. Experimentally, however, only 17 
variable exons were identified as follows (Figure 22; Lanes 7, 8 and 9 - refer to A2 in 
appendix). Exons 9.7 and 9.10 were identified by BstUI (Figure 22; Lane 2), exons  
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Figure 20: Diagrammatic representation showing the separation of Dscam exon 4 variants. The green 
box represents the population of Dscam exon 4 variants. Red boxes represent the flanking constitutive 
exons 3 and 5. The solid circle (•) indicates the 
32
P radiolabel at the 5’ end of the forward primer. 
Coloured arrows show the combination of enzymes that digest Dscam exon 4 variants at distinct sites 
resulting in fragments of different lengths that can be separated on a denaturing polyacrylamide gel. 
Note that exon 4 fragments are not drawn to scale. 
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Figure 21: Resolution of Dscam exon 4 cluster. Separation of Dscam exon 4 variants after RT-PCR 
using RNA extracted from wild type embryos (Canton S), with primers Dscam YH 3F2, radiolabeled 
with 
32
P, and Dscam YH 5R1 located in constitutive exons 3 and 5, respectively. The population of 
Dscam exon 4 variants was digested with MboI, AluI, HinP1I and Taq
α
I (Lane 5). Each band is 
assigned its corresponding variable exon number and identifying enzyme in brackets. The population 
of Dscam exon 4 variants was digested individually with MboI, AluI, HinP1I and Taq
α
I, respectively 
(Lanes 1-4). Unspecific bands are indicated by asterisks (*). Samples were run on an 8% denaturing 
polyacrylamide gel. M=50bp ladder (NEB). 
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Figure 22: Resolution of Dscam exon 9 cluster. Separation of Dscam exon 9 variants after RT-PCR 
using RNA extracted from wild type embryos (Canton S), with primers Dscam YH 8F1, radiolabeled 
with 
32
P, and Dscam YH 10R1 located in constitutive exons 8 and 10 respectively. The population of 
Dscam exon 9 variants was digested with BstNI, BstUI, MspI, XmnI, HaeIII and HpyCH4IV (Lanes 7-9, 
digest loaded three times). Each band is assigned its corresponding variable exon number and 
identifying enzyme in brackets. The population of Dscam exon 9 variants was digested individually 
with BstNI, BstUI, MspI, XmnI, HaeIII and HpyCH4IV, respectively (Lanes 1-6). Unspecific bands are 
indicated by asterisks (*). Samples were run on an 8% denaturing polyacrylamide gel. M=50bp ladder 
(NEB), phiX174 DNA/HinfI marker (Biotools). 
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9.4, 9.5, 9.22, 9.23 and 9.26 by MspI (Figure 22; Lane 3), exon 9.25 by XmnI (Figure 
22; Lane 4), exons 9.1, 9.2, 9.8, 9.19 and 9.24 by HaeIII (Figure 22; Lane 5) and 
exons 9.11, 9.20, 9.31 and 9.33 by HpyCH4IV (Figure 22; ane 6). Exons 9.11 and 
9.31 were detected at a very low level and in close proximity to highly expressed 
exons 9.14, 9.15 and 9.28 and exon 9.8, respectively. To avoid the potential overlap 
of radioactive signal between strong and weak bands, exons 9.11 and 9.31 were 
excluded from the analysis of Dscam exon 9 splicing regulation. Exons 9.14, 9.15 
and 9.28 as well as exons 9.16, 9.18 and 9.27 appeared as a single band as they 
were digested by BstNI to produce same sized fragments (Figure 22; Lane 1). Exons 
9.3 and 9.32, digested by BstNI, and exon 9.9 digested by BstUI also appeared 
together as a single band (not shown in figure 22). The remaining seven exon 
variants, namely 9.6, 9.12, 9.13, 9.17, 9.21, 9.29 and 9.30 were not detected at the 
predicted size likely because of low level of inclusion. A few unspecific bands, likely 
due to PCR artifacts, were also detected and are shown as ‘*’ bands (Figure 22). 
Although the focus of this study is on exon 4 and 9 clusters, a preliminary analysis of 
exon 6 cluster was also done. Exon 6 variants were identified by digestion with 
restriction enzymes MboI, AluI, MspI, BstUI, BstNI and TaqαI. Theoretically, this 
combination of enzymes would separate 28 out of the 48 exon 6 variants. 
Experimentally, however, only 23 variable exons were identified based on sequence 
annotation as follows (Figure 23 - refer to A3 in appendix). Exons 6.8, 6.17, 6.18 and 
6.23 were identified by MboI, exons 6.9, 6.13, 6.19, 6.21, 6.22, 6.32, 6.36, 6.38 and 
6.39 by AluI, exons 6.16 and 6.28 by MspI, exons 6.10, 6.15, 6.35 and 6.41 by BstUI, 
exons 6.1, 6.6 and 6.24 by BstNI and exon 6.44 by TaqαI. The unresolved exon 
variants appeared as single bands at distinct positions in groups of two or more  
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Figure 23: Resolution of Dscam exon 6 cluster. Separation of Dscam exon 6 variants after RT-PCR 
using RNA extracted from wild type embryos (Canton S), with primers Dscam YH 5F1, radiolabeled 
with 
32
P, and Dscam YH 7R1 located in constitutive exons 5 and 7, respectively. The population of 
Dscam exon 6 variants was digested with MboI, AluI, MspI, BstUI, BstNI and Taq
α
I (Lane 2). Each 
band is assigned its corresponding variable exon number. Unspecific bands are indicated by asterisks 
(*). Samples were run on an 8% denaturing polyacrylamide gel. M=phiX174 DNA/HinfI marker 
(Biotools). 
 101 
 
exons because they were digested by enzymes to produce the same sized 
fragments. The exon variants that could mot be separated include exons 6.2 and 
6.26 digested by AluI, exons 6.37 and 6.46 digested by BstNI, exons 6.3 and 6.5 
digested by BstUI, exons 6.7, 6.25 and 6.27 digested by MboI, exons 6.33, 6.40, 6.42 
and 6.48 digested by AluI and exons 6.30 and 6.45 digested by TaqαI and AluI, 
respectively. Exon 6.12 digested by AluI and exons 6.14 and 6.34 digested by TaqαI; 
and exons 6.4 and 6.31 digested by MspI also appeared together as single bands, 
respectively (not shown in the figure 23). 
The remaining five exon variants, namely 6.11, 6.20, 6.29, 6.43 and 6.47 were not 
detected at the predicted size likely because of low level of inclusion. A few 
unspecific bands, likely due to PCR artifacts were detected and are shown as ‘*’ 
bands (Figure 23). 
 
3.3. Dscam splicing pattern changes on exposure to 
pathogens in S2 cells 
The splicing pattern of AgDscam exon 4 cluster in Sua5B cells has been shown to 
change on exposure to pathogens and pathogenic determinants to express 
challenge-specific high affinity binding isoforms. Silencing these isoforms by RNAi 
reduces binding of AgDscam to the inducing pathogen and compromises their 
phagocytic uptake. Also, RNAi-mediated depletion of AgDscam in mosquitoes 
reduces their viability after bacterial infection (Dong et al., 2006).  
To test if the splicing pattern of Dscam exon 4 and 9 clusters changes upon 
pathogen exposure, S2 cells were challenged with E. coli, S. pombe, C. glutamicum, 
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M. smegmatis and M. marinum that were heat inactivated at 70°C for 30 min (Figures 
24A and B). Naïve cells expressed all exon 4 cluster variables, but exons 4.3 and 4.6 
were expressed at a very low level (Figure 24A; Lane 1).  Challenges with all 
pathogens increased exon 4.7 inclusion, maximally with S. pombe and M. marinum 
by an 11.2-fold and 9.2-fold upregulation, respectively (Figure 24A; Lanes 3 and 6). 
E. coli and C. glutamicum challenge resulted in a 5.5-fold and 6.1-fold increase in 
exon 4.7 splicing, respectively (Figure 24A; Lanes 2 and 4). Splicing of exon 4.3 was 
downregulated by 5.8-fold in S2 cells exposed to C. glutamicum (Figure 24A; Lane 
4). S2 cells infected with M. smegmatis showed the least overall change in Dscam 
exon 4 splicing (Figure 24A; Lane 5). To attribute the above changes in splicing 
pattern purely to the pathogenic exposure, Dscam exon 4 splicing was examined 
over 4 hr, 8 hr and 12 hr in naïve S2 cells to observe if Dscam splicing changes over 
time. This experiment revealed that Dscam splicing pattern is largely constant over a 
time period of 12 hours suggesting that changes in exon 4.7 splicing were purely due 
to the pathogen exposures (Figures 24C and D). Contrary to exon 4 cluster, S2 cells 
expressed a very limited repertoire of exon 9 cluster variants with exons 9.24, 9.20 
and 9.8 being the predominant exons. A quantification of only these strongly 
expressed exons revealed no significant differences between different pathogen 
challenges (Figures 24E and F).  
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Figure 24 (A,B): Dscam exon 4 splicing pattern changes on exposure to heat inactivated pathogens 
in S2 cells. (A) Analysis of Dscam exon 4 splicing pattern using RNA extracted from S2 cells exposed 
to E. coli (Lane 2), S. pombe (Lane 3), C. glutamicum (Lane 4), M. smegmatis (Lane 5) and M. 
Marinum (Lane 6). PBS added to S2 cells served as controls (Lane 1). (B) Heat map representation of 
Dscam splicing changes observed in A. Dscam exon variants were separated as explained in figure 
legend 21. Unspecific bands are indicated by asterisks (*). Samples were run on an 8% denaturing 
polyacrylamide gel. M=phiX174 DNA/HinfI marker (Biotools). 
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Figure 24 (C,D): Dscam exon 4 splicing pattern does not change in naïve S2 cells over a period of 12 
hr. (C) Analysis of Dscam exon 4 splicing pattern over a time course of 0 hr (Lane 1), 4 hr (Lane 2), 8 
hr (Lane 3) and 12 hr (Lane 4) in naïve S2 cells. (D) Heat map representation of Dscam splicing 
changes observed in C. Dscam exon variants were separated as explained in figure legend 21. 
Unspecific bands are indicated by asterisks (*). Samples were run on an 8% denaturing 
polyacrylamide gel. M=50bp ladder (NEB). 
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Figure 24 (E,F): Dscam exon 9 splicing pattern changes on exposure to heat inactivated pathogens in 
S2 cells. (E) Analysis of Dscam exon 9 splicing pattern using RNA extracted from S2 cells exposed to 
E. coli (Lane 2), S. pombe (Lane 3), C. glutamicum (Lane 4), M. smegmatis (Lane 5) and M. Marinum 
(Lane 6). PBS added to S2 cells served as controls (Lane 1). (F) Heat map representation of Dscam 
splicing changes observed in E. Dscam exon variants were separated as explained in figure legend 
22. Unspecific bands are indicated by asterisks (*). Samples were run on an 8% denaturing 
polyacrylamide gel. M=50bp ladder (NEB). 
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3.4. Variation in Dscam splicing between different 
developmental stages, strains and sexes 
To elucidate the mechanisms regulating Dscam splicing in adaptation to pathogen 
exposure or during neuronal development, it was thought to test mutants in candidate 
genes for splicing regulators. Since Dscam splicing in mushroom bodies and 
dendritic arborization neurons changes such that individual cells acquire a unique set 
of Dscam isoforms, it is possible that Dscam splicing is generally variable. To 
exclude that such variability is a key feature of Dscam, the pattern of Dscam splicing 
at various developmental stages and in individual flies was analysed. Consequently, 
Dscam exon 4 and 9 splicing pattern was analyzed between nine independent pools 
of ten Canton S embryos, ten individual Canton S males and eight individual yw 
females (Figures 25 and 26). These results of this analysis revealed that the choice 
of exon variants in Dscam exon 4 and 9 splicing followed a different trend between 
different developmental stages, wild type strains and sexes. For Dscam exon 4 
splicing, exon 4.9 accounted for 10.3% of all spliced exons in Canton S embryos, 
where as in Canton S males and yw females it accounted for only 3.9%. In Canton S 
males, exon 4.5 represented 12.7% of all splicing events, which was only 6.9% in yw 
females. Similarly, exon 4.8 accounted for 12.5% of all spliced variable exons in yw 
females, which was only 6.9% in Canton S males (Figures 25A-G).   
To attribute variation observed between Canton S males and yw females to strain or 
sex differences, and also to get a better understanding about tissue specific splicing, 
neuron rich head-thoraces were compared with neuron poor abdomens between 
Canton S and yw females. The results revealed that differences in proportions of 
exon variants included in Canton S and yw flies were due to strain differences as
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Figure 25 (A,B): Variation in Dscam exon 4 splicing pattern between different developmental stages, 
strains, sexes and tissues. (A) Analysis of Dscam exon 4 splicing pattern using RNA extracted from 
independent pools of ten 14-18 h old Canton S embryos (Lanes 1-9). (B) Heat map representation of 
Dscam splicing changes observed in A. p values for each exon variant are mentioned alongside. 
Dscam exon variants were separated as explained in figure legend 21. Samples were run on an 8% 
denaturing polyacrylamide gel. M=50bp ladder (NEB). 
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Figure 25 (C,D): Variation in Dscam exon 4 splicing pattern between different developmental stages, 
strains, sexes and tissues. (C) Analysis of Dscam exon 4 splicing pattern using RNA extracted from 
single Canton S males (Lanes 1-10). (D) Heat map representation of Dscam splicing changes 
observed in C. p values for each exon variant are mentioned alongside. Dscam exon variants were 
separated as explained in figure legend 21. Samples were run on an 8% denaturing polyacrylamide 
gel. M=phiX174 DNA/HinfI marker (Biotools). 
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Figure 25 (E,F,G): Variation in Dscam exon 4 splicing pattern between different developmental 
stages, strains, sexes and tissues. (E) Analysis of Dscam exon 4 splicing pattern using RNA extracted 
from single yw females (Lanes 1-8). (F) Heat map representation of Dscam splicing changes observed 
in E. p values for each exon variant are mentioned alongside. Dscam exon variants were separated as 
explained in figure legend 21. Samples were run on an 8% denaturing polyacrylamide gel. (G) 
Graphical representation of percentage inclusion levels of each exon 4 variant observed in A, C and E. 
M=phiX174 DNA/HinfI marker (Biotools). 
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Figure 25 (H,I,J): Variation in Dscam exon 4 splicing pattern between different developmental stages, 
strains, sexes and tissues. (H) Analysis of Dscam exon 4 splicing pattern using RNA extracted from 
head-thorax from single Canton S female (Lane 1) and yw female (Lane 2); abdomen from single 
Canton S female (Lane 3) and yw female (Lane 4). (I and J) Graphical representation of percentage 
inclusion levels of each exon 4 variant observed in H. Dscam exon variants were separated as 
explained in figure legend 21. Samples were run on an 8% denaturing polyacrylamide gel. M=phiX174 
DNA/HinfI marker (Biotools). 
 
H 
I 
J 
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observed in exons 4.5, 4.8 and 4.12.  The pattern between head-thoraces and 
abdomens was however, very similar within the same strain (Figures 25H-J). Similar 
levels of exon variants such as 4.2, 4.9 and 4.10 were also observed between 
Canton S males and yw females. Only exons 4.6 and 4.11 showed comparable levels 
of inclusion between all the three sample types (Figure 25G). For Dscam exon 9 
splicing, exons 9.7 and 9.8 both accounted for 15.5% of all exon 4 variants in Canton 
S embryos, which were expressed at levels less than 8.6% and 4.1% in Canton S 
males and yw females, respectively. Exon 9.24 was maximally included in yw 
females representing 33.4% of all exons included within the cluster, where as in 
Canton S embryos and flies it was only 9.2% and 19.32% respectively. Overall, exon 
9 cluster showed less variation between the three sample sources as compared to 
the exon 4 cluster (Figures 26A-G).  
The splicing pattern between individual pools of Canton S embryos, Canton S males 
and yw females was highly reproducible. To investigate reproducibility of Dscam 
splicing pattern between independent experiments a 2-tailed t-test was performed for 
each of the resolved exon 4 and 9 variants by comparing their inclusion levels across 
all experiments. The data set was randomly divided into 3 different pairs of arrays 
and their mean p value was calculated. The obtained p values for all exon 4 and 9 
variants were >0.05, which suggested that the results obtained between independent 
experiments are very similar. Hence, Dscam splicing pattern is highly reproducible 
between individual samples of the same source such as embryo pools and individual 
flies. The p values are shown adjacent to each exon 4 and 9 variants in figures 25 
and 26B, D and F, respectively. Between individual Canton S males, exons 4.4, 9.2,
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Figure 26 (A,B): Variation in Dscam exon 9 splicing pattern between different developmental stages, 
strains, sexes. (A) Analysis of Dscam exon 9 splicing pattern using RNA extracted from independent 
pools of ten 14-18 h old Canton S embryos (Lanes 1-5). (B) Heat map representation of Dscam 
splicing changes observed in A. p values for each exon variant are mentioned alongside. Dscam exon 
variants were separated as explained in figure legend 22. Unspecific bands are indicated by asterisks 
(*). Samples were run on an 8% denaturing polyacrylamide gel. M=phiX174 DNA/HinfI marker 
(Biotools).
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Figure 26 (C,D): Variation in Dscam exon 9 splicing pattern between different developmental stages, 
strains, sexes. (C) Analysis of Dscam exon 9 splicing pattern using RNA extracted from single Canton 
S males (Lnes 1-5). (D) Heat map representation of Dscam splicing changes observed in C. p values 
for each exon variant are mentioned alongside. Dscam exon variants were separated as explained in 
figure legend 22. Unspecific bands are indicated by asterisks (*). Samples were run on an 8% 
denaturing polyacrylamide gel. M=50bp ladder (NEB).
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Figure 26 (E,F,G): Variation in Dscam exon 9 splicing pattern between different developmental 
stages, strains, sexes. (E) Analysis of Dscam exon 9 splicing pattern using RNA extracted from single 
yw females (Lanes 1-5). (F) Heat map representation of Dscam splicing changes observed in E. p 
values for each exon variant are mentioned alongside. (G) Graphical representation of percentage 
inclusion levels of each exon 9 variant observed in A, C and E. Dscam exon variants were separated 
as explained in figure legend 22. Unspecific bands are indicated by asterisks (*). Samples were run on 
an 8% denaturing polyacrylamide gel. M=50bp ladder (NEB).
G 
E F 
 115 
9.5 and 9.33 showed the most variation. Females from the yw strain showed 
complete absence of exon 9.33.    
 
3.5. Analysis of Dscam splicing in mutants of genes 
involved in small RNA and mRNA processing 
Dscam mutants exhibit severe nervous system defects manifested in the disruption 
of connectives and commissures in the ventral nerve cord (Schmucker et al., 2000). 
Therefore, mutants of genes involved in RNA processing, which have similar nervous 
system defects to analyze Dscam splicing were searched. The genes that were 
identified with such a phenotype were elav and ago1 (Kataoka et al., 2001; Simionato 
et al., 2007) (Figure 27). ELAV is a neuron-specific RNA binding protein that 
regulates alternative splicing of erect wing and Neuroglian by binding to their pre-
mRNA (Lisbin et al., 2001; Soller and White, 2003). Ago1 is a key component of the 
RNAi machinery, which functions in the cytoplasm as a regulator of translation and 
RNA degradation, and in the nucleus as a regulator of chromatin remodeling 
(Bernstein and Allis, 2005; Hutvagner and Simard, 2008). Given Ago1’s role in 
chromatin remodeling, it was further reasoned that the inclusion of a specific Dscam 
exon in the variable cluster might be mediated by its RNA sequence through Ago1 by 
signaling back to the nucleus, potentially involving chromatin remodeling.  Thus, 
Ago1 might play a role in regulating Dscam splicing by an unknown RNA based 
mechanism of signaling from the cell surface to the nucleus to induce selection or 
repression of a particular Dscam isoform (shown later in Figure 35). In addition to 
Ago1, Drosophila has a second Argonaute protein; Ago2, which is primarily involved 
in siRNA-mediated silencing of exogenous genes in response to, for e.g. viruses or of  
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Figure 27: ago1 and elav show similar Dscam mutant phenotype. Similar nervous system defects 
manifested in abnormal connectives and commissures observed in stage 16 mutant embryos of (A) 
Dscam, (B) ago1 and (C) elav. Adapted from (Kataoka et al., 2001; Schmucker et al., 2000; Simionato 
et al., 2007). 
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endogenous genes primarily encoded by transposons (Chung et al., 2008; Okamura 
et al., 2004; van Mierlo et al., 2012).  
In this study, mutants in rrp6, the activity determining component of the nuclear 
exosome and trf4, a component of the TRAMP complex, involved in degradation of 
aberrant RNAs and spurious transcripts termed, cryptic transcripts were also included 
(Callahan and Butler, 2010). It was reasoned that such transcripts might be involved 
in selection of exons in the Dscam variable region. In particular, spurious antisense 
transcription has been shown to silence genes and such a mechanism could also 
occur in the Dscam region to suppress inclusion of specific exon variants (Camblong 
et al., 2007).   
Dscam splicing in mutants for the above genes in 14-18h old embryos were analyzed 
because ago1, rrp6 and elav null mutants are embryonic lethal. To analyze Dscam 
splicing in ago1 and rrp6 mutants, a genetic trick was applied to select for null mutant 
embryos because no GFP labeled balancers were available at this time that would 
allow selection of homozygous mutant embryos. Therefore, the GAL4/UAS system 
was used to mark the chromosome carrying the mutation with elavGAL4 and a 
chromosome carrying a deficiency of the locus with UAS GFP (Brand and Perrimon, 
1993). If these two strains are crossed together, only the mutant embryos will 
express GFP. This genetic selection system was used to identify ago1 and rrp6 
mutants. For selection of elav null embryos, the C155 enhancer trap GAL4 inserted in 
the elav gene was used in combination with UAS GFP to label the elav+ progeny 
from the following cross, elav/C155; UAS GFP/+ x C155/Y; UAS GFP/UAS GFP  
(refer to A4, A5 and A6 in appendix). Embryos of ago2 and trf4 mutants were directly 
collected from their stocks because they are homozygous viable. 
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Dscam exon 4, 6 and 9 splicing pattern was analyzed in ago1, ago2, rrp6, trf4 and 
elav mutant embryos. Analysis of Dscam exon 4 splicing pattern revealed that ago1 
mutants produced a severe overall effect in altering Dscam splicing. Exons 4.5 and 
4.11 were not detected (Figure 28A; Lane 3). Also, splicing of exons 4.3 and 4.10 
was reduced by over two-fold. Exon 4.4 splicing was enhanced in rrp6, ago2 and 
elav mutants by greater than five-fold (Figure 28A; Lanes 2, 5 and 6). Analysis of 
Dscam exon 9 splicing revealed that elav mutants produced the most dramatic 
changes. Exons 9.1, 9.4, 9.19, and 9.23 were all downregulated by over five-fold. 
The ago2 mutants also showed downregulation of exons 9.19 and 9.20 by 4.5 and 
6.8-fold, respectively (Figure 29A; Lane 3). Thus, exon cluster-specific effects in 
regulation of Dscam alternative splicing were observed with ago1 affecting exon 4 
and elav affecting exon 9 splicing. Also, a preliminary study on regulation of Dscam 
exon 6 splicing by the above mutants was carried out. None of the mutants produced 
any pronounced effects in splicing of exon 6 variants, except ago1 mutants which 
downregulated exon 6.6 by 2.3-fold (Figure 30A; Lane 2).  
 
3.6. Analysis of ago1 and rrp6 maternal mutants and 
redundancy between Agos and rrp6 in Dscam splicing 
regulation 
Although differences in Dscam exon 4 splicing were primarily observed in ago1 
mutants, the full effect of the Argonaute proteins might not have been seen because 
they might function redundantly in regulating Dscam splicing. To test if Ago1 and 
Ago2 play redundant roles in regulating Dscam splicing, double mutants of ago1 and 
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Figure 28: Analysis of Dscam exon 4 splicing in mutants of genes involved in small RNA and mRNA 
processing. (A) Analysis of Dscam exon 4 splicing pattern using RNA extracted from 14-18 h old 
mutant embryos of rrp6/Df (Lane 2), ago1/Df (Lane 3), elav/Y (Lane 4), ago2/ago2 (Lane 5) and 
trf4/trf4 (Lane 6). Canton S embryos served as control (Lane 1). (B) Heat map representation of 
Dscam splicing changes observed in A. Dscam exon variants were separated as explained in figure 
legend 21. Samples were run on an 8% denaturing polyacrylamide gel. M=phiX174 DNA/HinfI marker 
(Biotools). 
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Figure 29: Analysis of Dscam exon 9 splicing in mutants of genes involved in small RNA and mRNA 
processing. (A) Analysis of Dscam exon 9 splicing pattern using RNA extracted from 14-18 h old 
mutant embryos of ago1/Df (Lane 2), ago2/ago2 (Lane 3), rrp6/Df (Lane 4), trf4/trf4 (Lane 5) and 
elav/Y (Lane 6). Canton S embryos served as control (Lane 1). (B) Heat map representation of Dscam 
splicing changes observed in A. Dscam exon variants were separated as explained in figure legend 
22. Unspecific bands are indicated by asterisks (*). Samples were run on an 8% denaturing 
polyacrylamide gel. M=phiX174 DNA/HinfI marker (Biotools). 
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Figure 30: Analysis of Dscam exon 6 splicing in mutants of genes involved in small RNA and mRNA 
processing. (A) Analysis of Dscam exon 6 splicing pattern using RNA extracted from 14-18 h old 
mutant embryos of ago1/Df (Lane 2), ago2/ago2 (Lane 3), rrp6/Df (Lane 4), trf4/trf4 (Lane 5) and 
elav/Y (Lane 6). Canton S embryos served as control (Lane 1). (B) Heat map representation of Dscam 
most significant splicing changes observed in A. Dscam exon variants were separated as explained in 
figure legend 23. Samples were run on an 8% denaturing polyacrylamide gel. M= phiX174 DNA/HinfI 
marker (Biotools). 
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ago2 were generated. Since ago2 is located on a different chromosome than ago1 
and ago2 mutants are viable, the GAL4-UAS system could be used as before to 
recognize ago1 mutants in an ago2 background (refer to A7 in appendix). Potentially, 
ago1 and rrp6 could act redundantly in selection of Dscam isoforms and therefore 
double mutants were also tested. Testing these double mutants was possible 
because the genes are located on different chromosomes and GFP labeled 
balancers with no maternal expression of GFP were available (refer to A8 in 
appendix).  
Both, ago1 and rrp6 are expressed during oogenesis. Therefore, both proteins are 
deposited in eggs and provide functionality during embryogenesis. Hence, zygotic 
null mutants still contain protein that can last up to the end of embryogenesis. To 
remove maternal ago1 and rrp6, germ line clones for these mutants were generated 
(refer to A9 and A10 in appendix). The dominant female sterile technique utilizes the 
dominant ovoD mutation that does not allow development of oocytes. Mitotic 
recombination mediated by flp-FRT site specific recombination between homologous 
chromosomes, containing either an ovoD transgene or a mutation of choice in female 
germ cells, will result in the loss of ovoD and hence development of functional 
oocytes (Perrimon, 1998) (Figure 31). To allow the generation of germ line clones, 
FRT sites were added to mutant chromosome arms by meiotic recombination and 
validated by PCR (Figures 32A and B).  
Analysis of Dscam exon 4 splicing in ago1/Df;ago2/ago2 double mutants showed no 
significant differences in the splicing pattern (Figure 33A; Lane 3). Also, 
ago1/Df;rrp6/Df double mutants revealed no obvious differences in the splicing 
pattern. Exon 4.12 showed a 1.8-fold decrease in inclusion (Figure 33A; Lane 5).  
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Figure 31: Schematic representation of generating germ line clones using the dominant female sterile 
(DFS) technique. Mitotic recombination occurs between chromosomes with genotypes DFS FRT/lethal 
FRT. The FRT is inserted proximally to both DFS and the lethal mutation. On heat shock treatment, 
the heat shock promoter (on another chromosome) gets activated and provides recombinase activity 
which catalyses the site-specific chromosomal exchange at the FRT sequences. FLP-recombinase 
target sequences (FRT). Dominant Female Sterile (DFS). Recessive zygotic lethal mutation (lethal) 
Adapted from (Perrimon, 1998). 
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Figure 32: PCR validation showing recombined FRT sites on the same chromosome as the (A) ago1 
and (B) rrp6 lethal mutation. Primers pUChneoF1 and pUChneoR1 flanking the FRT sites on 42B and 
primers FRT F1 and Car3’InvR1 flanking the FRT sites on 82B were used to carry out single fly PCRs 
on FRTago1/CyoDfdGFP and FRTrrp6/TM6DfdGFP flies, respectively. The starting fly lines, 
elavGAL4ago1/CyO and elavGAL4rrp6/TM3Sb served as negative controls. The FRTL/SM6 and 
FRTSb/TM6 lines served as positive controls for FRT sites. In both the gels, Canton S males were 
used as negative controls.  
A 
B 
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Figure 33: Analysis of ago1 and rrp6 maternal mutants and redundancy between Agos and rrp6 in 
Dscam splicing regulation (A) Analysis of Dscam exon 4 splicing pattern using RNA extracted from 14-
18 h old mutant embryos of ago1 z&m (Lane 2), ago1/Df; ago2/ago2 (Lane 3), rrp6 z&m (Lane 4) and 
ago1/Df; rrp6/Df (Lane 5). Canton S embryos served as control (Lane 1). (B) Heat map representation 
of Dscam splicing changes observed in A. Dscam exon variants were separated as explained in figure  
 legend 21. Unspecific bands are indicated by asterisks (*). Samples were run on an 8% denaturing 
polyacrylamide gel. z&m = zygotic and maternal mutants. M=50bp ladder (NEB). 
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Germline clones for ago1 and rrp6, unexpectedly showed no obvious changes in 
Dscam exon 4 splicing pattern (Figure 33A; Lanes 2 and 4). 
 
3.7. Overexpression of a single Dscam isoform does not 
reinforce selection of the same variable exons 
The defects that were found in ago1 and rrp6 zygotic mutants were not conclusive 
regarding an RNA mediated mechanism involved in Dscam variable exon selection. 
Since this does not rule out that such a mechanism could apply, it was required to 
test if overexpression of a single Dscam transcript species can reinforce splicing of 
the same isoform. Therefore, a Dscam cDNA construct was generated that includes 
its entire 5’UTR and also includes the endogenous 3’ end-processing site as it was 
reasoned that cytoplasmic cleavage and/or polyadenylation might be involved in 
producing a relay of expression information to the nucleus and force selection of 
specific exons. To be able to distinguish the endogenous Dscam transcripts from the 
overexpressed exogenous isoform, a restriction site was included in front of exon 
clusters 4, 6 and 9, which is absent in the variable downstream cluster to cut off the 
label from PCR products that originate from the transfected cDNA (Figure 34).  
pAc5.1A Dscam Mut Exons 4-9, comprising a single Dscam isoform with variable 
exons 4.6, 6.32, 9.25 and 17.2, was transfected into S2 cells (as mentioned in 4.5.4). 
The splicing pattern of the endogenous Dscam was analyzed for exon clusters 4 and 
9 as before, but also including BsrGI and XbaI to cut the label off from the exogenous 
transcripts originating from the transfected cDNA construct. This analysis revealed 
that the splicing pattern of endogenous Dscam exon 4 and 9 cluster did not change, 
in particular did not reinforce the inclusion of the exogenously expressed variable  
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Figure 34: Diagrammatic representation of distinguishing the endogenous Dscam exon 4 variants 
from the exogenously overexpressed Dscam single isoform, containing exon variant 4.6. A BsrGI 
restriction site added before the variable exon cluster was used to cut off the 5’ radioactive label. The 
dark circle (•) represents 
32
P used to label the forward primer YH Dscam 3F2.  
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exons 4.6 and 9.25, respectively (Figures 3A5 and B).  
 
3.8. Dscam intracellular signaling is not involved in 
regulating its own splicing pattern 
The cytoplasmic domain of Dscam interacts with Dock, an SH3-SH2 adaptor protein, 
and Pak, a serine threonine kinase, to translate the recognized guidance signals into 
changes in the actin-based cytoskeleton and promote axon guidance (Schmucker et 
al., 2000). Individual mushroom body and da sensory neurons from an otherwise 
identical population acquire a unique splicing pattern resulting in canalization of a 
broad variety of Dscam isoforms into just a few unique isoforms (Matthews et al., 
2007; Zhan et al., 2004).  
To test if Dscam intracellular signaling is involved in canalization or in any form of 
exon selection, a set of transposon inserts that result in secreted Dscam (Figure 36A; 
mutants A and B), membrane bound Dscam without intracellular domain (Figure 36A; 
mutants C, D and E) or signaling compromised Dscam (Figure 36A; mutant F) were 
used. Analysis of Dscam exon 9 splicing showed no pronounced effects in any of the 
analyzed mutants.  Mutants D and E with transposons after the transmembrane 
domain behaved similarly, by upregulating exons 9.2 and 9.5 and downregulating 
exon 9.33 by over three-fold (Figure 36B; Lanes 5 and 6). Mutants C and F 
downregulated exon 9.7 by 7.2-fold. Although minor differences were observed, 
however, none of the changes observed in splicing pattern were striking (Figure 36B; 
Lanes 4 and 7). Mutants A and B produced the least effect in changing Dscam exon 
9 splicing (Figure 36B; Lanes 2 and 3).  
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Figure 35: Overexpression of a single Dscam isoform does not reinforce selection of the same 
variable exons. Analysis of endogenous Dscam variable exon 4.6 (A) and variable exon 9.25 (B) 
splicing in response to transfection of exogenous Dscam construct pAc5.1A Dscam Mut Exons 4-9 
into S2 cells by using DDAB (Lane 2) or TRANS-IT (Lane 3). Untransfected S2 cells served as control 
(Lane 1). Dscam exon variants were separated in A and B as explained in figure legend 21 and 22, 
respectively. Samples were run on an 8% denaturing polyacrylamide gel. M=50bp ladder (NEB). 
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Figure 36: Dscam intracellular signaling is not involved in regulating its own splicing pattern. (A) 
Analysis of Dscam exon 9 splicing pattern using RNA extracted from 14-18 h old mutant embryos of 
P[GawB]Dscam
NP3327
 (mutant A; Lane 2), P[RS3]Dscam
CB-0486-3
 (mutant B; Lane 3), P[XP]Dscam
d10584
 
(mutant C; Lane 4), P[EPgy2]Dscam
EY08820
 (mutant D; Lane 5), PBac[SAstopDsRed]LL01770 (mutant 
E; Lane 6) and PBac[RB]Dscam
e04629
 (mutant F; Lane 7). Canton S embryos served as control (Lane 
1). (B) Heat map representation of Dscam splicing changes observed in A. Dscam exon variants were 
separated as explained in figure legend 22. Unspecific bands are indicated by asterisks (*). Samples 
were run on an 8% denaturing polyacrylamide gel. M=50bp ladder (NEB). 
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3.9. Analysis of mRNA methylation for a role in Dscam 
splicing regulation 
The mRNAs of higher eukaryotes can be variably methylated at the cap or internally 
(Motorin). At the cap, the ribose of the first and second nucleotides can be 2’-O-
methylated sequentially by methyltransferases MTr1 and MTr2, respectively 
(Belanger et al., 2010; Kruse et al., 2011; Werner et al., 2011). The first 2’-O-
methylation results in the formation of cap1 and the subsequent methylation results in 
the formation of cap2.  Cap methylations are also present in U snRNAs and seem to 
be essential for splicing regulation (Donmez et al., 2004). Internally, mRNAs can be 
methylated at the N6 position of adenosine and this modification is introduced by a 
multimeric complex containing the catalytic activity of MT-A70 (Bokar et al., 1997). 
Intriguingly, the Arabidopsis thaliana homolog of MT-A70 interacts with the homolog 
of the Drosophila splicing regulator Female-Lethal 2D and m6A modification has 
been found in the vicinity of splice sites (Zhong et al., 2008). Thus, it was reasoned 
that nuclear mRNA methylation, either at the cap or internally might affect Dscam 
splicing by fixing a specific splicing pattern or positively marking specific exons for 
inclusion.  
Analysis of Dscam exon 9 splicing in mutants for cap 2’-O-methyltransferases, dMTr1 
and dMTr2 and double mutant dMTr1/dMTr2 revealed no significant changes in 
splicing pattern (Figure 37C; Lanes 2, 3 and 4). Analysis of Dscam exon 9 splicing in 
mutants for m6A methylase (dMT-A70) and two other putative RNA methylases 
(CG7818 and CG14906) downregulated the inclusion of exon 9.7 by less than two-
fold (Figure 37A; Lanes 2, 3 and 4). No other significant differences were observed.  
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Figure 37 (A,B): Analysis of mRNA methylation for a role in Dscam splicing regulation. (A) Analysis of 
Dscam exon 9 splicing pattern using RNA extracted from 14-18 h old mutant embryos of internal 
mRNA methylases dMT-A70 (Lane 2), CG7818 (Lane 3) and CG14906 (Lane 4). Canton S embryos 
served as control (Lane 1). (B) Heat map representation of Dscam splicing changes observed in A. 
Dscam exon variants were separated as explained in figure legend 22. Unspecific bands are indicated 
by asterisks (*). Samples were run on an 8% denaturing polyacrylamide gel. M=50bp ladder (NEB). 
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Figure 37 (C,D): Analysis of mRNA methylation for a role in Dscam splicing regulation. (C) Analysis of 
Dscam exon 9 splicing pattern using RNA extracted from 14-18 h old mutant embryos of internal cap 
methylases dMTr1 (Lane 2), dMTr2 (Lane 3) and dMTr1/dMTr2 (Lane 4). Canton S embryos served 
as control (Lane 1). (D) Heat map representation of Dscam splicing changes observed in C. Dscam 
exon variants were separated as explained in figure legend 22. Unspecific bands are indicated by 
asterisks (*). Samples were run on an 8% denaturing polyacrylamide gel. M=50bp ladder (NEB). 
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3.10. Analysis of Dscam exon 9 splicing regulation in 
mutants of genes differentially regulated in elav mutants 
Since Dscam exon 9 splicing is particularly affected in elav mutants, the introns of the 
exon 9 cluster were analyzed for potential ELAV binding sites. Although, some U-rich 
sequences are present in this exon cluster, these sequences are not bona fide ELAV 
binding sites and also no experimental evidence could be obtained so far which 
indicates that ELAV directly binds to Dscam pre-mRNA (Haussmann and Soller, 
unpublished). Gene expression analysis in elav mutants, however, has shown that 
numerous genes encoding RNA binding proteins, DNA binding proteins and proteins 
involved in chromatin remodeling are massively differentially expressed (Figure 38) 
suggesting that ELAV might regulate Dscam splicing indirectly. Therefore, all 
available mutants were obtained from these categories of genes (56 genes) that are 
differentially regulated in elav mutants to test their contribution in regulating Dscam 
splicing (refer A11 (A-H) in appendix). As a control to this analysis, mutants of 
metabolic genes were used that were differentially regulated in elav mutants as it was 
anticipated that these genes would not have a role in Dscam splicing regulation 
(Figure 39). Analysis of Dscam exon 9 splicing in mutants of genes differentially 
regulated in elav mutants revealed that Dscam splicing is affected by many genes, 
the pattern, however, is not random (refer A11 (A-H) in appendix). When taking 
exons into consideration that were two-fold or more differentially regulated, it was 
found that a group of exons tended to be preferentially upregulated in a set of 
mutants while a different group tended to be preferentially downregulated in a 
different set of mutants. For upregulated exons, it was found that exons 9.2, 9.7, 9.8, 
9.25 and 9.26 (Figure 39; Columns 2, 5, 6, 13 and 14) were mostly upregulated in  
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Figure 38: Graphical representation of proportions of genes differentially regulated in elav mutants. 
RNA binding proteins, transcription factors and chromatin remodeling genes account for 12%, 11% 
and 12%, respectively of all genes differentially regulated in elav mutants.  
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Figure 39: Heat map representation of Dscam exon 9 splicing analysis in mutants of genes that are 
differentially regulated in elav mutants. CR=chromatin remodeling; T=transcription factors; R=RNA 
binding proteins; M=metabolic genes; O=others, including zinc finger proteins (CG8108 and CG9293), 
RNA-dependent RNA polymerase (d-elp1), nuclear receptor coactivator (neos). 
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mutants of chromatin remodeling factors caf1, His2AV and dek (Figure 39; Rows 8, 
18 and 19). Similar upregulation of these exons was also observed in mutants for 
RNA binding proteins zuc and squ, involved in rasiRNA generation (Figure 39; Rows 
38 and 39, (Pane et al., 2007). 
For downregulated exons, it was found that exons 9.4, 9.19, 9.20, 9.22, 9.24 and 
9.33 (Figure 39; Columns 3, 8, 9, 10, 12 and 15) were mostly downregulated in 
mutants of chromatin remodeling factors CG9418, CG3995 and mcm7 (Figure 39; 
Rows 1, 2 and 27). Also, mutants for pnn, a splicing factor and neos, a nuclear 
receptor coactivator, showed a pronounced decrease in inclusion of most of these 
exons (Figure 39; Rows 41 and 56).     
I also observed that some mutants regulated the splicing pattern of Dscam exon 9 in 
a similar manner by affecting the same groups of exons. Mutants of chromatin 
remodeling genes snr1, His2AV, dek, spt4, not and Df-1 (Figure 39; Rows 17-22) 
showed a very similar Dscam exon 9 splicing pattern by upregulating inclusion of 
exons 9.7, 9.8, 9.23 and 9.25 (Figure 39; Columns 5, 6, 11 and 13) and 
downregulating inclusion of exons 9.1, 9.2, 9.19 and 9.20 (Figure 39; Columns 1, 2, 8 
and 9). Also mutants of zuc and squ regulated Dscam exon 9 splicing pattern in a 
very similar way (Figure 39; Rows 38 and 39). Contrary to expectation, however, no 
mutants were found where only one exon variant was affected, e.g. one exon that 
was massively upregulated or downregulated. This suggested that exon choice is 
regulated by combinatorial interactions of RNA binding proteins, DNA binding 
proteins and chromatin remodeling factors. Furthermore, Dscam exon 9 splicing 
seems to be generally sensitive to genetic perturbation as changes were found in 
mutants of metabolic genes (Figure 39; Rows 47-52). 
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3.11. RNA pol II processivity does not influence splicing of 
Dscam 
The processivity of RNA pol II has been shown to be critical for inclusion of the 
fibronectin EDI exon such that a slow polymerase favours inclusion while a fast 
polymerase results in preferential exclusion of the alternative exon (Kornblihtt et al., 
2004). Accordingly, it was speculated that polymerase processivity might be 
important for Dscam variable exon selection. In particular, pausing of RNA pol II at a 
specific exon variant could relieve its repressed state and result in its inclusion. To 
test if there is a correlation between the speed of the polymerase and inclusion of 
Dscam variable exons, the Drosophila C4 mutant of the RNA pol II subunit 215, 
which has a lower elongation rate was used. In addition, two inhibitors of RNA pol II 
elongation rate namely, 6-Azauracil and dichlororibofuranosylbenzimidazole (DRB) 
were used to analyze Dscam exon 9 splicing in S2 cells (Hrzenjak et al., 2006; 
Iglesias-Gato et al.; te Poele et al., 1999). If indeed a slow polymerase would affect 
inclusion of variable exons, my expectation was to see preferential inclusion of 
cluster proximal exons over cluster distal exons resulting in a polar effect. Alternative 
splicing of exon 23a of Nf1 gene has been shown to be affected by histone 
deacetylase activity such that inhibiting histone deacetylation results in an increased 
local RNA pol II elongation rate resulting in skipping of the alternative exon (Zhou et 
al., 2011). Thus, sodium valproate (Na-valproate), a potent inhibitor of histone 
deacetylase, was used to test if Dscam splicing is regulated by histone modifications. 
Analysis of Dscam exon 9 splicing in flies with a C4 mutation (Figure 40A; Lane 2) 
and S2 cells treated with 6-Azauracil, DRB or sodium valproate (Figure 40A; Lanes 4, 
6 and 8) showed no significant difference in the overall splicing pattern. In the C4  
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Figure 40: RNA pol II processivity does not influence splicing of Dscam. (A) Analysis of Dscam exon 9 
splicing pattern using RNA extracted from 14-18 h old mutant embryos of C4 slow polymerase (Lane 
2) and using RNA extracted from S2 cells after 12 h of exposure to 100 µg/ml azauracil (Lane 4), 100 
µg/ml DRB (Lane 6) and 0.83 mg/ml Na-valproate (Lane 8). Canton S embryos served as control for 
the C4 mutant (Lane 1); solvents NH4OH (Lane 3), DMSO (Lane 5) and water (lane 7) served as 
controls for azauracil, DRB and Na-valproate, respectively. (B) Heat map representation of Dscam 
splicing changes observed in A. Exon 9 variants not detected are represented in grey. Dscam exon 
variants were separated as explained in figure legend 22. Unspecific bands are indicated by asterisks 
(*). Samples were run on an 8% denaturing polyacrylamide gel. M=50bp ladder (NEB). 
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RNA pol II mutant, exon 9.26 was severely downregulated by over ten-fold and exon 
9.5 was not detected. However, this change does not support the relation between 
lower elongation rate and increased inclusion of alternative exons as none of the 
exons showed significant upregulation.  
 
3.12. Dscam diversity is not generated by differential 
stability of isoforms 
Although the sequence contribution of variable exons to the overall length of Dscam 
mRNA is minor (<0.1%) and variable exons have very similar sequences, these 
sequences could affect stability of Dscam mRNAs. To test if sequence variation 
provided by the variable exons contributed to the stability of Dscam isoforms, and this 
way affected steady state levels of different isoforms, the stability of Dscam mRNAs 
was analyzed in S2 cells by stopping transcription with Actinomycin D (Murph et al., 
2007). Analysis of Dscam exon 4 splicing pattern over a time course of 2 h, 4 h and 8 
h post Actinomycin D treatment showed no significant change in the levels of Dscam 
exon 4 variants, which suggested that Dscam diversity, is not generated by 
differential stability of its isoforms (Figures 41A and B). 
 
3.13. Development of a Dscam exon 9 reporter transgene 
recapitulating endogenous exon 9 splicing 
To analyze the sequence elements directing the inclusion of exon 9 variants, a 
reporter gene is required. Therefore, the exon 9 variable cluster was inserted with 
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Figure 41: Dscam diversity is not generated by differential stability of isoforms. (A) Analysis of Dscam 
exon 4 splicing by using RNA extracted from S2 cells exposed to 10µg/ml Actinomycin D over a time 
course of 2 h (Lane 4), 4 h (Lane 5) and 8 h (Lane 6). S2 cells treated with DMSO over a time course 
of 2 h (Lane 1), 4 h (Lane 2) and 8 h (Lane 3) served as controls. (B) Heat map representation of 
Dscam splicing changes observed in A. Dscam exon variants were separated as explained in figure 
legend 21. Unspecific bands are indicated by asterisks (*). Samples were run on an 8% denaturing 
polyacrylamide  gels. M=50bp ladder (NEB). 
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flanking constant exons 7 and 8 at the distal end and exons 10 and 11 at the 
proximal end into a UAS reporter construct and generated a transgenic line at a 
defined genomic location using phiC31 recombination (Bischof et al., 2007; Venken 
et al., 2006). Using the phiC31 transformation system, allows insertion of modified 
reporter transgenes at exactly the same position to control for position effects. To be 
able to distinguish endogenous Dscam transcripts originating from the reporter 
transgene, a reporter sequence for reverse transcription was included.  
Analysis of a transgene inserted at the landing site at 76A2 on the third chromosome 
revealed that it recapitulated the splicing pattern observed from endogenous Dscam 
when expressed with elavGAL4 (Figures 42A; Lane 3 and 43B). 
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Figure 42: Development of a Dscam exon 9 reporter transgene recapitulating endogenous exon 9 
splicing (A) Analysis of endogenous Dscam exon 9 splicing pattern using RNA extracted from 14-18 h 
old Canton S (Lane 1) and elavGal4/UAS Dscam 9L (Lane 2) embryos; and exogenous Dscam exon 9 
splicing pattern in elavGal4/UAS Dscam 9L embryos (Lane 3). Dscam exon variants were separated 
as explained in figure legend 22. Samples were run on an 8% denaturing polyacrylamide gel. (B) 
Western blot confirming expression of UAS Dscam 9L trasngene driven by elavGal4. M=50bp ladder 
(NEB). 
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CHAPTER 4 
DISCUSSION 
 
The most striking feature about the Dscam gene is its enormous molecular diversity 
generated by mutually exclusive splicing of its four variable exon clusters, namely 4, 
6 and 9 and 17 comprising 12, 48, 33 and 2 variable exons, respectively. Although, 
all exons in the variable clusters have splice sites comparably similar to the 
consensus sequence, only one exon is included at a time and no splicing together of 
adjacent exons is observed (Schmucker et al., 2000). It is still unclear how these 
exon clusters are kept in a repressed state and how inclusion of specific exons by 
release of this repression is regulated.  Particularly intriguing, pathogen exposure in 
mosquitoes results in a change of AgDscam splicing pattern favouring inclusion of 
isoforms that show higher binding affinity towards pathogen recognition (Dong et al., 
2006). These experiments suggest that Dscam splicing is under strict regulation by 
exogenous and endogenous cues. In the immune system, these cues are pathogens, 
which are recognized by Dscam and endocytosed by haemocytes and in the nervous 
system they are the neighbouring neurons that need to acquire a different 
complement of Dscam isoforms to allow for axon bifurcation in mushroom body 
neurons and generation of overlapping dendritic fields in dendritic arborization 
sensory neurons (Dong et al., 2006; Matthews et al., 2007; Zhan et al., 2004).   
The work described in the present thesis established a method to analyze Dscam 
splicing in the variable exon clusters where all exons have nearly the same length, 
but have sequences divergent enough to allow their separation on denaturing 
acrylamide gels by prior digestion with restriction enzymes. With this approach, the 
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exon 4 cluster was completely resolved and more than 50% of the exon 9 variants 
could be separated. However, the exon 6 cluster resolution was limited due to the 
large number of variables. The main limiting factor in exon 6 cluster is the short 
lengths of individual exon variants and their limited sequence variability, thus limiting 
the choice of restriction enzymes. Given that next generation sequencing techniques, 
(e.g. Illumina and 454 sequencing) are becoming cost effective, they can be applied 
to analyze Dscam splicing. One limitation to apply e.g. Illumina sequencing for 
amplicon analysis is the large capacity these machines have been currently designed 
for requiring combining multiple samples that are identified by unique bar codes. Next 
generation sequencing would also aid in recognizing the unexpected bands that were 
observed during the study, which could either be PCR artifacts or sequence 
associated mobility shifts. It is highly unlikely that the unexpected bands could be 
generated due to polymorphisms, resulting in generation or omission of a restriction 
site, because an almost identical Dscam splicing pattern was observed between 
numerous different strains.  
A key feature of Dscam in mosquitoes is the change in its splicing pattern on 
pathogen exposure (Dong et al., 2006), and it was demonstrated that pathogen 
exposure also induced changes in Dscam splicing in Drosophila. Contrary to the 
expectation, however, the changes observed in Dscam splicing in Drosophila were 
rather mild with either heat inactivated or untreated E. coli resulting in differential 
regulation of only a few exons.  
It remains to be shown that the isoforms that were highly upregulated show very high 
binding affinity with the treated E. coli. Adaptation to pathogen exposure by 
producing high affinity pathogen binding isoforms has also been observed in crayfish. 
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Moreover, coating pathogens with these high affinity binding isoforms allows the 
pathogens to escape phagocytosis (Watthanasurorot et al., 2011). Thus, Dscam 
splicing across arthropods appears to have a common feature of being sensitive to 
pathogenic triggers such that they alter Dscam diversity to generate a repertoire that 
allows better recognition, stronger binding and effective defense to the host against 
the invading pathogen.  
Dscam splicing pattern changes upon pathogen exposure or in certain developing 
neurons to unique signatures of variable exons for immune defense or neuronal 
wiring, respectively (Dong et al., 2006; Matthews et al., 2007; Neves et al., 2004). 
However, it was found that the Dscam splicing pattern in individual flies is quite 
robustly maintained and seems not to change between individuals. This suggested 
that variation in Dscam splicing might be specific to certain cell types such 
haemocytes, mushroom body neurons and da sensory neurons. A different mode of 
Dscam splicing regulation is indeed indicated from the analysis of projection of 
mechanosensory neurons in the ventral nerve cord. Here, reduced Dscam variability 
results in projection defects, which intriguingly had no effect on axon branching in 
mushroom body neurons. These results indicate that isoforms, specific to certain 
neurons, have counterparts in the areas where these neurons project to establish 
connectivity with their target cells (Chen et al., 2006). In this context, Dscam would 
acquire a cell type specific splicing pattern, which would need to be recapitulated in 
those cells located in the remote location in the brain. Since many neurons and also 
their precursors migrate during neuronal development, a common origin could result 
in the same Dscam splicing pattern. For example, segmental identity generated by 
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hox gene expression might be sufficient to generate a regionalized Dscam spliceform 
repertoire. 
The very reproducible splicing pattern observed in various developmental contexts, 
makes it possible to interrogate the regulation of Dscam splicing by using mutants in 
various candidate genes for splicing regulation. One such candidate that was 
analyzed is ago1, which has similar developmental defects in the nervous system as 
Dscam (Kataoka et al., 2001). 
Argonautes are further attractive candidates as they suggest an RNA mediated 
mechanism involved in reinforcement of splicing to a specific isoform upon encounter 
of a trigger via a relay of signal from the cell surface to the nucleus. Further analysis 
of mutants in genes involved in RNA mediated regulation and over expression of a 
single isoform did not further support such a hypothesis of an RNA mediated 
mechanism in canalization of Dscam diversity. Rather, the effect of Argonautes, as 
well as of other factors identified in this study in the regulation of Dscam splicing are 
cluster specific suggesting unique regulatory mechanisms directed by cluster 
dedicated factors. In Giardia lamblia, an RNAi mechanism is involved in generating 
diversity of variant-specific surface protein (VSP) genes. Here, all VSP genes are 
transcribed at a similar rate but except for a single transcript, all others are degraded 
by RNAi. From time to time, expression of VSP protein switches from one to another 
by changing the transcript complements degraded by RNAi (Prucca et al., 2008). 
Such a mechanism could potentially also apply to generate Dscam diversity. If this 
was the case, it could be expected that different Dscam isoforms would have different 
half lives resulting in different levels of inclusion of variable exons. When analyzing 
stability of Dscam isoforms, however no evidence for such a mechanism.  
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elav mutants show nervous system defects similar to Dscam mutants (Simionato et 
al., 2007) and indeed it was found that Dscam splicing regulation is particularly 
affected in exon 9 cluster. Analysis of the sequence in exon 9 cluster together with 
the lack of experimental evidence so far obtained for the identification of ELAV 
targets argues that elav regulates Dscam splicing indirectly. Indeed, many of genes 
differentially regulated in elav mutants encode for regulators of gene expression 
involving RNA binding proteins, DNA binding proteins and chromatin remodeling 
factors.  Analysis of Dscam exon 9 splicing by mutants of such genes revealed that 
Dscam splicing is very sensitive to changes in mutants of regulators of gene 
expression. Intriguingly, many exons were observed to be upregulated or 
downregulated in a specific set of mutants. However, none of the mutants regulated 
the splicing of just one exon variant. The screen revealed that Dscam splicing is very 
sensitive to genetic perturbation.  
 
4.1. Future work 
Given the biological complexity of higher vertebrates, it is assumed that mammalian 
genes involved in development of the nervous system are more in number and more 
complex than invertebrate genes. Dscam is an exceptional example of a highly 
complex gene in relatively simple arthropods. Despite vast structural differences 
between the insect Dscam and mammalian DSCAM, they share important roles in 
neuronal patterning. Understanding the molecular mechanisms of Dscam function in 
different organisms and species would reveal important clues about the evolution of 
CAMs into recognition units involved in neural wiring and immune recognition.  
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The key to understanding the dual role of Drosophila Dscam in the immune and 
nervous systems lies in its unique mechanism of generating extraordinary diversity. It 
is still unclear, which external cues trigger a change in alternative splicing of Dscam. 
Also, a unique mechanism whereby a neuronal or pathogenic trigger may result in 
the selection of a specific exon or set of exons in each variable cluster is unknown. 
Last but not the least, it would be interesting to determine if the Dscam sequence 
itself has a role to play in exon selection. 
It is crucial to find an external cue which would trigger a signal for change in 
Drosophila Dscam alternative splicing. S2 cells could be exposed to pure microbial 
cell surface determinants such as lipopolysaccharides or peptidoglycans and 
analyzed for changes in Dscam alternative splicing. Isoforms undergoing a change in 
inclusion can be silenced in S2 cells to test their ability to phagocytose pathogens 
expressing the specific cue.  Contrarily, pathogens that are mutant for the specific 
cue can be used to challenge S2 cells to observe, possibly, no splicing changes in 
the affected alternative exons. An alternative approach of investigating the role of 
Dscam in the Drosophila immune system could be to expose flies, mutant for genes 
that play a role in the immune system (e.g. imd, relish, dorsal and Myd88) with live or 
attenuated pathogens and subsequently test for Dscam splicing changes in their 
haemocytes. 
In this study, an exon 9 reporter transgene (UAS Dscam 9L), expressed 
heterologously, has been shown to recapitulate endogenous exon 9 splicing pattern, 
which suggests that the information regulating exon 9 alternative splicing lies within 
the cluster sequence itself. To further speculate which sequence elements within the 
cluster are crucial for selection of particular exon variants, different sequence altering 
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strategies may be adopted. Firstly, deletion of combinations of consecutive introns 
and exons such as, deletion of an intron and its preceeding or succeeding exon or an 
exon and its flanking introns, resulting in fusion of two alternate exons, may affect 
splicing of neighbouring exons. Secondly, reversing the sequence of an intron may 
influence the splicing of its adjoining exons. Thirdly, mutating the sequence of a 
particular intron could disrupt its RNA secondary structure which may alter the 
splicing of its flanking exons. Finally, swapping selective intronic sequences of one 
variable cluster into another may regulate its default splicing pattern such that an 
intron, which causes enhanced inclusion of a particular exon 4 variant, when inserted 
in the exon 9 cluster before or after an exon variant showing low expression, may 
allow enhanced splicing of that exon 9 variant. Such an approach may help in 
understanding whether intronic or exonic sequences are important for selection of a 
particular Dscam exon variant. 
Dscam is an extrodinary model to understand how a single gene plays vital roles in 
the nervous and immune systems. Unravelling the enigma around the splicing 
mechanism of this unique pattern recognition receptor may throw light on unexplored 
mechanisms of immune defence in vertebrates. 
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Appendices 
 
 
A1. Separation of Dscam 4 variants. The table shows all Dscam exon 4 variants, 
their annotated lengths, identifying enzymes and expected lengths on a denaturing 
polyacrylamide gel after restriction digest. 
 
Exon Variable no. Variable length Enzyme Fragment size 
     
4 2 162 - 238 
4 3 162 MboI 173 
4 5 162 TaqI 157 
4 7 162 TaqI 152 
4 1 162 TaqI 151 
4 8 171 MboI 124 
4 4 171 TaqI 123 
4 12 171 HinP1I 106 
4 10 171 TaqI 79 
4 6 162 HinP1I 67 
4 11 159 TaqI 64 
4 9 168 AluI 61 
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A2. Separation of Dscam 9 variants. The table shows all Dscam exon 9 variants, 
their annotated lengths, identifying enzymes and expected lengths on a denaturing 
polyacrylamide gel after restriction digest. 
 
 
 
 
Exon  Variable no. Variable length Enzyme Fragment size 
          
9 24 288 Haelll 261 
9 13 299 Mspl 253 
9 22 288 Mspl 241 
9 21 288 HpyCH4lV 233 
9 19 288 Haelll 231 
9 20 288 HpyCH4lV 197 
9 6 291 Xmnl 174 
9 23 288 Mspl 169 
9 25 288 Xmnl 158 
9 2 288 Haelll 151 
9 14 288 BstNl 134 
9 15 288 BstNl 134 
9 28 288 BstNl 134 
9 11 291 HpyCH4lV 132 
9 26 288 Mspl 109 
9 17 288 BstNl 108 
9 4 288 Mspl 107 
9 16 291 BstNl 99 
9 18 288 BstNl 99 
9 27 288 BstNl 99 
9 1 306 Haelll 90 
9 10 291 BstUl 87 
9 5 291 Mspl 85 
9 33 294 HpyCH4lV 82 
9 7 291 BstUl 73 
9 31 285 HpyCH4lV 67 
9 8 291 Haelll 66 
9 12 285 Haelll 63 
9 29 294 Mspl 52 
9 3 288 BstNl 33 
9 9 291 BstUl 33 
9 32 279 BstNl 33 
9 30 288 BstUl 32 
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A3. Separation of Dscam 6 variants. The table shows all Dscam exon 6 variants, 
their annotated lengths, identifying enzymes and expected lengths on a denaturing 
polyacrylamide gel after restriction digest. 
 
 
Exon  Variable no. Variable length Enzyme Fragment size 
          
6 20 124  - 152 
6 29 124 Alul 145 
6 32 121 Alul 136 
6 1 124 BstNI 127 
6 2 124 AluI 124 
6 26 124 Alul 124 
6 37 124 BstNl 121 
6 46 124 BstNl 121 
6 13 127 Alul 104 
6 21 124 Alul 101 
6 6 124 BstNl 100 
6 22 124 Alul 95 
6 24 124 BstNl 94 
6 9 124 Alul 93 
6 19 124 Alul 92 
6 44 124 Taql 91 
6 41 124 BstUl 89 
6 11 118 Alul 87 
6 8 124 Mbol 86 
6 16 124 Mspl 84 
6 10 124 BstUl 83 
6 23 124 Mbol 81 
6 3 124 BstUI 75 
6 5 124 BstUl 75 
6 30 124 Taql 74 
6 45 124 Alul 74 
6 36 124 Alul 72 
6 39 124 Alul 67 
6 18 124 Mbol 66 
6 15 124 BstUl 65 
6 28 124 Mspl 62 
6 47 116 Mspl 61 
6 35 124 BstUl 58 
6 17 124 Mbol 57 
6 7 124 Mbol 53 
6 25 124 Mbol 53 
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6 27 124 Mbol 53 
6 38 124 Alul 52 
6 33 127 Alul 46 
6 40 128 Alul 46 
6 42 124 Alul 46 
6 48 121 Alul 46 
6 43 124 BstNl 42 
6 12 124 Alul 37 
6 14 127 Mbol 37 
6 34 121 Taql 37 
6 4 133 Mspl 31 
6 31 121 Mspl 31 
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A4. Crossing scheme showing generation of zygotic ago1 mutants 
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A5. Crossing scheme showing generation of zygotic rrp6 mutants 
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A6. Crossing scheme showing generation of zygotic elav mutants 
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A7. Crossing scheme showing generation of ago1/Df; ago2/ago2 double mutants 
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A8. Crossing scheme showing generation of ago1/Df; rrp6/Df double mutants 
 160 
A9. Crossing scheme showing generation of ago1 zygotic and maternal mutants 
 161 
continued… 
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A10. Crossing scheme showing generation of rrp6 zygotic and maternal mutants 
 163 
continued… 
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A11. Analysis of Dscam exon 9 splicing in mutants of genes that are differentially 
regulated in elav mutants. (A) Analysis of Dscam exon 9 splicing pattern using RNA 
extracted from 14-18 h old mutant embryos of CG9418 (Lane 3), CG3995 (Lane 4), 
CG8149 (Lane 5), sirt7 (Lane 7) and set (Lane 9). Canton S embryos served as 
control (Lane 1). Lanes with red crosses were not included in the analysis. Dscam 
exon variants were separated as explained in figure legend 22. Samples were run on 
an 8% denaturing polyacrylamide gel. M=phiX174 DNA/HinfI marker (Biotools). 
 
A 
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(B) Analysis of Dscam exon 9 splicing pattern using RNA extracted from 14-18 h old 
mutant embryos of zuc (Lane 3), snr1 (Lane 4), squ (Lane 5), his2AV (Lane 6), dek 
(Lane 7), spt4 (Lane 8), not (Lane 9) and df-31 (Lane 10). Canton S embryos served 
as control (Lane 1). Lanes with red crosses were not included in the analysis. Dscam 
exon variants were separated as explained in figure legend 22. Samples were run on 
an 8% denaturing polyacrylamide gel. M=phiX174 DNA/HinfI marker (Biotools). 
B 
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(C) Analysis of Dscam exon 9 splicing pattern using RNA extracted from 14-18 h old 
mutant embryos of neos (Lane 3), zf30c (Lane 4), geminin (Lane 5), CG3523 (Lane 
6), CG8108 (Lane 7) and msl-1 (Lane 8). Canton S embryos served as control (Lane 
1). Lanes with red crosses were not included in the analysis. Dscam exon variants 
were separated as explained in figure legend 22. Samples were run on an 8% 
denaturing polyacrylamide gel. M=phiX174 DNA/HinfI marker (Biotools). 
C 
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(D) Analysis of Dscam exon 9 splicing pattern using RNA extracted from 14-18 h old 
mutant embryos of hel25E (Lane 3), d-elp1 (Lane 4), CG15514 (Lane 5), CG14965 
(Lane 6), CG9293 (Lane 7), CG8460 (Lane 8), CG4266 (Lane 9) and CG9512 (Lane 
10). Canton S embryos served as control (Lane 1). Lanes with red crosses were not 
included in the analysis. Dscam exon variants were separated as explained in figure 
legend 22. Samples were run on an 8% denaturing polyacrylamide gel. M=phiX174 
DNA/HinfI marker (Biotools). 
D 
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(E) Analysis of Dscam exon 9 splicing pattern using RNA extracted from 14-18 h old 
mutant embryos of pnn (Lane 3), CG6650 (Lane 4), top2 (Lane 5), CG3797 (Lane 6), 
sfmbt (Lane 7), mcm7 (Lane 8) and nufip (Lane 9). Canton S embryos served as 
control (Lane 1). Lanes with red crosses were not included in the analysis. Dscam 
exon variants were separated as explained in figure legend 22. Samples were run on 
an 8% denaturing polyacrylamide gel. M=phiX174 DNA/HinfI marker (Biotools). 
E 
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(F) Analysis of Dscam exon 9 splicing pattern using RNA extracted from 14-18 h old 
mutant embryos of xl6 (Lane 2), mcm10 (Lane 3), CG14710 (Lane 5) and sup-07 
(Lane 8). Canton S embryos served as control (Lane 1). Lanes with red crosses were 
not included in the analysis. Dscam exon variants were separated as explained in 
figure legend 22. Samples were run on an 8% denaturing polyacrylamide gel. 
M=phiX174 DNA/HinfI marker (Biotools). 
 
F 
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(G) Analysis of Dscam exon 9 splicing pattern using RNA extracted from 14-18 h old 
mutant embryos of CG3238 (Lane 6), swa (Lane 8), cathD (Lane 9), CG12877 (Lane 
10) and CG8378 (Lane 11). Canton S embryos served as control (Lane 1). Lanes 
with red crosses were not included in the analysis. Dscam exon variants were 
separated as explained in figure legend 22. Samples were run on an 8% denaturing 
polyacrylamide gel. M=phiX174 DNA/HinfI marker (Biotools). 
G 
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(H) Analysis of Dscam exon 9 splicing pattern using RNA extracted from 14-18 h old 
mutant embryos of tip60 (Lane 3), kdm4a (Lane 4), caf-1 (Lane 5), CG2051 (Lane 6), 
CG9883 (Lane 7), hp5 (Lane 8), chrac-14 (Lane 9), beaf-32 (Lane 10), rox-8 (Lane 
11), ball (Lane 13), jigr-1 (Lane 16), rpd3 (Lane 18) and iswi (Lane 19). Canton S 
embryos served as control (Lane 1). Lanes with red crosses were not included in the 
analysis. Dscam exon variants were separated as explained in figure legend 22. 
Samples were run on an 8% denaturing polyacrylamide gel. M=phiX174 DNA/HinfI 
marker (Biotools). 
 
H 
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A12. List of primers 
 
Primer Name Primer sequence 
Primers used to amplify Dscam variable exon 
clusters 
 
Dscam YH 3F2 GCAACCAGTTCGGAACCATTATCTCC 
Dscam YH 5R1 CCAGAGGGCAATACCAGGTACTTTC 
Dscam YH 5F1 GCCACAAAAGGACGATTGGTCATCACAG 
Dscam YH 7R1  CGGGTTGTTCCTACGATGAACTTGTACCAT 
Dscam YH 8F1 GATCTCTGGAAGTGCAAGTCATGG 
Dscam YH 10R1  GGCCTTATCGGTGGGCACGAGGtTCCATCTGGGAGGTA 
Dscam YH 16F1 GAATACGACTTTGCCACCTTAACCGTTAC 
Dscam YH 18R1 CCCATTGTCTGATTGTAAACTACATCG 
Dscam YH 11RT1 CGGAGCCTATTCCATTGATAGCCTCGCACAG 
Primers used to clone pAc5.1A Dscam Mut  
Exons 4-9 
 
Dscam cDNA end F1 Not1 EcoRV 
 
GTGCTGCGGCCGCGATATCCCGCCAACTGTGCCGAAGAGG
ACCAATATCG 
Dscam cDNA end R1  
 
AAATGCCACGCCCACCGCCGCAGAGGGCGCTTACAAATTA
CACTG 
Dscam 6kb frag F1  AAATGTTTTTGTACATCAATTTTCGTGTCTGTGGTCCG 
Dscam 6kb frag R1 Xho Spe GCGTCCTCGAGACTAGTCTGATAACTGCTCCCGCTGATCCT
GCTAATCCCTTG 
Dscam 5’UTR1 F1 BsrGI SalI BglII 
 
GCGTCTGTACAGTCGACAGATCTAGAACCGGATTTCAGCGC
TAGTCGGCG 
Dscam 5’UTR1 R1 ATTGTTAACACTCACACACACACACTTGTGAGAGTGGTG 
Dscam 5’UTR2 F2 TAATCGCATTTAAAAAACAATTTGGCCAGCCGCAG 
Dscam 5’UTR2 R2 Not1 EcoRV 
 
GCGTCGCGGCCGCGATATCTCGGGCATGGGATTGCCGCTG
GCCTTG 
Dscam Exon 1-4 F1 Xho NotI Xba HindIII Ase GCGTCCTCGAGACGCGGCCGCAGTCTAGAATAAGCTTGCA
TTAATCGCATTTAAAAAACAATTTGGCCAGCCGCAG 
Dscam Exon 1-4 R1 BsrGI 
 
GATATCGGCGCCGTAAAACTGATTCACAACGGCTCGCACAT
GTACATCCCGG 
Dscam Exon 4-5 F1 BsrG1 
 
CCGGGATGTACATGTGCGAGCCGTTGTGAATCAGTTTTACG
GCGCCGATATC 
Dscam Exon 4-5 R1 GTCGTCCTTTTGTGGCACTTAATCGGGTTTCTCCG      
Dscam Exon 1-4 F1 Xho NotI Xba HindIII Ase 
 
GCGTCCTCGAGACGCGGCCGCAGTCTAGAATAAGCTTGCA
TTAATCGCATTTAAAAAACAATTTGGCCAGCCGCAG 
Dscam Exon 4-5 R1 GTCGTCCTTTTGTGGCACTTAATCGGGTTTCTCCG      
Dscam Exon 5-7 F1 
 
TAGTCATCACAGAGCCCGTTAGCAGTAGTCCGCCCAAAATC
AATG         
Dscam Exon 5-7 R1 NgoMIV Spe Mlu BglII EcoRI 
 
GCGTCGAATTCAGAGATCTGCACGCGTAGACTAGTGCGCC
GGCGACGCACTTGAGGAATACACTTGGTCCGGGTTCCATG 
Dscam Exon 7-8 F1 NgoMIV GCGAGTGCTGAGCTGAAGCTCGGAGGCCGTTTCG 
Dscam Exon 7-8 R1 GAGATCCTCGAGCAGAGTATCCTTCCTGATTCTTGGC   
Dscam Exon 8-13 F1 
 
TAGAAGTGCAAGTCATGGTTCCACCCAAAATTACGCCCTTC
GACTTCG 
Dscam Exon 8-13 R1 EcoRI GTTGGCACTGAATTCGACGCCCTTGATCTTCCATGTG 
Primers used to validate presence of FRT sites  
pUChsneoF1 GCCGCTTTTCTGGATTCATCGACTGTG 
pUChsneoR1 CGATTCCGAAGCCCAACCTTTCATAG 
FRT F1 CAAAGCGTTTCCGAAAACGAGCGCTTCC 
Car3'invR1 GCATGTCCGTGGGGTTTGAATTAACTC 
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A13: List of fly stocks 
 
Genotype of fly lines Source 
Genes differentially regulated in elav mutants  
y
1
 w
67c23
; P{SUPor-P}CG9418
KG05183        
 Bloomington 
y[1] w[67c23]; P{w[+mC] y[+mDint2]=EPgy2}CG3995[EY03827] Bloomington 
y[1] w[67c23]; P{y[+t7.7] w[+mC]=wHy}CG8149[DG19311] Bloomington 
y[1] w[67c23] P{y[+m8]=Mae-UAS.6.11}Tip60[GG01739] Bloomington 
w[1118]; Sirt7[5.Scer\SceI.RS] Bloomington 
y[1] w[67c23]; P{y[+mDint2] w[BR.E.BR]=SUPor-P}Kdm4A[KG04636] Bloomington 
y[1] w[67c23]; P{w[+mC] y[+mDint2]=EPgy2}Set[EY09821] Bloomington 
y[1] w[67c23]; P{y[+t7.7] w[+mC]=wHy}Caf1[DG25308] Bloomington 
y[1] w[67c23]; P{w[+mC] y[+mDint2]=EPgy2}CG2051[EY21697] Bloomington 
y[1] w[*]; P{w[+mC]=EP}CG9883[G17999] Bloomington 
y[1] w[67c23] P{w[+mC] y[+mDint2]=EPgy2}HP5[EY10901] Bloomington 
y[1] w[67c23]; P{y[+mDint2] w[BR.E.BR]=SUPor-P}mus201[KG01051] Chrac-14[KG01051] Bloomington 
y[1] w[67c23]; P{y[+mDint2] w[BR.E.BR]=SUPor-P}BEAF-32[KG06904] Bloomington 
y[1] w[67c23]; P{w[+mC]=GSV1}His2Av[GS3052]/TM3, Sb[1] Ser[1] Kyoto 
P{ry[+t7.2]=PZ}Rpd3[04556] ry[506]/TM3, ry[RK] Sb[1] Ser[1] Bloomington 
PBac{RB}Rpd3[e01851] Harvard 
y[1] w[67c23]; P{y[+mDint2] w[BR.E.BR]=SUPor-P}Iswi[KG03354] Bloomington 
P{ry[+t7.2]=PZ}Snr1[01319] ry[506]/TM3, ry[RK] Sb[1] Ser[1] Bloomington 
w[*]; His2Av[810]/TM3, Sb[1] Bloomington 
y[1] w[67c23]; P{w[+mC]=lacW}Dek[k09907]/CyO Bloomington 
y[1] w[67c23]; P{w[+mC]=lacW}spt4[k05316]/CyO Bloomington 
y1 w67c23; P{wHy}notDG24306/TM3, Sb1 Ser1 Bloomington 
y1 w67c23; P{GSV6}GS16660/SM1 Kyoto 
y[1] w[67c23]; P{w[+mC]=lacW}geminin[k14019]/CyO Bloomington 
msl-1[gamma216] cn[1] bw[1]/CyO Bloomington 
y[1] w[*]; P{y[+m8]=Mae-UAS.6.11}Top2[LA00892] Bloomington 
y[1] w[*]; P{w[+mC]=EP}Sfmbt[G2280]/CyO Bloomington 
w[1118]; PBac{w[+mC]=WH}Mcm7[f03462] Bloomington 
y[1] w[67c23]; P{y[+mDint2] w[BR.E.BR]=SUPor-P}Mcm10[KG00233] Bloomington 
y[1] sc[*] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.HMS00608}attP2/TM3, Sb[1] Bloomington 
PBac{RB}jigr1[e03251] Harvard 
y[1] w[67c23]; P{w[+mC]=lacW}zf30C[k02506]/CyO Bloomington 
w[1118]; P{w[+mC]=EP}CG15514[EP1005]/TM6B, Tb[1] Bloomington 
y[1] w[67c23]; P{y[+mDint2] w[BR.E.BR]=SUPor-P}CG14965[KG05766] ry[506] Bloomington 
w[1118]; PBac{w[+mC]=WH}CG14710[f06000] Bloomington 
w[1118]; P{w[+mC] y[+mDint2]=EPgy2}CG8378[EY04267]/CyO, 
P{ry[+t7.2]=sevRas1.V12}FK1 
Bloomington 
w*; P{GawB}Rox8NP0528 / TM3, Ser1 Kyoto 
w[1118]; PBac{w[+mC]=WH}CG12877[f01800] Bloomington 
zuc[RS49] cn[1] bw[1]/CyO, l(2)DTS513[1] Bloomington 
squ[PP32] cn[1] bw[1]/CyO, l(2)DTS513[1] Bloomington 
y1 w67c23; P{lacW}Hel25Ek11511/CyO Bloomington 
y1 w67c23; P{EPgy2}EY06979 Bloomington 
y[1] w[67c23]; P{y[+m8]=Mae-UAS.6.11}Nufip[DP00363]/TM3, Sb[1] Bloomington 
y[1] w[*]; P{w[+mC]=EP}CG4266[G7664] Bloomington 
y[1] w[67c23]; P{w[+mC]=lacW}x16[k00230]/CyO Bloomington 
y1 w67c23; P{EPgy2}CG3238EY10295 Bloomington 
v[1] swa[1]/FM3 Bloomington 
w[1118]; P{y[+mDint2] w[BR.E.BR]=SUPor-P}CG3523[KG03696]/CyO, 
P{ry[+t7.2]=sevRas1.V12}FK1 
Bloomington 
y[1] w[1118]; PBac{y[+mDint]=3HPy[+]}CG6650[C151] Bloomington 
y[1] w[*]; P{w[+mC]=EP}CG3797[G8880] Bloomington 
y[1] w[*]; P{w[+mC]=EP}CG8460[G18835] Bloomington 
C(1;Y)1, y[1] P{y[+mDint2] w[BR.E.BR]=SUPor-P}Flo-2[KG00162]/C(1)DX, y[1] f[1]; ry[506] Bloomington 
w[1118]; P{w[+mC]=EP}cathD[EP2151] Bloomington 
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y[1] w[67c23]; P{w[+mC] y[+mDint2]=EPgy2}CG8108[EY14316]/TM3, Sb[1] Ser[1] Bloomington 
y1 w67c23; P{EPgy2}CG9293EY13364 Bloomington 
PBac{PB}CG10535c00296 Harvard 
y1 w1118; P{lacW}NeosL2249/TM3, Ser Bloomington 
Genes affecting cell signaling  
y* w*; P{GawB}DscamNP3327/CyO, P{UAS-lacZ.UW14}UW14 Kyoto 
w1118; P{RS3}DscamCB-0486-3 Kyoto 
P{XP}Dscamd10584 Harvard 
y1 w67c23; P{EPgy2}DscamEY08820 Bloomington 
y* w*; P{neoFRT}40A P{FRT(whs)}G13 PBac{SAstopDsRed}LL01770 cn1 bw1/CyO, 
S* bw1 
Kyoto 
PBac{RB}Dscame04629 Harvard 
Genes involved in mRNA methylation  
y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.GL01126}attP2/TM3, Sb[1] Bloomington 
w[1118]; PBac{w[+mC]=RB}CG7818[e00875] Bloomington 
w[1118]; PBac{w[+mC]=PB}CG14906[c00109] CG14907[c00109] Bloomington 
y, w; dMTr1/dMTr1 Soller Lab 
y, w; dMTr2/dMTr2 Soller Lab 
RNA pol II processivity mutant  
v
1
 RpII215
4
 Bloomington 
Dscam exon 9 reporter transgene  
w; UAS Dscam 9L Y Hemani, this study 
Lines used in generation of germline clones  
y
1
 w
67c23
; P{lacW}AGO1
k08121
/CyO Bloomington 
w
1118
; Df(2R)BSC307/CyO Bloomington 
PBac{WH}Rrp6f07001 Harvard 
w
1118
; Df(3R)Exel6275, P{XP-U}Exel6275/TM6B, Tb
1
 Bloomington 
w
1118
; P{FRT(w
hs
)}G13 L
*
/SM6a Bloomington 
y, w; Sco/CyO Soller Lab 
P{ry[+t7.2]=hsFLP}22, w[*] Bloomington 
w, elav
e5
,UAS CD8 GFP FRT19A/FM7iGFP; 201Y, RBP9/CyOGFP Soller Lab 
w, elav
e5
, FRT19A/FM7iGFP; elav ELAV
OH NLS
/SM6Roi  Soller Lab 
P{FRT(w
hs
)}G13 P{ovoD1-18}2R/T(1;2)OR64/CyO Bloomington 
y
1
 w
*
; P{neoFRT}82B Sb
1
/TM6 Bloomington 
Sco/SM6; PrDr/TM3SerGFP Soller Lab 
y, w, sn, ewg
 l1
/FM7iGFP; hsGAL4/TM3SbGFP Soller Lab 
y, w, sn, ewg 
l1
/FM7iGFP/Yy
+
; hsGAL4/TM3SerGFP Soller Lab 
FM7i/Y; PrDr/TM3SerGFP Soller Lab 
w
*
; P{neoFRT}82B P{ovoD1-18}3R/st
1
 βTub85D
D
 ss
1
 e
s
/TM3Sb
1
 Bloomington 
y, w; Sco/CyOGFP; PrDr/TM3Sb Soller Lab 
Genes involved in small RNA processing  
y
1
 w
67c23
; P{lacW}AGO1
k08121
/CyO Bloomington 
w
1118
; Df(2R)BSC307/CyO Bloomington 
PBac{WH}Rrp6f07001 Harvard 
w
1118
; Df(3R)Exel6275, P{XP-U}Exel6275/TM6B, Tb
1
 Bloomington 
w*; AGO2
414
 Harvard 
w
*
; trf4 1-3 Soller Lab 
elav[4] w[*]/FM6, w[*] ct[*]/Dp(1;Y)y[+]sc Soller Lab 
Lines expressing embryonic GFP marker  
w
*
 baz
4
 P{FRT(w
hs
)}9-2/FM7a, P{Dfd-GMR-nvYFP}1 Bloomington 
w
*
; noc
Sco
/CyO, P{Dfd-GMR-nvYFP}2 Bloomington 
w
*
; ry
506
 Dr
1
/TM3, P{Dfd-GMR-nvYFP}3, Sb
1
 Bloomington 
w
*
; ry
506
 Dr
1
/TM6B, P{Dfd-GMR-nvYFP}4, Sb
1
 Tb
1
 ca
1
 Bloomington 
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